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Osteoarthritis (OA), the most prevalent form of joint disease, afflicts nine percent of the US pop-
ulation over the age of thirty and costs the economy nearly $100 billion annually in healthcare
and socioeconomic costs. It is characterized by joint pain and dysfunction, though the pathophys-
iology remains largely unknown. The progressive loss of cartilage followed by inadequate repair
and remodeling of subchondral bone are common hallmarks of this degenerative disease. Due to
its avascular nature and limited cellularity, articular cartilage exhibits a poor intrinsic healing re-
sponse following injury. As such, significant research efforts are aimed at producing engineered
cartilage as a cell-based approach for articular cartilage repair. However, the knee joint is mechan-
ically demanding, and during injury, also a milieu of harsh inflammatory agents. The unforgiving
mechanochemical environment requires constructs that are capable of bearing such burdens.
To this end, previous work in our laboratory has explored the application of stimuli inspired by
the native joint environment in attempts to create tissue with functional properties similar to native
cartilage so that it may restore loading to the joint. While we have had success at producing these
replacement tissues, there is little evidence in the literature that the biological functionality (i.e.
response to in vivo-like conditions) of engineered cartilage matches native cartilage. Therefore, in an
effort to provide a more complete characterization of the functional nature of developing tissues and
facilitate their use clinically, the overarching motivation of the work described in this dissertation
is two-fold: 1) characterize the response of engineered cartilage to chemical and mechanical injury;
and 2) develop strategies for enhancing the performance and protection of engineered cartilage for
in vivo success.
Studies in the literature have extensively characterized the effects of wounding to native articular
cartilage as well as the effects of an inflammatory environment. For mechanical injuries, cell death
is immediate and progressive, ultimately leading to failure of the tissue. Chemical insult has been
shown to promote degradation of the matrix components, also leading to failure of the tissue. Under
a controlled application of injury (mechanical and chemical), it was found that engineered cartilage,
in contrast to native cartilage, has the potential to repair itself following an injury event, as long
as there is no catastrophic damage to the matrix. Additionally, when this matrix is intact and
well-developed, engineered cartilage constructs exhibit a resistance to degradation, highlighting the
potential utility of engineered cartilage as replacement tissues.
Enhancing functionality in engineered cartilage was also explored, with the aim of developing
strategies to improve, repair, and protect engineered cartilage constructs for their use in vivo. For
these purposes, the studies in this dissertation spanned both 2D migration studies to influence the
limited wound repair potential of cells as well as 3D culture studies to explore the possibility of
protection effects at a tissue level. Together, these models allowed us to capture the complexity
needed to fully develop approaches for cartilage repair. Though it has previously been found that
applied DC electric fields modulate cell migration, we have developed a novel strategy of employing
this technique to screen for desirable populations of cells (those with the greatest capacity for
directed migration) to use in cartilage repair. We also found that the AQP1 water channel plays a
key role in mechanosensing the extracellular environment, highlighting the potential for its use in
therapeutic strategies.
For tissue engineering efforts at creating functional cartilage replacement, we uncovered novel
strategies to foster better tissue development via co-culture systems and promote the resistance of
engineered cartilage to catabolic factors. These findings motivate their potential use in therapeutics
and in tissue engineering efforts at creating clinically-relevant tissue-engineered constructs for the
treatment of OA or following injury.
The research described in this dissertation has characterized the biological functionality of engi-
neered tissues and identified strategies for enhancing their use in vivo by modulating the subsequent
response to injury, laying the foundation for their use in clinical applications.
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CHAPTER 1. INTRODUCTION 1
Chapter 1
Introduction
Articular cartilage exhibits a poor healing response following injury due to its avascular nature and
limited cellularity. The ensuing biochemical changes that accompany injurious events ultimately
lead to disruption and failure of tissue function. Significant research efforts are aimed at producing
engineered cartilage as a cell-based approach for articular cartilage repair. In an effort to provide
a more complete characterization of the functional nature of developing tissues and facilitate their
use clinically, the overarching motivation of the work described in this dissertation is two-fold: 1)
characterize the response of engineered cartilage to chemical and mechanical injury; and 2) develop
strategies for enhancing the performance and protection of engineered cartilage for in vivo success.
To guide this effort, the hypotheses and specific aims are first presented, accompanied by the
significance of this work. An overview of the literature on articular cartilage and the consequences of
injury, with an emphasis on potential cartilage tissue engineering repair strategies, is also provided.
1.1 Hypotheses and Specific Aims
The presented research contained in this dissertation is motivated by two interconnected themes
aimed at facilitating successful replacement of engineered cartilage (Figure 1.1). By first under-
standing the response of engineered cartilage to various modes of injury, strategies for developing
constructs, within the context of functional tissue engineering (FTE), may be facilitated. To this
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• Application of DC Electric fields for enhanced cell migration 
(Chapters 4, 5) 
• Co-culture with soluble factors for enhanced tissue development 
(Chapter 6) 
• Preconditioning with chemical factors to increase resistance to 





• Influence of IL-1 exposure on developing tissues (Chapter 2) 
• Dependence on type of mechanical insult and use of chondro-
protective medium to prevent cell death progression (Chapter 3)
Scope of thesis
Figure 1.1: Schematic of studies described in this dissertation
Hypothesis 1: Maturity of engineered cartilage dictates response to in vitro mechan-
ical insult in a manner similar to native cartilage.
Specific Aim 1a: To impose different modes of mechanical insult mimicking iatrogenic injury
(drilling, cutting, cracking) on engineered cartilage constructs of various maturity levels and
monitor the long-term response through bulk mechanical and biochemical properties.
Specific Aim 1b: To determine whether chondrogenic medium offers protection against imposed
mechanical insult by monitoring the spread of cell death in long-term culture.
While the response of native cartilage explants - mechanical breakdown and chemical degradation
- to mechanical insult has been well characterized with in vitro wounding studies, little is known as
to the reaction of tissue engineered cartilage to the same stimuli. These studies aim to complement
these explant injury studies by providing an initial characterization of the in vitro injury response
of engineered cartilage. The use of a tissue engineering model as the surrogate tissue permits in-
jury to be studied on engineered tissues spanning a range of mechanical and biochemical properties
that reflect tissue culture maturation. The rationale of this work is that elucidation of potential
failure mechanisms of engineered tissues that may occur after implantation in the defect site may
be important for optimization of implantation guidelines and tissue construct design criteria.
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Hypothesis 2: Applied DC electric field (EF) stimulation drives directed migration of
repair cells in a manner dependent on 1) extracellular environment and 2) cell presen-
tation. The results can be ascribed to particular populations such that galvanotaxis
can be used in identifying desirable populations of cells.
Specific Aim 2a: To identify the role of AQP1 in EF-induced cell migration.
Specific Aim 2b: To elucidate the mechanotransduction of osmotic loading on cells during EF-
induced migration.
Specific Aim 2c: To characterize the effect of EF on migration response for interleukin-1 (IL-1)
treated-chondrocytes and synovium derived stem cells (SDSCs).
Specific Aim 2d: To characterize the passage-dependent effect of EF on migration response of
potential repair cells (chondrocytes, SDSCs, bone marrow-derived stem cells (bMSCs)) from
different sources (bovine, canine, human).
As field gradients exist in both wound healing and developing embryos (Robinson, 1985), under-
standing the effect on repair cells of changing extracellular environment in the context of EF-induced
migration is crucial. The rationale of this work is two fold: First, we aimed to investigate the ef-
fects of extracellular environment on migrating cells under an applied field. As aquaporin-1 (AQP1)
water channels are important mechanosensors that work to regulate cell volume, it is vital to under-
stand their role during migration. The influence of AQP1 may be especially pronounced when cells
undergo osmotic shock. Within the context of an inflammatory environment, cell migration has
been reported to be limited as the addition of IL-1 to chondrocyte culture has been shown to result
in a decrease in cytoskeletal components (tensin, talin, paxillin, and FAK) that is concomitant with
the loss of chondrocyte phenotype as assessed by a decrease in type II collagen expression levels
(Vinall et al., 2002). The alteration in expression of signaling molecules that associate with integrin-
containing adhesions can adversely affect cellular motility and function (Vicente-Manzanares and
Horwitz, 2011). Furthermore, it has been shown that IL-1 alters the normal volumetric response
of chondrocytes to osmotic stress due to alterations to and remodeling of the F-actin cytoskeleton
(Pritchard et al., 2008).
Secondly, further characterization of how factors of age, species, and cell presentation affect mi-
gration potential may allow for the possibility of using this established protocol of EF stimulation
to identify potentially desirable cell populations.
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Hypothesis 3: Preconditioning of engineered cartilage constructs with chemical fac-
tors affords development of functional tissue.
Specific Aim 3a: To co-culture fledgling tissue engineered cartilage constructs with metaboli-
cally active fresh chondrocytes. Measure bulk mechanical properties and biochemical content
of constructs over long-term culture. Culture tissue engineered construct and 2D monolayer in
contact with one another and apart to identify the mode of signaling between the two popula-
tions.
Specific Aim 3bi: To preexpose cartilage constructs to a low dose of interleukin to increase
resistance against the catabolic agent. Following preexposure period, expose constructs to
a dose of interleukin known to elicit tissue degradation and glycosaminoglycan breakdown.
Measure bulk mechanical properties and biochemical content of constructs before preexposure,
during preexposure, after preexposure, and after insult.
Specific Aim 3bii: To identify whether the activation of the hypoxia inducible factor-1α (HIF-
1α) pathway is responsible for the preconditioning effects noted with low doses of IL-1. Measure
bulk mechanical properties and biochemical content of cartilage constructs.
During OA and following surgical procedures, the environment of the knee is rich in proinflam-
matory cytokines such as IL-1 (Goldring and Goldring, 2004). Introduction of tissue engineered
cartilage constructs to a chemically harsh milieu may limit the functionality of the implanted tissue
over long periods. Cellular preconditioning schemes by physical (mechanical) and chemical ma-
nipulation have been used extensively in studies involving stem cells as a method to prime cells
to a state in which they can withstand a harsh microenvironment (Haider and Ashraf, 2010). In
particular, brief exposure to a catabolic agent afforded longer term protection against subsequent
attacks and this was found to be the most effective means of cytoprotection (Murry et al., 1986).
The rationale to this work, therefore, is that the application of one or more modes of precondi-
tioning can prepare the developing tissue to withstand potential catabolic factors present in the
inflammatory joint environment by providing an enhanced pericellular and extracellular matrix or
by increasing or activating the cells’ intrinsic survival signaling.
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1.2 Significance
OA represents a substantial economic burden for patients, health care systems, and businesses
(Elders, 2000; Gabriel et al., 1995; Leigh et al., 2001; Reginster, 2002). Caused by degeneration of
the synovial joint, OA includes a progressive loss of articular cartilage accompanied by inadequate
attempts to repair the damaged tissue, remodeling of the underlying subchondral bone, and the
formation of subchondral bony lesions (Buckwalter and Martin, 2006). Primary OA develops in
the absence of a known cause of joint degeneration, while secondary OA develops following joint
degeneration caused by injury (Buckwalter and Mankin, 1998a).
Extensive damage to the entire joint often requires a total knee replacement to replace the
articulating surface and underlying bone. These repairs, however, often require revision surgeries
due to wear, subsidence, and loosening of the implant in the bony union (Ayers, 1997; Bradley
et al., 1993; Mowery et al., 1987; Whiteside, 1989). For the repair of small defects such as focal
lesions, more conservative approaches including autograft cell/tissue transfer via periosteal grafts
(O’Driscoll et al., 2001), autologous osteochondral grafting such as mosaicplasty (Hangody et al.,
1997), and the Carticel method (Brittberg et al., 1996). These options provide temporary relief
from symptoms of pain and disability; however, they also introduce long-term problems. Primarily,
the availability of healthy cartilage from which to harvest cells is limited for cell-based therapies or
osteochondral graft harvesting. Furthermore, autologous osteochondral grafts are usually harvested
from non load-bearing regions that may provide tissue of sub-optimal material properties for use
in contact regions (Ahmad et al., 2001). The harvest procedure itself can induce significant cell
death in the surrounding region (Lee et al., 2000a,b), leading to further structural and biochemical
breakdown of the donor site tissue. As such, there have been recent attempts at developing cell-
based therapies for cartilage repair, including tissue engineered constructs of cultured cells on three-
dimensional scaffolds (Lima et al., 2004; Mauck et al., 2000; Pazzano et al., 2000; Vunjak-Novakovic
et al., 1999).
To develop strategies to mitigate tissue injury and promote repair, culture injury models have
been used to study the response of cartilage to trauma by taking advantage of the more controllable
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loading environment afforded by in vitro systems (Loening et al., 2000; Patwari et al., 2001). While
many studies have demonstrated the response of native cartilage to wounding, there exist no studies
in the literature describing the effect on engineered cartilage. Towards creating functional tissue
capable of withstanding the harsh mechanochemical regime present in the joint, the work contained
in this dissertation attempts to narrow the gaps in the literature by focusing on modalities of
injury and their subsequent responses in engineered constructs. The studies presented in Part
I of this dissertation provide new insight into the response of engineered cartilage to chemical
injury (Chapter 2) and mechanical injury (Chapter 3) and represent a model system from which
to study further modalities of injury propagation and repair (basic science impact) as well as a
guideline for in vitro culture (tissue engineering impact) to prepare constructs for the mechanical
and chemical stresses in the native knee joint.
In Part II, the studies described in this dissertation focus on developing strategies for enhancing
the performance of engineered cartilage for in vivo repair. First, from a basic science perspective,
we reexamine the limited migration of repair cells to injured cartilage and build upon the previous
literature on using electric field stimulation for directing cell migration by investigating the influence
of extracellular environment under EF strengths similar to those that are known to exist during
injury. By investigating the role of the AQP1 water channel, a key mechanosensor, our results
offer insights into a potential mechanism by which cells sense their environment and regulate key
aspects of migration, including cell volume and cytoskeletal organization (Chapter 4). This is then
extended to specific environments in which osmotic shock and cytokines are applied. Studying cell
migration in these contexts provides a new understanding for how cells may act in cartilage disease
and prompts further investigation into additional cell sources that may have more potential for
cartilage repair (Chapter 5).
Finally, for tissue engineering efforts at creating functional cartilage replacement, novel strate-
gies are examined to both foster better tissue development via co-culture systems (Chapter 6)
as well as enhance resistance to catabolic factors (Chapter 7). These results recommend the use
of preconditioning with mechanical and/or chemical factors to mediate the catabolic consequence
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of IL-1 exposure to produce clinically-relevant tissue-engineered constructs for treatment of OA or
following injury.
1.3 Background
1.3.1 Articular Cartilage: Biology and Structure
Articular cartilage, a white, dense connective tissue that lines diarthrodial joints, serves as the
load-bearing material of joints, and is characterized by excellent friction, lubrication, and wear
properties (Mow and Lai, 1990). Ranging from 1 to 7 mm thick, cartilage is composed primarily
of two phases, a solid matrix (collagen fibrils and proteoglycan (PG) macromolecules) (Clarke,
1971; Eyre, 1980; Muir et al., 1970) and a mobile interstitial fluid phase (mostly water) (Lipshitz
et al., 1976). The polyanionic nature of the glycosaminoglycan (GAG) chains of PG draw water
into the tissue, resulting in a large osmotic pressure that expands against the constraining collagen
network. The interplay between swelling pressure and tension in the collagen fibers results in a
highly specialized tissue that is well suited to bear compressive loads within the joint. To maintain
the necessary matrix composition, chondrocytes, which make up less than 10% of the tissue vol-
ume (Stockwell, 1979), balance extracellular degradation and matrix turnover by synthesizing and
secreting extracellular matrix (ECM).
The complexity of articular cartilage is evident by the changing composition, structure, and
material properties this is known to vary across the tissue’s depth (Guilak et al., 1995) and can
be divided into three discrete zones: the superficial (SZ), middle (MZ), and deep (DZ) zones
(Buckwalter and Mankin, 1998b; Donzelli et al., 1999). The SZ is a thin region at the articulating
surface marked by collagen fibers that are aligned parallel to the surface and it possesses the
highest concentrations of water and collagen compared to the other zones, but has the lowest level
of proteoglycan. Additionally, chondrocytes in this zone are flattened in morphology. In contrast,
the MZ is rich in collagen whose orientation is random, but contains the highest concentration of
proteoglycans with randomly dispersed cellular bodies. In the DZ, the chondrocytes are oriented
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perpendicular to the surface and arranged in a columnar structure with the lowest levels of collagen.
1.3.2 Articular Cartilage: Injury and Wound Repair
OA, the most prevalent form of joint disease, is characterized by joint pain and dysfunction (Buck-
walter and Martin, 2006), though the pathophysiology remains largely unknown. The progressive
loss of cartilage followed by inadequate repair and remodeling of subchondral bone are common
hallmarks of this degenerative disease (Buckwalter et al., 2000).
As the only cellular component of cartilage, chondrocytes maintain tissue homeostasis, respond
to injury and perform the limited remodeling process that comprises OA. Excessive mechanical
insult to articular cartilage can also reduce cell viability (Chen et al., 2001; Lewis et al., 2003;
Loening et al., 2000; Repo and Finlay, 1977), thereby leading to further tissue breakdown. Studies
in the literature have suggested two different types of chondrocyte death, apoptosis or necrosis.
Apoptosis is a form of programmed cell death and is regulated by cellular signaling systems that
lead to the disintegration of individual cells into the formation of apoptotic bodies (Farber, 1994;
Hockenbery, 1995). Necrosis, a form of accidental cell death, occurs as a consequence of a pathologic
event. While cell death has been primarily attributed to necrosis (Stockwell, 1979), apoptosis has
been identified through labeling techniques as the more likely form to elicit widespread chondrocyte
death (Loening et al., 2000; Tew et al., 2000).
The biochemical factors and mechanical stress to cartilage contribute to the progression of OA
by disrupting chondrocyte-matrix associations and altering the metabolic responses in the chondro-
cyte. This disruption in balance between anabolic and catabolic regulatory activities results in a
phenotypic shift, cell death, and an increase in expression of inflammation-related genes (Goldring
et al., 2011) that leads to a loss of cartilage matrix components and deterioration in the structural
and functional properties of cartilage (Lee et al., 2005; Stevens et al., 2009). Catabolic cytokines
may also be generated by the fibroblast- and macrophage-like cells in the synovium, the thin layer
that lines the non-articulating surfaces of diarthrodial joints and maintains a synovial fluid-filled
cavity (Fan et al., 2009), in response to the breakdown products from damaged cartilage. Conse-
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quently, elevated levels of inflammatory cytokines such as IL-1 and tumor necrosis factor-α (TNF-α)
have been measured in the synovial fluid during cartilage pathology (Pelletier et al., 1991; Sellam
and Berenbaum, 2010).
Similar changes to the cell’s biochemical, biophysical, and mechanical environment are elicited
following mechanical injury that occurs with traumatic loading of the joint as well as during surgical
procedures (Levin et al., 2005; Milentijevic et al., 2003; Tew et al., 2001). Such types of injury
are known risk factors for the development of secondary OA (Buckwalter and Mankin, 1998a), as
mechanical stimuli and injury regulate chondrocyte function and induce inflammatory mediators
(Fermor et al., 2001; Honda et al., 2000), matrix metalloproteinases (MMP) (Millward-Sadler et al.,
2000), and the release of PGs from cartilage explants (Quinn et al., 2001).
Cartilage exhibits an inability to fully repair itself following injury due to its hypocellular and
avascular nature (Tew et al., 2001); articular cartilage lesions that do not penetrate the subchondral
bone fail to heal due to the lack of nutrients and macrophages, endothelial cells, and mesenchymal
cells that reside in bone marrow. Additionally, the lack of removal of cellular or matrix debris
following trauma may confer a greater cellular response to injury (Hunziker, 1999).
Efforts to characterize the response of native behavior of cartilage in a wound environment have
prompted the development of in vitro models of induced mechanical insult. Histologic observations
of experimental wounding to articular cartilage have shown a reparative response that is marked
by a region of cell death surrounding the injured area (Chen et al., 2001; Lewis et al., 2003; Tew
et al., 2001, 2000). This area of cell death is apparent as soon as a few hours after and up to 7 days
post injury (Chen et al., 2001), after which empty lacunae and a loss of ECM are noted (Bennett
and Bauer, 1932). Adjacent to this zone of cell death is a zone of cellular proliferation (Carlson,
1957; Tew et al., 2001); 3H-thymidine incorporation into the intraarticular matrix of cells suggests
increased synthetic activity and altered metabolism. Disruption of the ECM, due to injury or as a
downstream effect of catabolic cellular activity, may modulate the behavior of chondrocytes in situ
(Fukai et al., 1998; Qi and Scully, 1998).
The extent of damage to articular cartilage following injury may then be dependent on the initial
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damage to both the chondrocytes themselves and the ECM. In further support of this, experimental
wounding of articular cartilage results in varying degrees of damage depending on the extent of
damage to the bulk ECM due to the type of injury (compression overload, trephine insertion,
scalpel cut), and the intensity and rate of loading to the bulk tissue. In addition, the maturity of
the cartilage may dictate the tissue’s response following injury, as the more elaborate pericellular
matrix (PCM) surrounding chondrocytes from mature cartilage may offer greater protection from
load-induced injury(Levin et al., 2005; Tew et al., 2001). The mechanotransduction from traumatic
loading to cartilage, nonetheless, is implicated in the pathophysiology of joint degeneration and the
onset of OA.
1.3.3 Cell Migration
Cell migration occurs during both physiological processes such as embryonic morphogenesis as well
as pathological processes including tissue repair and inflammatory response. The process of cell
migration is conceptualized as a cyclic process. Initially, cells detect a chemotactic gradient and
polarize and extend protrusions in the direction of migration (Vicente-Manzanares and Horwitz,
2011). These protrusions, which can be large, broad, sheet-like lamellipodia or long, thin filopodia,
are formed by actin reorganization and provide a foundation for the cell to move forward (Vicente-
Manzanares and Horwitz, 2011). Extended protrusions then adhere to the extracellular matrix
through integrins, generating traction forces at the site of adhesion due to the interaction of myosin
II with actin. Following transient disassembly of integrin adhesions, protrusions are able to extend;
reassembled adhesions then impart traction to allow the cell to pull forward on the substrate.
During the formation and retraction of cell membrane protrusions, cells undergo rapid cell shape
changes that are accompanied by changes in cell volume that may be due to changes in the physical
properties of the cell membrane and the activity of channels and transporters (Guilak et al., 2002;
Mobasheri et al., 2002). These changes in cell volume may work to propel the cell during migration;
in fact, unequal rates of water entry to the front and back parts of the cell has generated forces
sufficient to propel forward motion of a cell in the absence of actin (Jaeger et al., 1999). As such,
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regulators of water transport across cellular membranes such as AQP1 water channels have been
implicated in the mechanotransduction and regulation of cell volume (Liang et al., 2008; Mobasheri
et al., 2002).
1.3.3.1 Bioelectrical Stimulation for Wound Repair
The delayed, ultimately poor healing ability of articular cartilage is thought to be due, in large
part, to insufficient migration to the damage site of cells that have the potential to repair the lesion
(Hehenberger et al., 1998). Thus, strategies that enhance and direct cell migration could amplify
the intrinsic repair process. One approach that our lab has focused on has been the application
of an applied DC electric field (Chao et al., 2000). Electric field strengths as high as 1-2 V/cm
are generated at the cut surface of wounds due to the ion flux through leaky cell membranes and
exist locally for days (Soong et al., 1990). Furthermore, electric fields have been suggested to play
a role in regulating cellular proliferation and differentiation, as well as synthesis of growth factors
and matrix proteins (Aaron et al., 2004; Hartig et al., 2000). Externally applied electric fields are
already being used in orthopaedic practices to treat fracture nonunions and spinal fusions (Paterson
et al., 1977), though the mechanism of the bioelectrical stimulus on the targeted cells is not well
understood. In vitro applications of EFs have been demonstrated to elicit galvanotaxis (migration)
and galvanotropism (shape change) for a number of cell types including chondrocytes, fibroblasts,
meniscal cells, and keratinocytes (Chao et al., 2000, 2007; Frenkel et al., 1996; Gunja et al., 2011;
Nishimura et al., 1996). In these studies, the strength of the field necessary to induce migration
(1-10 V/cm) was on the order of that which has been shown to exist in developing embryos and
during wound healing (Robinson, 1985). Given their potential to induce cell migration and regulate
cellular biosynthetic activity, DC electric fields represent a potential tool to aid in the reparative
response of wounded cartilage.
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1.3.4 Functional Tissue Engineering of Articular Cartilage
Functional tissue engineering (FTE) for the regeneration of cartilage tissue damaged by disease
or trauma relies on the approach of using scaffolds, cells, and exogenous factors to develop tissue
constructs capable of meeting the functional (mechanical) load-bearing demands in vivo (Butler
et al., 2000). To this end, our lab has approached this paradigm with a long-term hypothesis that
by first cultivating constructs in vitro to match the material properties of native cartilage, prior to
implantation, long-term success is improved.
Studies characterizing the contact stresses within the knee joint have found mean stress mag-
nitudes at the articular surface range from 2MPa during daily activities, 6MPa under moderately
strenuous activities, and 12MPa under vigorous, but non-traumatic conditions (Ahmed and Burke,
1983; Brown and Shaw, 1984; Fukubayashi and Kurosawa, 1980; Huberti and Hayes, 1984; Kurosawa
et al., 1980; Manouel et al., 1992). Underdeveloped constructs lacking the integrity to withstand
such loads, therefore, would be unsuccessful.
To this end, our lab and many others have manipulated aspects central to the themes of tissue
engineering to produce engineered cartilage with functional properties. The choice of scaffold, cell
type, and mechanical or chemical stimulation are major variables that influence the outcome. An
overview of some of the emerging trends in cartilage tissue engineering are described below, with a
particular focus on how they may be useful in human clinical translation. However, the majority of
the work described in this dissertation utilizes a well-established model whereby primary or passaged
juvenile bovine chondrocytes are encapsulated in an agarose hydrogel. This choice provides a
relatively simple and robust system with which to study relevant phenomena.
1.3.4.1 Scaffold Choice
Hydrogels have become the scaffold material of choice for cartilage tissue engineering due to their
intrinsic hydrophilic nature and high water content, similar to native soft hydrated tissues (Smetana,
1993). Hydrogels being explored include polyethylene(glycol) (Rice et al., 2008), hyaluronic acid
(Burdick et al., 2005), silk (Chao et al., 2010), alginate and collagen (van Susante et al., 1995).
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Agarose, a neutrally charged polysaccharide from seaweed, has been used extensively in cartilage
biology for maintaining long-term chondrocyte suspension cultures due to its ability to promote
and maintain the chondrocyte phenotype (Benya and Shaffer, 1982; Buschmann et al., 1995, 1992;
Lee and Bader, 1995; Mauck et al., 2002, 2000), as well as being non-degradable and non-interactive
with chondrocytes.
These advantages have prompted the use of agarose for cartilage tissue engineering applications,
where agarose-embedded chondrocytes have been shown to successfully repair articular cartilage
and tibial defects in in vivo models (Cook et al., 2003; Rahfoth et al., 1998). The properties of
agarose permit application of physiologic deformational loading immediately upon encapsulation
such that constructs may be physically stimulated before extensive ECM development is present.
Together, these characteristics of the agarose hydrogel system have allowed for the fabrication of the
most reproducible and robust cartilage tissue growth in culture (Lima et al., 2007). Furthermore,
this system serves as an important tool to study tissue engineering strategies. Clinically, agarose is
being used as a co-polymer with alginate as a hydrogel scaffold for ACI (Cartipatch) for cartilage
defect repair and has demonstrated good 2-year clinical follow up (Selmi et al., 2007, 2008).
1.3.4.2 Cell Source
Many studies have utilized isolated juvenile bovine chondrocytes encapsulated in hydrogel systems
to recreate and even surpass the properties of native bovine tissue by the temporal application
of chemical (Byers et al., 2006) or physical factors (Martin et al., 2000), or a combination of the
two (Lima et al., 2007). These studies capitalize on the significantly greater biosynthetic capacity
of juvenile cells relative to their adult counterparts (Tran-Khanh et al., 2005), also reported for
human chondrocytes (Adkisson et al., 2010). However, a juvenile cell source is limited for clini-
cal applications due to the challenges related to tissue procurement. As such, differentiated adult
chondrocytes may be obtained from a patient’s own healthy, non-load bearing cartilage, although
this may lead to donor site morbidity and further tissue degeneration (Gilbert, 1998). Chondro-
cytes from the diseased knee may be also harvested during preliminary debridement procedures.
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In both cases, though, obtaining sufficient cell number to produce constructs with sufficient me-
chanical properties is challenging due to the reduced biosynthetic activity of cells from patients
with advanced stages of the disease (Bulstra et al., 1989; Wang et al., 2003). Alternatively, due to
the immunoprivileged nature of diarthrodial joints, the implantation of allogeneic cells from other
patients may be expanded for use (Glenn et al., 2006), following from the clinical use of living
osteochondral allografts (Garrett, 1998).
Finally, undifferentiated cartilage precursor cells, including those isolated from patient bone
marrow aspirate (Tew et al., 2008), from adipose tissue (Xu et al., 2007; Zuk et al., 2002, 2001),
or from the synovium (Arufe et al., 2010; Kim et al., 2011; Li and Pei, 2010) have been explored
as alternative sources of cells, however, to date, constructs made with these human cells have
not been capable of attaining mechanical properties at native tissue levels. Co-culture of human
embryonic stem cells (hESCs) with chondrocytes and fibrochondrocytes can modulate chondrogenic
expression and matrix synthesis (Hoben et al., 2009; Hwang et al., 2008). However, stem cells may
have different cell density or cell-cell contact requirements than chondrocytes (Huang et al., 2009)
in order to form cartilaginous tissue. Micromass, self assembled constructs (scaffold-free), and
suspension in hydrogel show potential for human ESC chondrogenesis (Hoben et al., 2009; Hwang
et al., 2008).
Regardless the source, the number of cells required to recreate engineered cartilage with func-
tional properties surpasses the number that is readily available clinically. To address the limited
supply of cells, one way to increase the cell number is by expanding cells through passaging under
appropriate growth factors. Similar to the cocktail of growth factors used for the culture of chon-
drocytes encapsulated in an agarose hydrogel, these same growth factors encourage and maintain
the chondrocyte phenotype. For adult chondrocytes that are less biosynthetically active, expansion
in a cocktail of appropriate growth factors has been shown to rapidly expand cell number, prime
the cells to reactivate rapid matrix synthesis when cultured in a 3D scaffold environment, and pre-
vent phenotype dedifferentiation which is typically seen in monolayer culture (Benya and Shaffer,
1982; Francioli et al., 2007; Ng et al., 2010). For undifferentiated stem cells, the application of a
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growth factor cocktail offers the ability to direct the differentiation of these plastic cells down the
chondrocyte lineage (Guilak et al., 2004; Hwang et al., 2006; Williams et al., 2003).
1.3.4.3 Exogenous factors
Joint loading gives rise to a plethora of physical stimuli, including osmotic loading, hydrostatic
pressure, electrokinetic phenomena, stress and strain (Guilak and Hung, 2005). For FTE, physi-
ologically relevant stimuli are applied to encourage the development in vitro for tissues that can
meet the in vivo functional demands, as well as mimic the composition of native tissue (Hung
et al., 2004). The choice of scaffold material and its inherent material characteristics, therefore,
dictate the nature of loading that can be applied on developing cartilage tissue constructs. Rotat-
ing wall bioreactors have been used to provide a hydrodynamic, low-shear environment supportive
of enhanced nutrient transport (Gooch et al., 2001; Kaysen et al., 1999) and cartilage-like tissue
growth (Freed et al., 1997; Obradovic et al., 1999; Vunjak-Novakovic et al., 1999). However, these
bioreactors do not reproduce the physiologic deformational loading and hydrostatic pressure en-
vironment of the chondrocyte (Ateshian and Hung, 2003). In comparison, applying physiologic
loading through a combination of applied physiologic hydrostatic pressure and perfusion (Carver
and Heath, 1999) or through physiologic dynamic deformation loading (Mauck et al., 2002, 2000,
2003c) can achieve near-physiologic values for equilibrium modulus and GAG content. Such defor-
mational loading gives rise to enhanced convection of nutrients (Albro et al., 2008; Mauck et al.,
2003a), in a mechanism similar to how joint loading provides nutrients from the synovial fluid to
avascular cartilage in situ. There is a growing body of literature suggesting that physical forces can
be used to modulate chondrogenesis of mesenchymal stem cells (Elders, 2000; Huang et al., 2004;
Kisiday et al., 2009; Miyanishi et al., 2006), as reviewed by Huang and co-workers (Huang et al.,
2010).
In addition to mechanical loading to promote tissue growth, many groups have focused on the
application of a range of chemical cues such as growth factors (transforming growth factor (TGF)-
β3, TGF-β1, insulin-like growth factor (IGF), fibroblast growth factor (FGF2) (Byers et al., 2006;
CHAPTER 1. INTRODUCTION 16
Mauck et al., 2003b, 2001; Thorp et al., 1992)), corticosteroids (Awad et al., 2003; Bian et al.,
2010b), and interleukins (Aydelotte et al., 1992; Lima et al., 2008b; Ratcliffe et al., 1986). Through
paracrine signaling and direct cell-cell contact, the exchange of these chemical factors has been
found to promote ECM development. Physical loading may act to increase convective transport of
growth factors, leading to possible synergistic interactions (Mauck et al., 2003b).
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Chapter 2
Response of Native and Tissue
Engineered Cartilage to Chemical
Injury
2.1 Introduction
Repair strategies for load bearing tissues such as articular cartilage have relied on tenets of func-
tional tissue engineering (Butler et al., 2000), centering on the idea that engineered tissues will
have greater success following implantation if they possess properties similar to those found in the
native joint. The application of exogeneous factors such as mechanical loading (Mauck et al., 2000;
Sampat et al., 2013) and chemical cues (Sampat et al., 2011) have shaped the development of tis-
sue in an effort to create functional tissue with properties comparable to native articular cartilage
(Lima et al., 2007).
Mechanical, biochemical, and histological properties have been the primary modalities to assess
the integrity of these constructs when considering their potential for in vivo repair. We have
strived, however, to understand how closely the biological response of our engineered cartilage
mimics that of the native tissue, in particular, the response to cytokine exposure. To this end,
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in an effort to measure how successfully our engineered cartilage mimics native cartilage, I was a
significant contributor on a cohort of earlier studies by our laboratory that compared the cytokine
response of engineered to native cartilage. The insights from these studies, as reviewed herein,
lay the foundation for study aims of this dissertation, focusing on examination of the response of
engineered cartilage to imposed injury to gain insights towards developing strategies for enhancing
cartilage repair.
Engineered cartilage is initially a fragile tissue, characterized mainly by the agarose scaffold
material that houses the cells. With time in culture, extracellular matrix is deposited, leading
to an increased stiffness and composition. The dense matrix also may act as a chondroprotective
enclosure for the encapsulated cells (Li et al., 2003), ensuring survival in the harsh mechanical
loading environment of the knee joint. However, within the joint, the chemical environment is
likely to contain potent catabolic mediators that stem from chronic joint inflammation (Goldring,
1999; Goldring and Goldring, 2004; Lotz, 2001; van den Berg, 2001) or the surgical intervention
(Schmal et al., 2009; Smeets et al., 2003). As such, engineered cartilage must possess the fortitude
to withstand these catabolic factors. Here, we review our lab’s efforts in first characterizing the
response of native articular cartilage to in vitro cytokine exposure to understand the potential
effects of catabolic degradation on tissue properties. Next, we looked at whether tissue-engineered
constructs exposed to a similar insult responded in a comparable manner. Finally, after noticing
that engineered cartilage behaved differently than native cartilage and indeed was susceptible to
IL-1-induced tissue breakdown, we explored the use of genipin as a way to permanently cross-link
components of the existing extracellular matrix in an effort to protect the constructs.
A summary of the key findings of each study is described below, with full-length papers included
in Appendix A.
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2.1.1 Differences in interleukin-1 response between engineered and native car-
tilage
Articular cartilage explants exhibit a resistance in vitro to IL-1 induced degradation in our culture
system. This may be due to the presence of a chondro-protective chemical mediator (dexametha-
sone) in the culture medium. The same mode of protection was noted for engineered cartilage only
when properties of the tissue neared native values. However, for fledgling constructs that have not
attained maturity (characterized by sufficient mechanical integrity and biochemical composition
similar to native cartilage), the addition of IL-1 induced a catabolic effect that was persistent even
after the removal of the cytokine. Accordingly, mature engineered cartilage constructs possess a
greater potential for withstanding the harsh mechanochemical environment of the joint and should
be preferentially chosen for implantation.
2.1.2 Physiologic deformational loading does not counteract the catabolic ef-
fects of interleukin-1 in long-term culture of chondrocyte seeded agarose
constructs
Studies looking at short-term (Table 2.1) application of physiologic loading have found protective
effects against IL-1 induced catabolic degradation, attributable to a decrease in synthesis of nitric
oxide and PGE2 as a consequence of deformational loading (Chowdhury et al., 2001, 2003; Gassner
et al., 1999; Long et al., 2001). We prioritized functional properties of engineered tissues, char-
acterized by cellular matrix output, during long-term culture, rather than temporal expression of
soluble factors that many of the previous shorter studies have employed. To this end, loading over
a long-term period with the addition of cytokine resulted in a decrease in material and biochemical
properties, even when the concentration of IL-1 was lowered 10-fold. It is important to note, how-
ever, that the total number of cycles for our loading protocol far exceed those utilized in short-term
studies and may account for the noticeable differences observed.
CHAPTER 2. RESPONSE OF NATIVE AND TISSUE ENGINEERED CARTILAGE TO
CHEMICAL INJURY 21
Table 2.1: Previous studies examining the effect of concurrent dynamic loading with cytokine exposure
Author Loading Regime Inflammatory Response
Chowdhury
(2001,2003)
Dynamic compression: 1Hz, 15% amplitude dy-
namic strain, 48hr
Inhibition of NO, PGE2
Gassner (1999), Xu
(2000), Long (2001)
Cyclic tension: 0.05Hz, 6% equibiaxial strain,
24hr
Suppression of IL-1β-induced NO
production
Lima (2008) Dynamic compression: 1 Hz, 5% amplitude dy-
namic strain, 3hr/day for 28 days
IL-induced degradation not miti-
gated; decrease in material and bio-
chemical properties
2.1.3 Genipin enhances the mechanical properties of tissue engineered cartilage
and protects against inflammatory degradation when used as a medium
supplement
Genipin is a naturally-derived cross-linking agent that reacts with free amine groups, such as those
found on tropocollagen or proteoglycan molecules. We hypothesized that the cross-linking of extra-
cellular matrix components would increase their resistance to catabolic degradation brought about
by IL-1 exposure. Indeed, genipin-treated constructs maintained significantly higher material and
biochemical properties following insult with IL-1 compared to their non genipin-treated constructs.
Interestingly, while the stiffness was moderately lower in the presence of cytokine, the biochemical
composition of the tissue was maintained, suggesting it is likely that the crosslinks formed between
the extracellular matrix components trap degraded products.
2.2 Conclusion
Together, these studies indicate that engineered tissues, while capable of reaching native properties
akin to article cartilage, are vulnerable to IL-1 exposure depending on the manner in which the
cytokine is applied. However, when able to attain material and biochemical properties similar
to native cartilage, these engineered tissues are better able to withstand the chemical assault,
hence pointing to the importance of growing functional tissue before implantation. Furthermore,
we have shown one exciting potential for mediating the effect of cytokine exposure by pretreating
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constructs (such as with genipin crosslinking). The study aims of this dissertation are predicated on
these insights; understanding the response of engineered cartilage to mechanical injury is examined
(Chapter 3) and further modalities for enhancing cartilage repair are explored (Chapters 4-7).
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Chapter 3
Response of Native and Engineered
Cartilage to Mechanical Injury
3.1 Introduction
Articular cartilage exhibits a poor intrinsic healing response subsequent to injury (Tew et al., 2000)
that engenders a need for cell-based therapies for repair. As the growing promise of engineered
cartilage grafts is realized in clinical practice, it will be important to understand the engineered
construct’s response to the joint loading environment after implantation, including potential injuri-
ous loading. Mechanical injury to cartilage can occur with traumatic loading of the joint (traumatic
injury) as well as in surgical procedures that include graft harvesting (iatrogenic injury, see section
3.2). In native cartilage, the mechanotransduction resulting from injury has been shown to induce
chondrocyte death as early as a few hours after, and up to 7 days, post injury (Chen et al., 2001).
Histologic observations of experimental wounding to articular cartilage have shown a reparative
response that is marked by a region of cell death surrounding the injured area (Chen et al., 2001;
Lewis et al., 2003; Tew et al., 2001, 2000). Adjacent to this zone of cell death is a zone of cellular
proliferation (Carlson, 1957; Tew et al., 2001); 3H-thymidine incorporation into the intraarticular
matrix of cells suggests increased synthetic activity and altered metabolism. Disruption of the
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ECM, due to injury or as a downstream effect of catabolic cellular activity, may modulate the
behavior of chondrocytes in situ (Fukai et al., 1998; Qi and Scully, 1998). The extent of damage
to articular cartilage following injury may then be dependent on the initial damage to both the
chondrocytes themselves and the ECM.
To develop strategies that mitigate tissue injury and promote repair, culture injury models
have been used to study the response of cartilage to trauma by taking advantage of the more
controllable loading environment afforded by in vitro systems (Loening et al., 2000; Patwari et al.,
2001). Experimental wounding of articular cartilage results in varying degrees of damage depending
on the extent of damage to the bulk ECM due to the type of injury (compression overload, trephine
insertion, scalpel cut (Amin et al., 2008b; Costouros and Kim, 2007; Tew et al., 2001)), and the
intensity and rate of loading to the bulk tissue. In addition, the maturity of the cartilage may dictate
the tissue’s response following injury, as the more elaborate pericellular matrix (PCM) surrounding
chondrocytes from mature cartilage may offer greater protection from load-induced injury (Levin
et al., 2005; Tew et al., 2000). The mechanotransduction from traumatic loading to cartilage,
nonetheless, is implicated in the pathophysiology of joint degeneration and the onset of OA. In this
chapter, we explore the response of native and engineered cartilage to imposed mechanical injury.
In the first part of this chapter, we add to the existing literature on iatrogenic injury by examining
two different modes of osteochondral graft harvesting (Section 3.2). By comparing the ensuing
degree of cell death, we offer some recommendations on best practices for tissue repair. Next, we
examine the response of engineered cartilage to mechanical insult (Section 3.3) to offer comparisons
to native cartilage. Finally, in the last part of the chapter, we discuss the impact of the use of a
chondrogenic medium for prevention of cell death (Section 3.4).
CHAPTER 3. RESPONSE OF NATIVE AND ENGINEERED CARTILAGE TO
MECHANICAL INJURY 25
3.2 Controlling Iatrogenic Injury during Graft Harvesting
3.2.1 Introduction
Removal of diseased or damaged osteochondral tissue is necessary before implantation of a replace-
ment tissue can be performed. While the work described in this thesis focuses on an engineered
cartilage tissue replacement, replacement tissue can also include autologous cartilage plugs taken
from healthy non-load bearing regions of the knee. In both cases, the diseased tissue is first re-
moved using specific instrumentation. Two methods of harvesting osteochondral grafts are common
to most systems, either a hand-held power trephine (CORE, Innovasive) or a manual punch (e.g.
OATS, Arthrex). Though these two modalities are commonly used, they have also been shown to
cause donor site morbidity, leading to knee pain, locking, and a requirement for additional arthro-
scopic surgery (Huntley et al., 2005). Previous findings in the literature suggest that cutting forces
are minimized when there is simultaneous pushing and rotation (Atkins et al., 2004), such as with
drilling. However, when the two techniques were compared, serated hand-held power trephines were
found to significantly decrease chondrocyte viability (Evans et al., 2004). We hypothesized that the
damaging effect may be due to increased strains exerted on the cartilage surface at the moment of
impact arising from the lack of stabilization of the tool. To this end, we explored modified versions
of these two forms of iatrogenic injury under our controlled culture condition whereby the punch
or drill was fixed to a solid support with only one degree of freedom and tested whether cell death
continued progressing over long-term culture (weeks) compared to previous studies which looked
at immediate changes (hours to days).
3.2.2 Materials and Methods
3.2.2.1 Explant Harvesting
∅6.35mm explants (full thickness cartilage with attached subchondral bone) were cored out of
the carpal face of juvenile bovine wrist joints (n=2). Joints showing any contraindications were
discarded. Explants were stored in chondrogenic media (serum-free DMEM supplemented with
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ITS+, dexamethasone, and ascorbic acid).
3.2.2.2 Osteochondral Graft Coring
∅1mm cylindrical plugs were aseptically cored out of the center of each explant using a custom-
programmed milling machine (Figure 3.1) equipped with a disposable biopsy punch. For each
explant removal, cartilage plugs were extracted at varying rotational speeds (0, 60, 100, 1000, 2000
rpm) and insertion rates (30, 60, 120, 240 mm/min) with a fresh punch and then returned to
culture.
Figure 3.1: Custom drilling setup with (1) rotating collar, (2) disposable punch, and (3) ∅6.35mm collet,
permitting user prescribed punch rotational speeds and insertion rates into the cartilage explant.
3.2.2.3 Cell Death Assessment
At 1, 10, and 28 days after injury, cell viability of explants was assessed with the Live/Dead viability
assay (Molecular Probes, Eugene, OR) and images were acquired on a confocal microscope (Leica,
Bannockburn, IL). Explants were then returned to culture to allow for assessment of the same
sample at later timepoints. Overlaid images of live and dead cells were analyzed using ImageJ
(NIH) to measure the area of cell death emanating away from the site of injury.
3.2.2.4 Statistics
Statistics were performed using two-way ANOVA with Tukey’s HSD post-hoc tests (Statistica,
Tulsa, OK), with α=0.05 and statistical significance set at p≤0.05 to compare groups across day
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and treatment. All data are reported as the mean ± 95% confidence interval of 4-5 samples per
time point and group.
3.2.3 Results
Cell death was mitigated depending on the harvesting extraction technique. Immediately following
extraction, an area of cell death was noticeable directly adjacent to the site of the punch, regardless
of harvesting technique. When punches were extracted by a straight push with zero rotation,
faster insertion rates (120mm/min and 240mm/min) exhibited significantly less cell death in the
surrounding region at 1 day after extraction, but with time, this trend disappeared, with all samples
showing similar amounts of cell death by 28 days post extraction (Figure 3.2a). When a constant
insertion rate was applied (120mm/min), the area of cell death surrounding the extracted punch
varied depending on harvest conditions. Samples that were punched with the slowest rotational
speeds exhibited regions of cell death that continued to grow over time; with increased rotational
speeds (1000rpm, 2000rpm), cell death was contained to the original area and was significantly less
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Figure 3.2: Area of cell death (mm2) surrounding the site of graft extraction as a function of (a) insertion
rate and (b) rotational speed. #p<0.05 vs. 30mm/min, *p<0.05 vs. 0 RPM, n=20-25/group.
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3.2.4 Discussion
Maintaining cell viability is critical to continuing proper mechanical function of the joint following
osteochondral graft harvesting and reducing donor site morbidity. While grafts are typically taken
from non-load bearing surfaces, it is understood that mechanical injury causing necrosis and lead-
ing to subsequent apoptosis of surrounding tissue may trigger a degenerative cascade characterized
by increased collagen degradation and reduced proteoglycan synthesis, two hallmarks of the os-
teoarthritic pathology. Here, we demonstrate that by controlling the insertion rate and rotational
speed of the punch associated with the harvesting technique, cell death in the surrounding area
may be significantly reduced in half.
That varying the insertion rate of a sharp punch into the tissue had no significant effect on
cell viability suggests that there may be a strain threshold, below which propagation of death does
not occur. Similarly, rotating punches may minimize local strains felt by the tissue at the moment
of punch insertion, thereby maintaining cell viability in the surrounding area. Interestingly, the
results observed here contradict those previously reported in the literature that automated drilling
is significantly more harmful than a straight punch. There may be a few reasons for the disparity.
First, in traditional drills, a serrated tooth design is used on the drill bit, which may in fact tear up
the surrounding tissue as it progresses through the depth of the cartilage. In our setup, a sharp,
fresh biopsy punch was utilized to core out the plug. From preliminary studies, we detected that
the initial point of contact of a sharp-edged punch to the articular cartilage surface is marked
by minimal localized tensile strain compared to a large diffuse compressive strain produced by
dull-edged punches (Figure 3.3).
Figure 3.3: Strain (EY Y ) maps generated from digital image correlation of the cartilage explant undergoing
graft extraction with a (a) dull punch and (b) sharp punch.
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These larger strains may then predispose the tissue to greater mechanical failure and subsequent
cell death. Secondly, due to the constraints of a fixed system with only one degree of freedom, it is
likely that the manner in which the extraction was performed was more controlled. This may have
led to less peripheral damage to the tissue that might otherwise have contributed to the injury
response. Finally, we must consider the specific culture conditions under which these experiments
were performed. It is possible that components in the chondrogenic medium afford protection
against progressive cell death. Further work exploring this possibility is described in Section 3.3.
Nonetheless, the results described here identify, for the first time, the possibility of selecting
key parameters that affect cell viability, thereby making it possible to successfully reduce donor
site morbidity through optimized harvesting procedures.
3.3 Engineered Tissue Construct Maturity Dictates Response to
Injury
3.3.1 Introduction
Previous studies performed by our lab (Section 3.2) and others have identified native articular
cartilage damage when exposed to mechanical insult. The effect on engineered cartilage, however,
has not been identified. As such, the current investigation aims to complement these explant
injury studies by providing an initial characterization of the in vitro injury response of engineered
cartilage. The use of a tissue engineering model as the surrogate tissue permits injury to be studied
on constructs spanning a range of mechanical and biochemical properties that reflect tissue culture
maturation. Elucidation of potential failure mechanisms of engineered tissues that may occur after
implantation in the defect site may be important for optimization of implantation guidelines and
tissue construct design criteria.
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3.3.2 Materials and Methods
3.3.2.1 Experimental Design
To understand the influence of tissue maturity at the time of applied injury on cellular response and
extracellular matrix remodeling, we have developed a trauma model to induce chondrocyte death
in engineered cartilage constructs of increasing culture age, in response to controlled mechanical
overloading (compression-induced cracking), or sharp cutting. The cutting injury served as a
method of controlling the location and extent of injury, relative to the greater uncertainty in
the extent and location of cracking.
The timeline of the studies is detailed in Figure 3.4. There are two variables in the experiments:
(1) the day on which trauma is imparted to the developing construct, and (2) the type of injury
imposed (‘crack’ or ‘cut’). Specifically, subsets of constructs were exposed to trauma, after which









Figure 3.4: Timeline of experimental setup for different groups exposed to trauma. Arrows indicate time
in culture when injury was imposed.
3.3.2.2 Tissue Isolation and Cell Culture
Articular cartilage was harvested from bovine CMC joints of freshly slaughtered 2-4-week-old calves.
Four to six joints were used for each experiment and cells were pooled from all joints. Cartilage
was digested in high-glucose DMEM with collagenase type V (Sigma, St. Louis, MO) for 11 hours
at 37°C with shaking. Cell suspensions were filtered through a 70µm porous mesh and sedimented
in a bench-top centrifuge for 15 min at 1500g. Viable cells were counted with a hemacytometer and
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trypan blue. Cell suspensions (60×106 cells/mL) were mixed in equal parts with 4% low-gelling
agarose (type VII, Sigma) at 37°C to yield a final cell concentration of 30×106 cells/mL in 2%
agarose. The chondrocyte/agarose mixture was cast into slabs and cored using a sterile disposable
punch (Miltex) to final dimensions of 4mm diameter and 2.34 mm thick. Constructs were cultured
in hgDMEM supplemented with 1X PSF, 0.1µM dexamethasone, 50µg/mL ascorbate 2-phosphate,
40µg/mL L-proline, 100µg/mL sodium pyruvate, and 1X ITS+ premix (insulin, human transferrin,
and selenous acid, Becton Dickinson, Franklin Lakes, NJ). Medium was further supplemented with
10ng/mL TGF-β3 (Invitrogen, Carlsbad, CA) for the first 14 days of culture. Culture media was
changed every other day.
3.3.2.3 Injury
On days 5 and 35 of culture, constructs were subjected to one of two injury modes: compression-
induced cracking or cutting (Figure 3.5).
Briefly, to produce cracking, constructs were loaded using a computer-controlled custom device
and ramped to failure at a constant strain rate of 0.3% sec−1. Mechanical failure was identified
by a drop in applied load on a force-displacement plot and confirmed by gross visual inspection of
each construct to ensure that constructs had sustained a fissure throughout the sample. For the
cutting injury, two orthogonal cuts were made in constructs by pushing a razor blade to 50% of the
construct’s original thickness. Razor blades were pushed straight down to prevent the application
of additional shear forces, and were replaced after every five constructs to prevent dulling of the
blade. Afterwards, samples (including controls manipulated similarly to injured constructs, without
actual trauma) were returned to culture in freshly supplemented media and allowed to recover in
culture to day 70 for mechanical testing, or to day 85 for viability staining.
3.3.2.4 Cell Viability Assessment
Assessment of cell viability was performed using the Live/Dead cytotoxicity assay (Molecular
Probes, Eugene, OR) at immediate- (1 day), short- (3, 7 days), and long- (14, 28, 50 days) time









Figure 3.5: Experimental setup of the (a) cracking and (b) cutting setups with a blown up schematic of
the injurious device. Compression was applied with an impermeable platen until cracking was achieved. For
the cutting setup, blades were cut into the construct to a depth of 50%
points post trauma. After each viability assay, constructs were aseptically returned to culture me-
dia to allow for assessment of cell death in the same sample at later timepoints. Live and dead
images were taken separately on an inverted confocal fluorescent microscope (Olympus Imaging
America, Inc., Center Valley, PA) and overlaid to produce a composite image of the region (Adobe
Systems Inc., San Jose, CA).
To quantify cell viability over time for an injured sample, live and dead images were processed
separately for automated counting of fluorescing particles (ImageJ, NIH). The fraction of live cells
present in an image was determined by calculating the area fraction of particles in a centered region
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of an 8-bit, thresholded image. Live cells were characterized as those particles with sizes ranging
from 0-2500 pixel2 (approx. cell size for the given image magnification). These sizes were previously
determined using other sample images by calculating average cell body sizes for multiple images.
Data was collected from the ImageJ program, and the fraction of live cells reported by normalizing
to respective controls.
3.3.2.5 Mechanical Testing
Samples were tested in unconfined compression to assess equilibrium modulus (EY ) and dynamic
modulus (G*) using a custom computer-controlled system (Soltz and Ateshian, 1998). An initial
0.02N tare load was applied, followed by compression to 10% strain, at a strain rate of 0.05% sec−1.
After stress-relaxation was achieved, a 2% peak-to-peak strain was superimposed at 0.1Hz. EY was
measured from the stress-relaxation equilibrium response, and G* from the slope of the stress-strain
response under dynamic loading.
3.3.2.6 Biochemical Content
Full constructs were used for biochemical analysis to ensure that any biochemical changes from
the effect of the injury (crack or cut) would be captured. Construct swelling was quantified by
measuring the gross water content of the constructs (Lima et al., 2007). Samples were dried and
digested in proteinase-K buffer overnight at 56°C, as described previously (Kelly et al., 2006).
An aliquot was analyzed for GAG content via the 1,9-dimethylmethylene blue dye-binding assay
(Farndale et al., 1982). A further aliquot was hydrolyzed in 12N HCl at 110°C for 16 hours,
dried, and resuspended in assay buffer (Kelly et al., 2006). OHP content was determined using
a colorimetric assay via a reaction with chloramine T and dimethylaminobenzaldehyde , scaled
for microplates. Overall collagen content was calculated by assuming a 1:7.64 OHP-to-collagen
mass ratio (Stegeman and Stalder, 1967). dsDNA content was also assessed by the Picogreen assay
according to the manufacturer’s standard protocols. Each biochemical constituent was normalized
to either tissue wet or dry weight.
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3.3.2.7 Statistics
Statistics were performed using two-way ANOVA with Tukey’s HSD post hoc tests (Statistica,
Tulsa, OK), with α=0.05 and statistical significance set at p≤0.05 to compare groups across day
and treatment. All data are reported as the mean ± 95% confidence interval of 4-5 samples per
time point and group.
3.3.3 Results
3.3.3.1 Gross Cracking Response as a Function of Tissue Culture Maturity























Figure 3.6: Timeline of experimental setup for different groups exposed to trauma. Arrows indicate time
in culture when injury was imposed.
Using a computer-controlled system to impart strain, force-displacement profiles were generated to
study the gross failure response of the constructs subjected to cracking, under controlled deforma-
tion. At early culture time points, when constructs were immature, load increased steadily to 36.1
± 0.85% strain before cracking the construct (Figure 3.6a). In comparison, compression-induced
cracking of more mature constructs produced catastrophic damage, where compaction of the ex-
tracellular matrix produced bulk tissue compression (Figure 3.6b, inset) before crack initiation at
50.3 ± 0.13% strain (Figure 3.6b).
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3.3.3.2 Cell Viability and Proliferation Post Injury
Cellular viability and subsequent response after insult, as assessed by the Live/Dead cytotoxicity
assay, was found to vary with mode of trauma as well as culture maturity at time of injury. For
cut constructs, exposed to trauma on days 5 and 35, the area fraction of live cells within the same
region of each construct increased significantly at 50 days post injury (d5 injury: 31.1 ± 2.81%,
d35 injury: 59.1 ± 4.40%, Table 3.1, p<0.001, n=5/group) by the end of culture.
Table 3.1: Normalized area fraction of live cells in a centralized portion of cut constructs compared to
control samples at different time points after early (d5) and late (d35) injury. d5 injury: 31.1±2.81%, d35
injury: 59.1±4.40%, P<0.001, n=5/group
d5 injury d35 injury
1 day post cut 1.02 0.44
3 days post cut 1.05 0.54
50 days post cut 1.34 0.70
At early times in culture, immediately following induced trauma on day 5, both cracked and cut
constructs exhibited little cellular damage, with the only loss of cells contained to the immediate
vicinity of the site of injury (Figure 3.7a,d). Over time, as early as 14 days post injury, cellular
infiltration from neighboring regions into the injured space was observed, depending on the type
of injury: Cellular infiltration and elongation along the site of injury was observed for constructs
exposed to compression-induced cracking (Figure 3.7b). By 28 days after injury, injured sites for
cracked constructs were fully infiltrated with neighboring cells (Figure 3.7c). For cut constructs,
however, neighboring cells did not infiltrate the void space, leaving a clearly demarcated region of
cell loss throughout the culture period (Figure 3.7e,f).
Following a longer time in culture, the response of the engineered cartilage to injury was immedi-
ately noticeable. Constructs catastrophically damaged on day 35 by compression-induced cracking
exhibited a large loss of cell viability in the immediate and peripheral regions to the site of injury;
these regions were not subsequently filled with neighboring cells over the remaining time in culture
(Figure 3.8a-c). For constructs cut at this later time point, a larger void space demarcated the




Figure 3.7: Representative superimposed live and dead images of immature cracked (top) and cut (bottom)
constructs at 1 day (a, d), 14 days (b, e), and 28 days (c, f) after injury. Scalebar: 0.5 mm. With time
in culture, neighboring cells infiltrate into the cracked region of constructs. For constructs injured with a
scalpel cut, cells did not infiltrate the cut region, leaving a void space (represented by black space), which
was still present at 28 days after injury. Dead cells are visible upon further magnification of the region only
immediately (1 day) after injury.
region of injury and these constructs responded similarly to constructs cut earlier in culture (Figure
3.8d-f)
3.3.3.3 Recovery of Mechanical Response
Mechanical properties of constructs injured on day 5 of culture recovered to uninjured control
values by day 14, despite the overload-cracking or cutting injury imposed on the nascent tissue
(pEY >0.999, pG∗>0.999, Figure 3.9). After recovery, at the end of the culture period, constructs
achieved properties similar to the Young’s modulus of native bovine juvenile tissue (EY : 587 ±
43.9 kPa, G*: 2.4 ± 0.1 MPa, control; EY : 513 ± 43.8 kPa, G*: 2.2 ± 0.2 MPa, crack, pEY =0.794,
pG∗=0.998; EY : 552 ± 74.9 kPa, G*: 2.3 ± 0.2 MPa, cut, pEY >0.999, pG∗>0.999).




Figure 3.8: Representative superimposed live and dead images of mature cracked (top) and cut (bottom)
constructs at 1 day (a, d), 28 days (b, e), and 50 days (c, f) after injury. Scalebar: 0.5 mm. Loss of cell
viability (represented by black/void space) is present in the immediate and peripheral regions to the site of
injury (crack or cut), which is not recovered with time in culture. Dead cells (nuclei of dead cells are stained
red) are visible upon further magnification of the region at 1 day (for cut samples) and up to 28 days (for
cracked samples) after injury.
When injured on day 35, however, the response of constructs depended on the mode of injury,
with overloaded constructs exhibiting an immediate drop in the compressive moduli at day 42 and
thereafter continually weakening, never recovering mechanical integrity even by the end of culture
(EY : 73.9 ± 20.9 kPa, G*: 0.4 ± 0.1 MPa, pEY <0.001, pG∗<0.001, Figure 3.9). Cut constructs,
however, were not significantly different from uninjured samples by the end of the culture period
(EY : 502 ± 70.1 kPa, G*: 2.2 ± 0.2 MPa, pEY =0.521, pG∗>0.999, Figure 3.9).
3.3.3.4 Biochemical Composition After Injury
Water content and biochemical composition were measured at each time point following injury.
Water content for injured constructs remained similar to uninjured control samples except for those
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* * * * * *
Figure 3.9: (a) Young’s modulus (EY ) and (b) Dynamic modulus (G*) of constructs with time in culture.
*p<0.05 vs. control, n=5/group. Crack d35 vs. control, EY : pday42<0.001, pday56<0.001, Pday70<0.001.
Crack d35 vs. control, G*: pday42<0.001, pday56<0.001, pday70<0.001.
exposed to compression-induced cracking on day 35 (pday42=0.020, pday56<0.001, pday70<0.001,
Figure 3.10). For all time points, biochemical composition was normalized to construct wet weight.
In cases when significant tissue swelling was noted (days 42-70), biochemical content was also
normalized to construct dry weight (Figure 3.11).




















Figure 3.10: Water content of engineered constructs over time. *p<0.05 vs. control, n=5/group. pday42 =
0.020, pday56<0.001, pday70<0.001.
Regardless of culture maturity at the time of injury, constructs retained their biochemical
constituents immediately following insult, as well as throughout the culture period. Specifically,
constructs injured early in culture were able to recover their biochemical content with time in
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Figure 3.11: (a) GAG and (b) collagen content of control and injured constructs over time normalized to
both construct wet weight (left) and dry weight (right). *p<0.05 vs. control, n=5/group. Crack d35 vs.
control, GAG: Pday42<0.001, Pday56<0.001, Pday70<0.001.
culture relative to uninjured controls (GAG: 7.9 ± 0.3% ww, collagen: 4.2 ± 0.4% ww, control
day 70; GAG: 7.4 ± 0.3% ww, collagen: 4.4 ± 1.5% ww, crack d5, pGAG>0.999, pCOL>0.999;
GAG: 9.0 ± 1.0% ww, collagen: 5.3 ± 0.9% ww, cut d5, pGAG = 0.208, pCOL=0.150, Figure 3.11).
When injured later in culture (d35), cut constructs similarly retained their biochemical makeup
(GAG: 7.4 ± 0.5% ww, collagen: 4.6 ± 0.4% ww, pGAG>0.999, pCOL=0.546, Figure 3.11). Mature
constructs cracked on day 35 exhibited an apparent loss in GAG content (4.8 ± 0.3% ww, p<0.001,
Figure 3.11), however, when normalized to dry weight to account for tissue swelling and increased
water content, GAG content was comparable to uninjured controls (56 ± 3.4% dw, control; 48 ±
CHAPTER 3. RESPONSE OF NATIVE AND ENGINEERED CARTILAGE TO
MECHANICAL INJURY 40
3.8% dw, crack d35, p=0.556, Figure 3.11). Collagen content was consistent for control and injured
groups regardless of normalization method.
3.3.4 Discussion
Currently, the predominant approach to clinical applications of cartilage tissue engineering is to
design a delivery system and scaffold that promote tissue growth in situ (e.g., (Caplan et al., 1997,
1993; Gao et al., 2002; Kawamura et al., 1998; Orr et al., 1999; Wakitani et al., 2007)). However,
based on our understanding of the biomechanics of diarthrodial joints, we believe that the in situ
environment is too harsh to allow a fledgling engineered tissue construct to develop a functional
cartilage matrix that can withstand the native mechanical and chemical loading conditions. In
particular, as the biomechanical environment is dictated by several factors including contact geom-
etry, size of defect, and degree of load sharing, the extent of functional tissue elaboration needed
to ensure the construct’s survival after implantation into a joint defect remains unclear. As a first
step toward predicting and characterizing the response to this harsh mechanical environment, engi-
neered cartilage constructs of different culture maturity were exposed to either compression-induced
cracking or controlled cutting.
While Young’s modulus and GAG are at native levels in 8 weeks or less, the dynamic modulus (a
functional measure that reflects tissue attributes such as radial tensile properties) and collagen levels
remain significantly lower (native juvenile bovine: G*: ∼40MPa, %Collagen/ww: ∼10%, (Bian
et al., 2008)) thereby signifying a major difference between our engineered cartilage and the native
tissue. The ability to achieve native collagen levels, presumably needed to recapitulate the normal
structure-function relationships of articular cartilage, continues to represent a significant challenge
to the field of cartilage tissue engineering. In the current study, mature (day 35) engineered cartilage
constructs exhibiting physiologic values of Young’s modulus demonstrated a poor healing capacity
following a cracking injury, in analogy to the known behavior of native cartilage (Kühn et al., 2004;
Lewis et al., 2003; Quinn et al., 2001). In contrast, cracking of immature (day 5) constructs was
followed by a complete recovery to control values by the end of the culture period.
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This maturation-dependent response may be attributed to the advanced development of ex-
tracellular matrix (ECM) in the day 35 constructs. At an early stage of culture, chondrocytes
embedded in the agarose hydrogel are not mechanically tethered to each other, due to the absence
of a continuous collagen fibrillar matrix. The deformation applied to the construct is transduced
to the cells only via the agarose hydrogel. In fact, chondrocytes deform less than the surrounding
agarose because of the formation of a local pericellular matrix (PCM), which occurs around day 4
in culture (Lee and Bader, 1995), making them stiff inclusions in a soft matrix. Therefore, when
cracking occurs, it is primarily a failure of the agarose hydrogel, which is known to have a limited
resistance to tensile stresses, exhibiting a relatively brittle behavior (Huang et al., 2008). The chon-
drocytes are only subjected to a transient deformation mitigated by their pericellular matrix, and
are thus able to survive the agarose cracking event (Figure 3.7) and continue to thrive by producing
a functional matrix, as evident from the observed results (Figures 3.9 to 3.11).
However, as the cell-elaborated matrix begins to coalesce into tissue islands that eventually form
a more contiguous ECM, the construct deformation may now be transduced to the chondrocytes
via pulling of the collagen fibers (Quinn et al., 2002), and the cracking event may rip at the cells
via integrin attachments. Therefore, cracking of more mature constructs leads to greater loss of
cells (Figure 3.8) and poor recovery of mechanical integrity (Figure 3.9). The role of the ECM
in mediating the deformation of mature constructs is directly evident in the load response at the
gross level (Figure 3.6b). The biphasic load response noted in Figure 3.6b may be attributed
to initial cracking of the less dense ECM inside the construct (Bian et al., 2009), followed by
subsequent cracking of the denser collagenous matrix known to grow on the outer surface of the
construct. Similarly, the ability of collagen fibrils to resist radial and circumferential tension is
manifested in the later onset of failure in mature versus immature constructs (∼50% versus ∼36%
axial compression). Furthermore, due to the increased compressive stiffness of the GAG-laden
mature constructs, chondrocytes are no longer able to resist the deformation of their surrounding
matrix, so that the crack-inducing loading event may cause significantly greater cell deformation,
and possibly cell death, than in immature constructs.
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In contrast, sharp cutting does not exhibit the same long-term detrimental effects as cracking,
analogous to native cartilage’s response to partial-thickness cutting (Meachim, 1963) The response
of immature constructs to cutting is similar to the cracking event: the cut primarily affects the
agarose hydrogel and, other than cells that come in direct contact with the blade, chondrocytes
remain unaffected by the cutting event (Figure 3.7d). Thus, the biosynthetic capacity of the
surrounding cells is maintained and constructs are able to grow a functional matrix over time. In
mature constructs, the blade now cuts through an elaborated ECM, causing more significant pulling
of the connected network of collagen fibers and producing cell death beyond the immediate path
of the blade (Figure 3.8d). However, cell death is significantly less widespread than with cracking,
such that cell death is no longer observed at later time point (Figures 3.8b versus 3.8e). Since the
chasms produced by the blade are not as wide as the cracks, a collagen network is apparently able
to bridge these gaps over time, as evident from the measured functional properties (Figure 3.9).
The lack of pervasive and continuing cell death after injury observed in this study may also
reflect the unique situation in which core biochemical constituents are maintained both immediately
and long-term after imposition of trauma. In both modes of injury, overloading or cutting, transient
indications of cell death were localized around crack and lesion sites. In extreme loading conditions,
articular cartilage can exhibit fissuring after mechanical insult (Atkinson et al., 1998), with cell
death in the proximity of tissue matrix cracks (Lewis et al., 2003). With time in culture, however,
cell death is consistently seen to emanate away from the site of injury as paracrine factors are
released from necrotic cells (dying from cell injury) and subsequently influence neighboring cells to
undergo programmed cell death, a consequence of apoptosis (Tew et al., 2000). Similarly, in the
most extreme loading condition of this study, constructs exposed to catastrophic damage exhibited
prolonged cell death almost 4 weeks after injury (Figure 3.8b), suggesting that the mode of cell
death is no longer necrotic, which occurs within hours or days (Chen et al., 2001), but rather in
a manner consistent with apoptosis. However, in contrast to native cartilage, with further time in
culture, cell death in overloaded constructs was mitigated, and further signs of continual cell death
were not observed (Figure 3.8c). In comparison, for constructs injured earlier in culture or less
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severely, patterns of delayed cell loss after injury were not observed, suggesting that cells either
were not continually dying or new cells from cell division were repopulating injured regions and
masking cell loss, as indicated by the comparable DNA content across all groups. This possibility is
supported by analysis of the fraction of live cells in the center region of cut constructs which found
that cells proliferated at a greater rate than uninjured control constructs and may have offset the
loss in cell number stemming from the initial cell death after injury.
Explant studies have previously shown that chondrocytes close to an injury site tend to react to
the imposed trauma by either dying or proliferating (Stockwell, 1979), although it is unclear what
triggers one path over the other. The findings of this study suggest that while cells in engineered
cartilage are immediately mechanically compromised after injury, the alternative downstream path-
ways of cell death or proliferation depend on the culture maturity of the construct. For constructs
injured early in culture or injured less severely, rather than entering apoptotic pathways, the cells
proliferate in the regions adjacent to the lesion. For engineered constructs exposed to catastrophic
matrix damage, some cells enter apoptotic pathways and exhibit delayed death, but interestingly,
the system seems to only reside in this state transiently with little effects on the biochemical
composition of the tissue.
However, while we did not observe biochemical content degradation or continual cell death,
constructs cracked late in culture were unable to recover their mechanical properties and intrinsi-
cally repair themselves, similar to that which is seen with cartilage explants in vitro and suggested
to happen in vivo. The observed mechanical failure suggests immediate catastrophic structural
damage of the construct rather than subsequent degradation cascades. This proposed mechanism
of failure is further supported by the different responses seen with compression-induced cracking
and cutting. Like cartilage explants exposed to scalpel injuries (Amin et al., 2008a; Tew et al.,
2001), cut constructs lack the traumatic structural changes associated with other modes of injury
such as compression (Chahine et al., 2004; Loening et al., 2000; Torzilli et al., 2006; Wang et al.,
2002), indentation (Chen et al., 2001; Levin et al., 2001), and trephine punches (Tew et al., 2001,
2000). As such, it may be that localized structural damage from the blade is insufficient to cause
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bulk structural damage of the construct that is necessary for mechanical failure.
It is important to note, however, that this response to mechanical overload as well as cutting
likely reflects the conditions of the experimental setup, specifically the chosen scaffold system and
the cell type used, which together define the nature of the cell-matrix interactions that develop
in culture. There exist several possible mechanisms that may underscore differences in the injury
response of engineered cartilage to literature reports of cartilage explant injury. First, while our
engineered tissues recapitulate many of the structure-function relationships of native cartilage (Lima
et al., 2007), the collagen content remains significantly lower than native levels, in contrast to
GAG levels that reach native content. Collagen content is likely to affect cell-matrix coupling.
Additionally, variations in engineered extracellular matrix organization may lead to differences in
how dead cells and apoptotic bodies are entrapped. The avascular nature of cartilage and lack
of mononuclear phagocytes in vivo prohibit the removal of apoptotic bodies, which subsequently
become lodged in surrounding lacunae (Hashimoto et al., 1998). As such, for cartilage explants
injured in vitro, the inherently dense extracellular matrix may act to keep apoptotic bodies bound to
the tissue. The prolonged presence of these bodies has been suggested to perpetuate a degradative
cascade, as is seen in osteoarthritis (Blanco et al., 1998; Kouŕı et al., 2000). In contrast, the less
dense matrix of engineered cartilage may facilitate the removal of dead cells and apoptotic bodies;
therefore, injured constructs, even in the most severe cases, do not exhibit continual cell death at
50 days post injury (Figure 3.8c).
We note that constructs having Young’s modulus of approximately 300 kPa failing at 40g of
force experienced a compressive stress of 0.03MPa, much lower than what is reported in vitro for
cartilage (Milentijevic and Torzilli, 2001), but with perhaps similar failure strain levels (Ewers et al.,
2001; Flachsmann et al., 2001). We attribute this disparity as a consequence of the low collagen
content of our engineered cartilage as well as the unconfined compression experimental injury setup,
which may exacerbate the latter by permitting free radial tissue expansion during axial compressive
loading. Whether the current tissues could survive undamaged in a living joint is a complex question
and would depend on the location of the focal defect on the joint being treated and its dimensions
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relative to intact articulating surface, as the surrounding tissue (around the defect) would shoulder
a portion of the joint loads depending on the contact geometry. Tissues grown in our laboratory
with native Young’s modulus have survived in focal defects (4 mm diameter) created in the canine
stifle joint (trochlear groove) for 12 weeks (Ng et al., 2010). As the tissue construct gets increasingly
larger, such as for replacing an entire articular surface, such as for a patella, the loading demands
would increase as the contribution from surrounding tissues diminishes (Hung et al., 2003).
Furthermore, unlike native cartilage, the engineered cartilage consists of a mixed population of
chondrocytes isolated from full-thickness cartilage. As such, the normal zonal (cellular, biochemical,
structural and mechanical) organization of cartilage is not recapitulated. Yet, it is known that
zonal cell-to-cell differences may predispose certain chondrocytes to exhibit strain-induced loss of
viability (Chahine et al., 2007). In the future, the injury response of constructs with specific zonal
cell populations and/or with stratified engineered hydrogel layers may need to be examined (Ng
et al., 2005). To the best of our knowledge, this study represents the first attempt to model
and characterize injury and the subsequent response of engineered cartilage constructs under a
controlled loading environment. Unlike native cartilage explants, engineered cartilage possesses the
ability to heal and repair with further time in culture as long as the bulk structural makeup of the
construct is left intact. The results of this study begin to characterize the conditions under which
mechanical failure occurs and provide greater insight to the behavior and response of engineered
cartilage tissue grafts to mechanical insult.
3.4 Culture in Chondrogenic Medium Fosters Protection Against
Propagative Cell Death
3.4.1 Introduction
The use of FBS, whose composition is highly variable and unknown, for tissue culture has been
largely precluded. Instead, many groups have chosen to employ more consistent formulations of
a chemically defined serum-free medium for the culture of cartilage (Dumont et al., 1999; Mauck
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et al., 2006). In particular, our lab has adopted a serum-free media composition (also referred to as
chondrogenic medium - CM) that has been shown to induce chondrogenesis in bone marrow-derived
stem cells and promote extracellular matrix development in tissue engineered cartilage (Mauck
et al., 2006). Notably, when cartilage explants were cultured in serum-supplemented medium, they
exhibited significant tissue swelling degradation (Bian et al., 2008; Sah et al., 1989; Torzilli et al.,
1997). In contrast, explants cultured in CM were enhanced in as little as 2 weeks and remained
stable for the duration of the study (Bian et al., 2008). Hypothesized to be due to the inclusion
of dexamethasone, a synthetic adrenal corticosteroid, this CM formulation contains soluble factors
that promote mechanical properties of cartilage explants and protect it against catabolic factors.
In this way, we observed a potentially protective effect for cartilage explants exposed to a
harsh mechanical injury (See Section 3.2). This is in contrast to reports in the literature that have
consistently shown that cell death continues to emanate away from the site of injury and persist long
after the initial insult. Here, we revisit that injury model and probe whether the protective effects
noted earlier for explants cultured in CM translate to engineered cartilage constructs (Section 3.3:
Study 1 ) and directly compare the use of CM with FBS-containing medium (Section 3.3: Study 2 ).
3.4.2 Materials and Methods
3.4.2.1 Tissue Isolation and Cell Culture
∅6.35mm explants (full thickness cartilage with attached subchondral bone) were cored out of
the carpal face of juvenile bovine wrist joints (n=2). Joints showing any contraindications were
discarded. Explants were stored in chondrogenic media (serum-free DMEM supplemented with
ITS+, dexamethasone, and ascorbic acid).
Articular cartilage shavings were also harvested from CMC joints of freshly slaughtered 2-4-
week-old calves (n=4-6 joints). Cartilage was digested in high-glucose DMEM with collagenase
type V (Sigma, St. Louis, MO) for 11 hours at 37°C with shaking. Cell suspensions were filtered
through a 70µm porous mesh and sedimented in a bench-top centrifuge for 15 min at 1500g. Viable
cells were counted with a hemacytometer and trypan blue. Cell suspensions (60×106 cells/mL)
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were mixed in equal parts with 4% low-gelling agarose (type VII, Sigma) at 37°C to yield a final
cell concentration of 30×106 cells/mL in 2% agarose. The chondrocyte/agarose mixture was cast
into slabs and cored using a sterile disposable punch (Miltex) to final dimensions of 4mm diameter
and 2.34 mm thick.
Constructs were cultured in hgDMEM supplemented with 1X PSF, 0.1µM dexamethasone,
50µg/mL ascorbate 2-phosphate, 40µg/mL L-proline, 100µg/mL sodium pyruvate, and 1X ITS+
premix (insulin, human transferrin, and selenous acid, Becton Dickinson, Franklin Lakes, NJ).
Medium was further supplemented with 10ng/mL TGF-β3 (Invitrogen, Carlsbad, CA) for the first
14 days of culture. Culture media was changed every other day.
3.4.2.2 Injury
Study 1: On day 35 of culture, constructs exhibiting properties similar to native cartilage (Young’s
modulus and glycosaminoglycan content) were subjected to a cutting injury. Specifically, two or-
thogonal cuts were made in constructs by pushing a razor blade to 50% of the construct’s original
thickness (Figure 3.12). Razor blades were pushed straight down to prevent the application of ad-
ditional shear forces, and were replaced after every five constructs to prevent dulling of the blade.
Afterwards, samples (including controls manipulated similarly to injured constructs, without actual
trauma) were returned to culture in freshly supplemented media and allowed to recover in culture
to day 21 for viability staining. Explants were similarly injured by cutting 5 days after harvest.
Figure 3.12: Schematic of cutting scheme. Blades were pushed straight into the sample to a depth of 50%
and then removed. Blades were replaced every 5 samples to avoid dulling.
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Study 2: To control whether this effect was specific to the cutting injury and the chondrogenic
media formulation, a second set of explants was harvested, similarly cultured out to 5 days in the
same medium, but then a ∅1mm cylindrical plug was aseptically cored out of the center of each
explant using a custom-programmed milling machine (Section 3.2.2.2, Figure 3.1) equipped with a
disposable biopsy punch. Post injury, samples were returned to culture in either CM media or in
media supplemented with FBS.
3.4.2.3 Cell Viability Assessment
Assessment of cell viability was performed using the Live/Dead cytotoxicity assay (Molecular
Probes, Eugene, OR) at immediate- (1 day), short- (10 days), and long- (21, days) time points
post trauma. The assay is based on calcein AM permeating the membranes of cells with intact
cell membranes, producing a green fluorescence (live), while ethidium homodimer permeates the
nuclei of dead cells (with compromised cell membranes) to produce a red fluorescence (dead). An
apoptosis assay (Molecular Probes, Eugene, OR) was also performed on a second set of identical
constructs and explants to assess the mechanism of cell death. The assay is based on Yo-Pro©-1
(green) dye entering the permeant membrane while propidium iodide (red) dye is excluded. When
used together to stain a cell population, apoptotic cells shown green fluorescence, dead cells show
red and green fluorescence, and live cells show little or no fluorescence. After each viability assay,
constructs were aseptically returned to culture media to allow for assessment of cell death in the
same sample at later timepoints. Live and dead images were taken separately on an inverted con-
focal fluorescent microscope (Leica, Bannockburn, IL). Overlaid images of live and dead cells were
analyzed using ImageJ (NIH) to measure the area of cell death emanating away from the site of
injury (Figure 3.13).
3.4.2.4 Statistics
Statistics were performed using two-way ANOVA with Tukey’s HSD post-hoc tests (Statistica,
Tulsa, OK), with α=0.05 and statistical significance set at p≤0.05 to compare groups across media
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Figure 3.13: Representative overlaid live/dead stains with lines demarcating the regions of cell death
adjacent to the site of injury.
type and time. All data are reported as the mean ± 95% confidence interval of 4-5 samples per
time point and group.
3.4.3 Results
Study 1: Cellular viability, as assessed by the Live/Dead cytotoxicity assay and the apoptosis assay
kit, was found to be maintained in both engineered constructs and cartilage explants following the
cutting injury. With time in culture, the area surrounding the cut remained constant, with no
infiltration of neighboring cells (Figure 3.14, p>0.05).
Study 2: Cored explants stored in CM exhibited similar results to the explants and tissue engineered
constructs from Study 1 (Figure 3.15, p>0.05). Cell death area remained confined with no spreading
of the paracrine factors associated with apoptosis. When FBS-containing medium was used as a
storage solution, however, by day 28, cell death area was significantly increased in those constructs
as compared to those stored in CM (Figure 3.15, p<0.05).
3.4.4 Discussion
Tissue culture storage in CM protects native and mature engineered cartilage by confining cell
death to the injury site. Regardless of the mode of injury applied in these studies, cell death was
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Figure 3.14: Representative overlaid live/dead images of cut (top) engineered constructs and (bottom)
native cartilage with time in culture after (left) 1 day, (middle) 7 days, and (right) 21 days in culture.
mitigated and did not appear to exhibit the paracrine soluble factors that are typically associated
with apoptosis after injury in cartilage (Chen et al., 2001). However, when these same explants
were stored in FBS-containing medium, the area of cell death was significantly increased, agreeing
with findings in the literature reporting a zone of inhibition following injury.
Though CM was observed here to prevent the progression of tissue injury, it is important to
note that, as reported in Section 3.2, some modes of injury, such as stress-induced cracking, are too
severe to resist the catabolic cascade that ensues following insult, no matter the culture medium
formulation. However, in showing the disparity in the size of the cell death zone for constructs
cultured in CM and serum-containing media for the same type of injury, as performed here, we can
postulate that the protective effect against cell death propagation indeed is a direct consequence
CHAPTER 3. RESPONSE OF NATIVE AND ENGINEERED CARTILAGE TO
MECHANICAL INJURY 51
Figure 3.15: Measured cell death area for explants after punching with time in culture with different
storage media. *p<0.05, n=20/group.
of soluble factors that are present in the CM formulation. Detailed high-throughput screening of
the chemical mediators present in the CM formulation will be necessary, however, to elucidate the
particular factor(s) responsible for this protective effect.
3.5 Conclusion
Understanding the response of cartilage, both native and engineered, to mechanical insult is cru-
cial towards efforts in designing repair strategies. In this chapter of the dissertation, new culture
systems are described, which complement existing in vitro injury model studies described in the
literature. First, we assessed two common modes of iatrogenic injury stemming from graft har-
vesting procedures and examined whether modifications in stabilizing one degree of freedom could
mitigate the spread of cell death described previously. Our results found that controlled drilling
with optimized parameters of insertion rate and rotational speed were far superior to the simple
punch motion, offering insights into considerations for improving graft transplantation techniques.
Secondly, we characterized, for the first time, the influence of mechanical insult on engineered car-
tilage, and found that both the type of injury as well as construct maturity are significant factors
in the consequent response. In particular, engineered cartilage, unlike native cartilage, possesses
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the inherent ability to repair following injury unless catastrophic matrix failure is noted. These
findings contribute to the literature on tissue engineering for cartilage replacement and strongly
imply that a specific window of time exists for optimal implantation. Finally, we explored further
the role of culture medium in mediating the progression of cell death. Collectively, these studies
offer a more complete characterization of the response of cartilage to mechanical injury, and begin
to provide insights into how the damage may be contained.
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Chapter 4
Influence of Extracellular Osmotic
Environment during EF-Induced Cell
Migration and the Role of AQP1
4.1 Introduction
As field gradients exist in both wound healing and developing embryos (Robinson, 1985), under-
standing osmotic challenges in the context of EF-induced migration is crucial. To this end, we
examined whether changes to the osmotic extracellular environment induce cellular changes suf-
ficient to influence cell migration patterns. As osmotic effects are highly regulated by membrane
channels and transporters, we first examined the role of the AQP1 water channel during EF-induced
migration (Section 4.2). Subsequently, we osmotically challenged these cells and observed their re-
sponse under EF (Section 4.2). Finally, since IL-1 exposure in chondrocyte culture has been shown
to result in a decrease in cytoskeletal components (tensin, talin, paxillin, and FAK, (Vinall et al.,
2002)) and correspondingly volumetric response (Pritchard et al., 2008), behaviors mediated by
the activity of AQP1, we examined a clinically relevant IL-1-rich environment to the examine the
response of migration (Section 4.3).
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4.2 Role of AQP1 in Regulating Extracellular Osmotic Environ-
ment during EF-Induced Migration
4.2.1 Introduction
Proteoglycan molecules make up 20-30% of the solid organic matrix of cartilage and their polyan-
ionic chains bind and attract water, leading to an increase in internal swelling pressure (Buschmann
et al., 1995; Lai et al., 1991). In situ osmolarity of cartilage tissue has been estimated to be 350-450
mOsm (Koo et al., 2010; Urban et al., 1993), depending on the zone. During osteoarthritis, degra-
dation of matrix molecules leads to a corresponding decrease in osmolarity (Maroudas and Venn,
1977). Similarly, synovial fluid extracted from healthy knees is 400 mOsm and becomes hypotonic
(∼300 mOsm) with joint injury and arthritis (Baumgarten et al., 1985; Jensen and Zachariae,
1959; Newman and Grana, 1988; Shanfield et al., 1988). Transient osmotic challenges have been
shown to modulate chondrocyte intracellular signaling events and biosynthetic activities (Chao
et al., 2006; Erickson et al., 2003; Yamazaki et al., 2000). Therefore, the osmotic environment and
ensuing mechanotransduction events may be significant factors that influence cell migration. Pre-
vious studies have found that the extracellular osmotic environment changes membrane hydraulic
permeability of chondrocytes and cell volume (Hall et al., 1996; Oswald et al., 2008; Pritchard and
Guilak, 2004; Shen et al., 2002; Wang and Zhu, 2011) by alterations to the membrane structure
(Borghetti et al., 1995; Erickson et al., 2001; Hopewell and Urban, 2003; Yellowley et al., 2002) and
AQP1 water channels (Elmoazzen et al., 2002; Guilak et al., 2002; Jaeger et al., 1999; Mobasheri
et al., 2002). These changes in cell volume may work to propel the cell during migration; in fact,
unequal rates of water entry to the front and back parts of the cell has generated forces sufficient
to propel forward motion of a cell even in the absence of actin (Jaeger et al., 1999). As such, AQP1
been implicated in the mechanotransduction of cell volume from theoretical principles (Liang et al.,
2008; Mobasheri et al., 2002). Recently, studies have identified the presence of the AQP1 water
channel in cultured human and equine articular chondrocytes (Mobasheri et al., 2004; Trujillo et al.,
2004).
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4.2.2 Materials and Methods
4.2.2.1 Experimental Design
Two consecutive studies are described herein that utilize our established galvanotaxis protocol.
In the first study, cells were treated with an AQP1 channel inhibitor (silver sulfadiazine) and
exposed to EF strengths previously shown to induce migration. In the second study, cells were first
osmotically challenged before undergoing migration experiments.
4.2.2.2 Cell Harvesting and Expansion
Articular cartilage was harvested from bovine knee joints of four freshly slaughtered 2-4 week
old calves and digested in high-glucose DMEM with collagenase IV (Worthington Biochemical
Corporation, Lakewood, NJ) for 11 h at 37°C with shaking.
Cell suspensions were filtered through a 70µm porous mesh and sedimented in a bench-top
centrifuge for 15 min at 1500g. Viable cells were counted with a hemocytometer and trypan blue
and plated at high density (20×103 cells/cm2). DMEM was supplemented with 10% fetal bovine
serum, 100 U/mL each of penicillin, streptomycin, and fungizone, and a growth factor cocktail (1
ng/mL TGF-β1, 5 ng/mL bFGF, and 10 ng/mL PDGF-ββ (Ng et al., 2010; Sampat et al., 2011)).
Medium was changed every three days. Chondrocytes were expanded and used after 1 passage
(Chao et al., 2000).
Aquaporin-1 Inhibitor : 1mM silver sulfadiazine was dissolved in DMSO and used at a final
concentration of 5µM in 0.5% DMSO.
Osmotic Solutions: Osmotic solutions were made with DMEM and water or sucrose was added
to the base media (337 mOsm) to make hypo- (200 mOsm, 300 mOsm) or hypertonic (400
mOsm) solutions, respectively. Sucrose was chosen, as opposed to NaCl/KCl as previously
established (Sampat et al., 2013), to maintain constant ionic content and conductivity of the
bathing medium across all groups. While both sucrose and sodium chloride decrease chon-
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drocyte volume, with the latter, there is an additional increase in the intracellular sodium ion
concentration that may lead to altered activity of sodium-dependent membrane transporters
which in turn facilitate cell migration (Schwab, 2001).
For galvanotaxis experiments, DMEM was supplemented with 5% fetal bovine serum (FBS, Atlanta
Biologicals), 1% PSAM (Invitrogen, CA) and buffers. The osmolarity of the final solutions was
confirmed to be ∼250, 350, and 450 mOsm using a freezing-point depression osmometer (Advanced
Instruments, MA).
4.2.2.3 Galvanotaxis
Study 1 : At confluence, chondrocytes were released from culture with trypsin, suspended in media
for one hour to allow for equilibration, and then plated at 2.65×104 cells/cm2 onto sterile glass
slides using removable silicone wells. During the equilibration phase, for one subset of cells, silver
sulfadiazine was added to the cell suspension.
Study 2 : At confluence, chondrocytes were released from culture with trypsin, suspended in osmotic
media (250 mOsm, 350 mOsm, and 450 mOsm) for at least two hours to allow for equilibration.
Control studies have shown no observable differences from cells that equilibrated in osmotic media
overnight or longer. Cell suspensions were then plated at 2.65×104 cells/cm2 onto sterile glass
slides using removable silicone wells.
For both studies, after attachment for 1 hour in a 5% CO2 incubator at 37°C, the slide was gently
rinsed to remove non-adherent cells and then positioned in the chamber. A modified parallel-plate
flow chamber was used, as described previously (Chao et al., 2000). A power supply (Kiethley
Instruments) delivered a current of 3.3 mA (6 V/cm EF strength) through the chamber (Figure 4.1,
and experiments were performed at room temperature for 3 h. Control slides were treated similarly,
except no EF was applied. Cell migration patterns were captured using an Olympus IX-70 inverted
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Figure 4.1: Schematic of galvanotaxis setup. Cells seeded on a glass slide were inserted into a custom
chamber and exposed to an electric field gradient.
microscope equipped with a MicroMax 5-MHz interline transfer chip digital camera (Princeton
Instruments, NJ) linked to a computer running Metamorph software (Universal Imaging). Using
a Hoffman contrast filter and 10× objective (1 pixel = 0.68 µm), approximately 30-40 cells were
observed in each field of view; images were acquired at 10 min intervals.
4.2.2.4 Cell Migration Parameters
The position of each cell was manually tracked via a custom MATLAB program that utilizes
measurements of the net centroid displacement from the starting position (set as origin) to calculate
overall speed of migration for each cell (the net displacement in the experiment divided by the 3 h
time span of observation). Migration direction was quantified as sinφ, where φ is the angle between
the x-coordinate axis and the migration vector, such that sinφ was defined as the value -1 when φ
= 4.71 rad (270°), the direction of the cathode. The directional velocity, defined as the component
of the speed directed toward the negative pole (e.g. (Chao et al., 2000, 2007)), was obtained by
multiplying a cell’s speed by sinφ. Each data point represents the mean and standard error of the
mean from 60-80 samples.
4.2.2.5 Statistics
A two-way ANOVA was performed on cell speed, directed velocity, and total displacement for
factors of treatment (applied EF vs. control), and condition (either for AQP-1 inhibition (study 1 )
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or osmolarity (study 2 )) to determine significance (p<0.05) of the effect of each factor and also the
interaction of the factors. Tukey’s honest significant difference (HSD) post hoc test was performed
to assess significance (p<0.05).
4.2.2.6 Immunocytochemical Staining
Study 1: Aquaporin-1 Immunofluorescence: Following galvanotaxis, cells were fixed in ice-cold
methanol for 10 minutes at -20°C, blocked with PBS containing 10% NGS for 1 hour at room tem-
perature, and then incubated with primary polyclonal antibody to AQP1 (Millipore, diluted 1:200
in PBS containing 1% NGS) for 2 hours at room temperature and followed by Alexa Fluor 488-
conjugated anti-rabbit IgG (Invitrogen) and TRITC-conjugated phalloidin. Cells were mounted in
mounting medium containing a DAPI counterstain and then examined with an Olympus fluores-
cence microscope.
Study 2: Actin Cytoskeleton Immunofluorescence: Following galvanotaxis experiments, cells were
fixed with 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1%
Triton X-100 (Sigma, MO), blocked with 1% BSA in PBS, and then incubated with primary
antibody to Vinculin (Millipore, diluted 1:100 in 1% BSA in PBS) for 1 hour at room temperature
and followed by Alexa Fluor 488-conjugated anti-goat (Invitrogen, diluted 1:50 in PBS) and TRITC-
conjugated phalloidin (Millipore, diluted 1:100 in PBS). Cells were mounted in mounting medium
containing a DAPI counterstain and then examined with an Olympus fluorescence microscope.
4.2.3 Results
4.2.3.1 Role of AQP1 in EF-Induced Cell Migration
Efficacy of silver sulfadiazine as an AQP1 inhibitor was first confirmed by analyzing cell volume
change with a Coulter counter following osmotic loading. Addition of deionized water to a cell
suspension (∼380 mOsm) to create a final solution of 300mOsm yielded no volume change when
chondrocytes were pretreated with silver sulfadiazine (Figure 4.2).
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Figure 4.2: Normalized cell volume change after introduction of D.W. to 380 mOsm cell suspension to create
a final osmolarity of 300mOsm. Arrow indicates point of influx, approximately 200,000 cells counted/group.
Cells treated with the AQP1 inhibitor exhibited significantly altered migration behavior; both
control and electric field stimulated cells showed decreased displacement (Figure 4.3a, p<0.05).
Furthermore, these cells exhibited less preferential migration after exposure to an electric field
and showed no significant bias in direction, similar to control cells (Figure 4.3b, p>0.05). When
these cells were stained for AQP1, actin cytoskeleton, and DAPI, differences were observed between











































Figure 4.3: Effect of silver sulfadiazine on migration parameters ((a) displacement, (b) directed velocity)
for chondrocytes after 3hr of applied DC electric field. *p<0.05 vs. no EF control, #p<0.05 vs. respective
control (no inhibitor). n=50-60 cells/group.
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field stimulation, control cells reoriented their long axis perpendicular to the direction of field
and exhibited elongated and outstretched processes (Figure 4.4). Furthermore, AQP1 proteins
localized to the periphery of the pseudopods. In contrast, cells treated with silver sulfadiazine
remained spherical with diffuse AQP1 labeling.
Figure 4.4: Representative immunofluorescence micrographs of cells at t=3hr after DC electric field was
turned on. Alexa Fluor 488 (green): AQP1; DAPI (blue): nucleus; TRITC (red): phalloidin. Scalebar = 20
µm.
4.2.3.2 Osmotic Extracellular Environment Modulates Cell Migration Behavior
Chondrocytes exhibited a change in cell volume and shape following suspension in the chamber with
the differing osmolarities. 250 mOsm-treated cells appeared stretched with spread focal adhesions
(Figure 4.5). In contrast, 350 mOsm and 450 mOsm cells retained a spherical shape with minimal
spreading of focal adhesions or attachment plaques. These osmolarity-dependent changes were not
visible for cells that were exposed to EF; regardless of osmotic environment, all cells stretched out
and oriented themselves perpendicular to the direction of field (Figure 4.5).
The baseline migration of chondrocytes was not altered with osmotic loading. Control cells
moved an average of 2.64 ± 0.40 µm/hr and showed no significant differences (p>0.05, Figure 4.6a)
across all osmolarity groups. Similarly, these cells exhibited no preferential direction of migration,
resulting in an average directed velocity of 0.13 ± 0.51 µm/hr across all groups (p>0.05, Figure
4.6b). In contrast, when EF was applied, the migration response of chondrocytes to EF was
highly dependent on osmotic environment. A parabolic trend was noted for increasing osmolarity,
whereby cells traveled faster and farther at hypotonic (250 mOsm) and hypertonic (450 mOsm)
osmolarities that was not significantly different from one another (12.1 ± 1.24 µm/hr vs. 10.6 ±
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Figure 4.5: Actin cytoskeleton staining of chondrocytes exposed to various osmotic environments in the
absence or presence of EF. Alexa Fluor 488 (green): vinculin; DAPI (blue): nucleus; TRITC (red): phalloidin.
Scalebar = 50 µm.
0.94 µm/hr, p=0.36). Chondrocytes in isotonic medium traveled significantly slower, only reaching
7.03 ± 0.70 µm/hr (p250−350<0.0001, p350−450=0.0014, Figure 4.6a). The direction in which these
cells traveled did not exhibit a similar parabolic trend, with hypotonic cells exceedingly traveling
toward the cathode (negative pole). Meanwhile, isotonic and hypertonic cells exposed to EF were
statistically similar to control cells (p=0.9999, p=0.9213, respectively, Figure 4.6b) and did not
exhibit large changes in migration direction.
4.2.4 Discussion
These results showed, for the first time, that AQP1 water channels modulate chondrocyte migration
with exposure to an applied DC electric field. Our findings corroborate previous studies that have
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Figure 4.6: Effect of osmotic extracellular environment on migration parameters ((a) speed, (b) directed
velocity) of chondrocytes. *p<0.05 vs. no EF control, #p<0.05 vs. isotonic (350 mOsm) condition.
identified AQP1 as essential for cell migration and wound healing through beta-catenin mediated
cytoskeletal reorganization (Liang et al., 2008; Monzani et al., 2009; Ruiz-Ederra and Verkman,
2009). Furthermore, chondrocytes from AQP-1 knockout mice exhibit significantly reduced adhe-
sion and migration abilities (Liang et al., 2008). Interestingly, contrary to reports in the literature
that AQP1 proteins are localized to the front edge of the migrating cell (Liang et al., 2008; Monzani
et al., 2009; Ruiz-Ederra and Verkman, 2009; Verkman, 2005), here we have shown that following
exposure to electric field stimulation, AQP1 proteins are localized to the perimeters of the extended
protrusions. This may be due to the addition of the electric field, which can redistribute surface
proteins and alter reorganization of the cytoskeletal make-up.
Extracellular osmolarity has been shown to be responsible for changes in cell volume, cytoskele-
ton organization and gene expression (Erickson et al., 2001; Sanchez and Wilkins, 2003; Yellowley
et al., 2002). We have observed that the osmotic environment significantly impacts the chondro-
cyte’s actin cytoskeleton, and subsequently, motility in the presence of an applied EF. Hypotonic
(250 mOsm) chondrocytes exhibited prominent cytoskeletal organization with dramatically en-
hanced cellular migration toward the cathode. In contrast, the isotonic or the more “physiologic”
350 mOsm group appeared to be smaller and exhibit a more spherical morphology. In control
conditions (no EF), cells exhibited trends consistent with findings in the literature that describe
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enhanced migration for cells in a hypotonic environment. In these studies, exposure to hypotonic
shock led to recruitment of focal adhesion kinase (FAK) in osteoblasts via opening of large conduc-
tance calcium-and voltage-dependent potassium channels (Rezzonico et al., 2003). FAK has been
shown to regulate the recruitment of key proteins necessary for stimulated cell migration (Sieg
et al., 1999). With hyperosmotic environments, the opposite was found, whereby hypertonic saline
in fact attenuates tumor cell migration by reducing integrin expression (Shields et al., 2006, 2004).
Interestingly, this negative trend in migration behavior was not paralleled when EF was ap-
plied. Instead, a parabolic trend was observed, whereby both hypo- and hyper-tonic cells exhibited
enhanced migration. The contrasting effects noted here suggest an additional influence from the
applied EF that directs migration. One possibility may be polarized redistribution of channels and
transporters. The findings from Study 1 confirm that AQP channels are localized to the perimeters
of the cell during EF-induced migration, contrary to their location during normal migration in the
absence of EF; as a consequence, physical presentation of the cell (swollen in hypotonic conditions,
shrunken in hypertonic conditions) could influence the degree of polarization and consequently the
rate at which water flux occurs. This is further supported by our observations that significant
directional (cathodal) migration was noted only for cells incubated in a hypotonic medium.
4.3 Characterizing Chondrocyte and SDSC Migration in an In-
flammatory Environment
4.3.1 Introduction
SDSCs have shown resistance to the catabolic factors (e.g. interleukin 1β and tumor necrosis factor-
α) that are present in synovial fluid during injury (Nagase et al., 2008; Zimmermann et al., 2001).
Additionally, it has been speculated that in the presence of partial thickness defects in rabbits,
SDSCs are recruited to the wound site (Hunziker and Rosenberg, 1996), although the mechanism
of inducing their migration is unknown. While IL-1 has been widely implicated in the degradation
of extracellular matrix components, less is known regarding how isolated synovium derived stem
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cells (SDSCs) exposed to IL-1 behave. In studies reported in the literature, the addition of IL-
1 to chondrocytes in 2D culture induced a loss of phenotype and decreased the expression of
cytoskeletal components such as tensin, talin, paxillin, and focal adhesion kinase (Vinall et al.,
2002), thereby altering their migration behavior. Whether the resistant nature of SDSCs extends
to migration response has not been examined. Accordingly, we sought to determine the effect of
cytokine exposure on the response of expanded SDSCs and chondrocytes, for comparison, to an
applied DC electric field. A more complete understanding of how IL-1, a common pro inflammatory
agent present during injury and disease, influences cell migration may provide new insight into the
wound healing process and techniques that may be used to guide and direct the repair of articular
cartilage.
4.3.2 Materials and Methods
4.3.2.1 Cell Isolation and Expansion
Articular cartilage and the intimal layer of the synovium were harvested from bovine knee joints
of four freshly slaughtered 2-4 week old calves. Cartilage was digested in high-glucose DMEM
with collagenase IV (Worthington Biochemical Corporation, Lakewood, NJ) for 11 h at 37°C with
shaking. Synovial tissue was digested in alpha Modified Eagle’s Medium (α-MEM) with collagenase
type IV (Worthington, Lakewood, NJ) for only 4 h at 37°C with gentle shaking.
Cell suspensions were filtered through a 70µm porous mesh and sedimented in a bench-top
centrifuge for 15 min at 1500g. Viable cells were counted with a hemocytometer and trypan blue
and plated at high density (20×103 cells/cm2) for chondrocytes and at low density (1.76×103
cells/cm2) for SDSCs. Medium (DMEM or α-MEM for chondrocytes and SDSCs, respectively)
was supplemented with 10% fetal bovine serum, 100 U/mL each of penicillin, streptomycin, and
fungizone, and a growth factor cocktail (1 ng/mL TGF-β1, 5 ng/mL bFGF, and 10 ng/mL PDGF-
ββ (Ng et al., 2010; Sampat et al., 2011)). Medium was changed every three days. Chondrocytes
were expanded and used after 1 passage (Chao et al., 2000), while SDSCs were cultured for 4
passages before use, as informed by Section 4.2. A subset of each of these cell types was also
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expanded in the presence of 10 ng/mL IL-1α for the passage immediately prior to their use.
4.3.2.2 Galvanotaxis
At confluence, cells were trypsinized and resuspended at 50×103 cells/mL in DMEM containing
5% (v/v) FBS, amino acids (0.5× minimal essential amino acids, 1× nonessential amino acids),
buffers (10 mM HEPES, 10 mM sodium bicarbonate, 10 mM TES, 10 mM BES), and antibiotics
(100 U/mL penicillin, 100 mg/mL streptomycin) and allowed to equilibrate for 1 h. Cells were
then plated at 2.65×104 cells/cm2 onto sterile glass slides (Fisher Scientific, Pittsburgh, PA) using
removable silicone wells. After cells were allowed to attach for 1 h in a 5% CO2 incubator at
37°C, the slide was rinsed with medium to remove any nonadherent cells and placed into a custom
galvanotaxis chamber (described in Section 4.2.2.3) under aseptic conditions. Approximately 30-40
cells were observed in each field of view; images were acquired at 5 min intervals.
4.3.2.3 Cell Migration Parameters
The position of each cell was manually tracked via a custom MATLAB program that utilizes
measurements of the net centroid displacement from the starting position (set as origin) to calculate
overall speed of migration for each cell (the net displacement in the experiment divided by the 3 h
time span of observation). Migration direction was quantified as sinφ, where φ is the angle between
the x-coordinate axis and the migration vector, such that sinφ was defined as the value -1 when φ
= 4.71 rad (270°), the direction of the cathode. The directional velocity, defined as the component
of the speed directed toward the negative pole (e.g. (Chao et al., 2000, 2007)), was obtained by
multiplying a cell’s speed by sinφ. Each data point represents the mean and standard deviation
60-80 samples.
4.3.2.4 Statistics
A two-way ANOVA was performed on cell speed, directed velocity, and total displacement for
factors of treatment (applied EF vs. control), and interleukin exposure to determine significance
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(p<0.05) of the effect of each factor and also the interaction of the factors. Tukey’s honest significant
difference (HSD) post hoc test was performed to assess significance (p<0.05).
4.3.3 Results
Chondrocytes expanded in the presence of IL-1 exhibited diminished proliferative capacity, reaching
confluence in 1.25x the time of normal expanded cells, perhaps due to apoptosis following IL-1
exposure. In comparison, SDSCs yielded no significantly observable differences in proliferation
rate. At t=3hr following application of DC electric field, both chondrocytes and SDSCs which had
been cultured in normal expansion media reoriented their long axis perpendicular to the direction of
field. SDSCs exposed to IL-1 showed similar behavior following field. However, only chondrocytes
exposed to IL-1 during expansion failed to elongate perpendicular to the applied field (Figure 4.7).
Figure 4.7: Representative images of chondrocytes and SDSCs for both expansion groups (IL-1 and no
IL-1) at t=0hr and t=3hr after DC electric field was turned on. Scalebar = 20 µm.
Cell migration parameters followed these noted behaviors regarding cell proliferation and pre-
sentation; for normally expanded chondrocytes and SDSCs, cells moved faster and preferentially
toward the cathode compared with no EF control cells (Figure 4.8a,b, p<0.05). The response of
IL-expanded cells to a field depended on the specific cell type; chondrocytes exhibited a signifi-
cant change in migration patterns (slower movement, reversal in migration direction, Figure 4.8c,
p<0.05) while SDSCs showed no significant variation in speed or directed velocity (Figure 4.8d,
p>0.05). Control cells exhibited no significant differences in speed or directed velocity regardless
of expansion method.
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Figure 4.8: Migration parameters ((a,b) speed, (c,d) directed velocity) for chondrocytes (at P1) and SDSCs
(at P4). *p<0.05 vs. no EF control, #p<0.05 vs. no IL control, n=60-70 cells/group.
4.3.4 Discussion
Our results have confirmed current literature findings that exposure to IL-1 negatively affects
chondrocyte proliferation and alters and stymies migration ability, possibly due to stabilization of
F-actin by a pathway of activated members of the Rho family of small GTPases (Pritchard and
Guilak, 2006). Surprisingly, individually isolated SDSCs that have been primed with a growth
factor cocktail, to induce chondrogenesis, appear resilient to such catabolic insult and show little
change in their migration behavior. The implications of this work suggest that SDSCs may be a
more favorable cell source for guided wound repair of articular cartilage, as they possess a natural
ability to withstand the harsh environment of the injured joint.
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4.4 Conclusion
Varying extracellular osmotic environment was noted to significantly alter cell migration patterns in
a way not previously characterized by the existing literature. This dissertation provides new insights
into the mechanotransduction ensuing from extracellular osmotic challenges within the context of
clinically relevant electric fields, and highlights the role of AQP1 in modulating migration. Notably,
the redistribution of AQP1 membrane proteins to the periphery of the pseudopods rather than to
the leading edge is surprising. In injured tissues, injury potentials are created and produce electric
fields that exist for days. The relative local changes in extracellular osmotic environment stemming
from injury may therefore have significant influence on wound repair. Interestingly, while we noted
agreement with the literature that during exposure to IL-1, chondrocytes exhibit impaired migration
due to their disrupted cytoskeletal networks, the same was not true for SDSCs, suggesting that
these AQP1 channels may be sensing the extracellular environment differently, leading to more
effective regulation of volume changes and migration capacity.
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Chapter 5
Directing Mesenchymal Stem Cell
Migration using Applied Direct
Current Electric Fields
5.1 Introduction
An intriguing potential for galvanotaxis studies is the use of electric fields as a procedure to identify
desirable populations of cells. To establish this paradigm, detailed characterization of the response
of a wide range of clinically relevant cells is needed. As such, we first focused on distinguishing fa-
vorable (defined to be responsive to EF stimulus) cell populations. Though autologous cell sources
are most suitable for cartilage repair, these tissues pose a number of challenges, including a lack
of viable tissue and donor site morbidity. In consideration of these limitations, we and others have
investigated the use of MSCs, in particular SDSCs, as substitutes for chondrocytes (Pei et al., 2008;
Sakaguchi et al., 2005; Yoshimura et al., 2007) and have successfully generated material and me-
chanical properties similar to native cartilage when encapsulated in agarose hydrogel (Sampat et al.,
2011). Bovine SDSCs from skeletally immature animals are readily available, well characterized,
and found to be capable of robust tissue growth in culture and their use facilitates comparisons
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of our current findings to our earlier work with juvenile bovine SDSCs (Sampat et al., 2011) and
chondrocytes (Chao et al., 2000). To facilitate translation to a canine pre-clinical model as well
as potential translation in humans, the migration behavior of cells from these other sources was
assessed to identify promising populations of cells for cartilage repair.
To this end, first, we performed a thorough analysis of the passage-dependent behavior of
juvenile bovine SDSCs to correlate any noticeable changes in cell migration with cell makeup and
presentation (Section 5.2). After observing a migration response dependency in juvenile bovine
SDSCs, we expanded our exploration to see whether the effect was conditional on the particular
age and species of the cells (Section 5.3). Together, these findings add to the repertoire of already
performed studies and provide a baseline to use when designing strategies for guided wound repair.
5.2 Passage-Dependent Migration Behavior of SDSCs
5.2.1 Introduction
Stem cells such as SDSCs exhibit phenotypic and behavioral changes as terminal differentiation
is reached. Previously, we determined via flow cytometry that changes in cell surface molecules
are measurable throughout differentiation; some of these surface molecules may in fact serve as
growth factor receptors or adhesion molecules that play a direct role in the differentiation process.
Further, it was shown that manipulation of cell surface charges with chemical modifiers such as
neuraminidase, an enzyme that removes sialic acids (Schengrund et al., 1976), or lectins (Patel
and Poo, 1982), alters EF motility (Finkelstein et al., 2007), pointing to a strong influence of
surface molecules in directed migration. Taken together, these results suggest the hypothesis that
differentiating SDSCs exhibit markedly different behavior depending on culture expansion age.
To date, previous studies have not correlated a change in cell surface marker expression with
a change in migration response to EF. It is not clear whether certain passage cells are preferen-
tially more likely to adopt a phenotype favorable for cartilage matrix development. Thus, here,
we examined the surface markers and migration characteristics of SDSCs through four passages of
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culture; we hypothesized that as SDSCs reach a chondrocytic phenotype, their migration charac-
teristics begin to resemble those reported for chondrocytes (Chao et al., 2000). In parallel, through
3D pellet cultures using cells from each passage, we attempted to elucidate the passage at which
SDSCs exhibit the greatest potential to synthesize cartilaginous matrix, in order to optimize their
use for tissue-engineered constructs.
5.2.2 Materials and Methods
5.2.2.1 Experimental Design
Three controlled and concurrent cell culture studies are described herein, aimed at characterizing
the behavior of juvenile bovine SDSCs. Specifically, study one examined the effect of cell passage
number on the expression of four cell surface markers found on MSCs. Study two characterized
the cellular response of these cells at each passage to an applied DC EF of comparable magnitude
as those found at the cut surface of wounds in order to identify a cell population most suitable for
wound repair. Finally, study three explored the development of tissue generated from cells derived
from each passage to investigate a potential correlation between cell migration behavior and matrix
composition.
5.2.2.2 Cell Isolation and Expansion
The intimal layer of the synovium was harvested from bovine knee joints of four freshly slaughtered
2-4 week old calves. Synovial tissue was digested in αMEM with collagenase type IV (Worthington,
Lakewood, NJ) for 4 h at 37°C with gentle shaking. Cell suspensions were filtered through 70 µm
mesh filters and then retrieved from the pellet after bench-top centrifugation for 15 min at 1500 g.
Viable cells were counted in a hemacytometer with trypan blue and plated at 1.76×103 cells/cm2
in αMEM containing 10% fetal bovine serum, 100 U/mL each of penicillin, streptomycin, and
fungizone, and a growth factor cocktail (1 ng/mL TGF-β1, 5 ng/mL bFGF, and 10 ng/mL PDGF-
ββ (Ng et al., 2010; Sampat et al., 2011); all media components were from Invitrogen). Medium
was changed every three days. At confluence, cells were trypsinized and then counted. One subset
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of the cells at each passage was replated for further expansion, another subset was used for flow
cytometry analysis, a third subset was used for galvanotaxis experiments, and a final subset was
used for 3D micropellet culture.
5.2.2.3 Cell Surface Marker Assessment
The phenotype of bovine SDSCs at each passage was assessed by flow cytometry. At each passage
(P1 to P4), cells in suspension were incubated with fluorescein isothiocyanate (FITC)- or phy-
coerythrin (PE)-conjugated monoclonal antibodies in phosphate-buffered saline (PBS, Invitrogen)
containing 2 mM EDTA (Invitrogen). Unstained cells were used as a negative control to assess
background fluorescence. Cells were stained with antibodies against CD31 (endothelial cell marker,
Thermo Scientific), CD34 (hematopoietic cell marker, Abcam), and mesenchymal markers CD49c
(Thermo Scientific) and CD73 (BioLegend) (Chamberlain et al., 2007; Fan et al., 2009); Positive
MSC classification required the absence of CD31 and CD34 and presence of CD73 (Dominici et al.,
2006), while CD49c is a marker of chondrogenic potential of MSCs. Cells were incubated in the
dark at room temperature for 15 min, after which they were washed and resuspended in 0.5 mL
PBS containing 2 mM EDTA for analysis. Cellular fluorescence was evaluated using a FACSCal-
ibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ) and the resulting data analyzed with
FlowJo software (version 9.3.2).
5.2.2.4 Galvanotaxis
After trypsinization, cells were resuspended at 50×103 cells/mL in DMEM containing 5% (v/v)
FBS, amino acids (0.5× minimal essential amino acids, 1× nonessential amino acids), buffers (10
mM HEPES, 10 mM sodium bicarbonate, 10 mM TES, 10 mM BES), and antibiotics (100 U/mL
penicillin, 100 mg/mL streptomycin) and allowed to equilibrate for 1 h. Cells were then plated
at 2.65×104 cells/cm2 onto sterile glass slides (Fisher Scientific, Pittsburgh, PA) using removable
silicone wells. After cells were allowed to attach for 1 h in a 5% CO2 incubator at 37°C, the slide
was rinsed with medium to remove any nonadherent cells and placed into a custom galvanotaxis
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chamber under aseptic conditions, as described in Section 4.2.2.3 (Figure 4.1).
5.2.2.5 Cell Migration Parameters
The position of each cell was manually tracked via a custom MATLAB program that utilizes
measurements of the net centroid displacement from the starting position (set as origin) to calculate
overall speed of migration for each cell (the net displacement in the experiment divided by the 3 h
time span of observation). Migration direction was quantified as sinφ, where φ is the angle between
the x-coordinate axis and the migration vector, such that sinφ was defined as the value -1 when φ
= 4.71 rad (270°), the direction of the cathode. The directional velocity, defined as the component
of the speed directed toward the negative pole (e.g. (Chao et al., 2000, 2007)), was obtained by
multiplying a cell’s speed by sinφ. Each data point represents the mean and standard deviation
60-80 samples. A two-way ANOVA was performed on cell speed, directed velocity, and total
displacement for factors of treatment (applied EF vs. control), and passage number to determine
significance (p<0.05) of the effect of each factor and also the interaction of the factors. Tukey’s
honest significant difference (HSD) post hoc test was performed to assess significance (p<0.05)
between each treatment and passage group. Chi square tests for linear trends were used to analyze
the percentage of responding cells migrating in the cathodal direction.
5.2.2.6 Micropellet Culture
Following trypsinization at each passage, cells were counted and 0.5 mL each of a 1×106 cell suspen-
sion was aliquotted into 1.5 mL sterile screw-top tubes. The tubes were spun in a microcentrifuge
at 37°C and 2500 rpm for 20 minutes to form a visible cell pellet at the base of the tube. Micropel-
lets were stored in an incubator maintained at 37°C and 5% CO2 for the duration of the study (42
days). Media was prepared from high-glucose DMEM with the addition of 100 nM dexamethasone
(Sigma), 100 µg/mL sodium pyruvate (Sigma), 50 µg/mL L-proline (Sigma), 1% ITS+ premix
(Becton Dickinson), and 1% antibiotic-antimycotic (Invitrogen). 50 µg/mL ascorbic acid (Sigma)
was added fresh to the media on each media change day and 10 ng/mL TGF-β3 (R&D Systems)
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was introduced for the first 21 days in culture. At days 14, 28, and 42, micropellet samples were
harvested. Media was completely removed and one subset of the micropellets was individually
stored at -20°C for biochemical assaying (n=5). The other subset of micropellets was fixed in acid
formalin ethanol for immunohistological analysis.
5.2.2.7 Micropellet Immunohistological Analysis
Fixed samples were paraffin embedded, sectioned (8µm thick), and stained for type I and type II
collagen, as previously described (Kelly et al., 2004). Briefly, sections were digested in 0.5 mg/mL
testicular hyaluronidase, swollen in 0.5M of acetic acid, blocked in 10% normal goat serum (NGS)
and labeled with 10% NGS containing monoclonal primary antibody for type I and II collagens
(Abcam). Alexa Fluor 488-conjugated goat anti-mouse secondary antibody labeling (Invitrogen)
and TOTO-3 nuclear counterstaining (Invitrogen) were performed to visualize the collagen networks
and cells, respectively. After staining, slides were coverslipped with Fluoroshield (Sigma) and
sections were analyzed using an inverted microscope with an Olympus Fluoview confocal system
with dual wavelengths excitation at 488 and 640 nm. Intensity profiles of the stains were generated
from a line drawn through the center of the pellet and a 6th order smoothing curve (32 neighbors)
was superimposed to capture and characterize distribution profiles of collagen matrix formation.
5.2.2.8 Micropellet Biochemical Analysis
Samples were thawed, lyophilized, weighed dry, and digested for 16h at 56°C in proteinase K (MP
Biomedicals), as described previously (Riesle et al., 1998). Aliquots of digest were analyzed for
DNA content as quantified by the PicoGreen assay (Invitrogen) (McGowan et al., 2002). Gly-
cosaminoglycan (GAG) content was measured by the 1,9 dimethylmethylene blue (Sigma) dye-
binding assay (Farndale et al., 1982). A third aliquot of digest was acid hydrolyzed in 12N HCl at
110°C for 16h, dried, and resuspended in assay buffer, as previous described (Kelly et al., 2006).
Ortho-hydroxyproline (OHP) content was determined via a colorimetric reaction with chloramine T
(Sigma) and dimethylaminobenzaldehyde (Sigma) (Stegeman and Stalder, 1967); collagen content
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was calculated using a 1:7.64 OHP-to-collagen mass ratio (Hollander et al., 1994). Each data point
represents the mean and standard deviation of five samples. Groups were examined for significant
differences by two-way analysis of variance (ANOVA), with GAG, DNA, or OHP as the dependent
variables, and passage number as the independent variable. Tukey’s honest significant difference
(HSD) post hoc test was performed to assess significance (p<0.05).
5.2.3 Results
5.2.3.1 Cell Surface Marker Expression
The expression of cell surface markers in bovine SDSCs from P1 to P4 was evaluated by flow cytom-
etry. Less than 3% of the analyzed population expressed CD31 or CD34 at any passage. Conversely,
CD49c and CD73 were expressed. Expression of CD49c (α3 integrin) was stable and high (>93%)
during all passages. However, CD73 expression (ecto-5′nucleotidase, SH3, SH4) showed a net
change in expression from P1 (49.3%) to P4 (27.9%); CD73 expression initially increased from P1
to P2 (p<0.05) and then decreased at P3 and P4 (p<0.01) (Figure 5.1).















CD31 CD34 CD49c CD73
Figure 5.1: Cell surface marker expression of CD31, CD34, CD49c, and CD73 over culture passage time
in a growth factor cocktail. Each data point represents the average expression of cells from three separate
harvests.
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Figure 5.2: (a) Representative endpoint (t=3hr) EF cells with realignment of the long axis perpendicular
to the direction of the field. Representative micrographs of (b) control cells and EF cells at (c) P1 and (d)
P4. Final cell positions (images on right) were compared to initial cell positions (images on left) and used
to calculate overall displacement, speed, and directed velocity. Scalebar = 50 µm.
5.2.3.2 EF-Induced Cell Realignment and Migration
Following exposure to an applied DC EF, the majority of cells reoriented their long axis perpen-
dicular to the direction of the field; this orientation was not influenced by passage number (Figure
5.2a). The passage number of the cells, however, did directly influence the direction of induced
migration. At P1, 85% of cells migrated primarily toward the positive pole (anode, Figure 5.2c); by
P4, nearly 70% of SDSCs had changed their direction of migration and moved toward the negative
pole (cathode, Figure 5.2d). A chi square test used to detect linear trends showed a significant de-
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crease at each passage in cells migrating toward the anode (Figure 5.3b, p<0.05). For comparison,
control cells showed little bias toward either pole at all passages, (57% ± 6.7 toward the anode)
and their net displacement away from the point of origin was not significant (p=0.13, Figure 5.2b,
Figure 5.3a).




























Figure 5.3: Percentage of cells migrating toward the anode (positive pole) and the cathode (negative pole).
(a) Control cells showed no significant difference in migration direction across all passages. (b) EF cells
significantly changed direction with increasing passage. *p<0.0001.
5.2.3.3 Cell Migration Parameters: Speed and Displacement depend on Passage
Number
At all passages, SDSCs exposed to an applied DC EF traveled faster and migrated a further net
distance than cells expanded similarly, but not exposed to a field (p<0.05, Table 5.1). Through-
out passages P1-P4, the spontaneous migration for control cells remained similar to passage P1
(pP1−P2=0.15; pP1−P3=0.42; pP1−P4=0.57), though there was a significant drop in speed (p<0.0001)
and displacement (p<0.0001) following P2. Decreased motility mirrored the decrease in CD73 sur-
face marker expression (p<0.0001). Similarly, under the influence of the applied EF, cells also
showed a significant drop in speed following P2 (p<0.0001).
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Table 5.1: Migration data from galvanotaxis studies performed for 3 hours
Net displacement
(µm)
φ (rad) Speed (µm/hr) Directed Velocity
(µm/hr)
P1
Control 12.1 ± 7.13 3.12 ± 1.64 4.03 ± 2.38 -0.43 ± 3.00
EF 20.6 ± 13.9 2.58 ± 1.70 9.18 ± 5.48 4.03 ± 4.74
P2
Control 18.7 ± 9.85 2.74 ± 2.02 6.22 ± 3.28 0.46 ± 4.98
EF 29.1 ± 16.1 2.77 ± 1.84 9.69 ± 5.38 1.38 ± 5.65
P3
Control 6.93 ± 5.61 2.40 ± 1.81 2.31 ± 1.87 0.17 ± 1.95
EF 14.2 ± 10.9 3.47 ± 1.76 4.75 ± 3.65 -0.93 ± 4.82
P4
Control 7.33 ± 5.42 2.40 ± 2.01 2.45 ± 1.81 0.38 ± 1.96
EF 21.1 ± 13.7 3.91 ± 1.75 7.03 ± 4.58 -3.26 ± 6.02
5.2.3.4 Passage-Dependent Tissue Development
ECM development from SDSC pellet culture was increasingly dependent on the extent to which
cells had been expanded in a growth factor cocktail and the corresponding passage number. Pellets
comprised of early passage cells (P1) elaborated significantly greater amounts of GAG/dw compared
to pellets containing late passage cells (P4) by day 28 (16.3 ± 1.89 %/dw vs. 10.5 ± 1.20 %/dw,
p<0.0001) and this trend was consistent for day 42 (20.2 ± 3.64 %/dw vs. 7.35 ± 0.85 %/dw,
p<0.0001, Figure 5.4a). In fact, P1 pellets appeared to continue elaborating GAG following day
28, while P4 pellets began losing GAG content. In comparison, an opposing trend was noticed with
collagen content; P4 pellets showed significantly increased amounts of collagen at all timepoints






































Figure 5.4: Biochemical content ((a) GAG/dry wt and (b) COL/dry wt) of SDSC pellets from cells at
different passages.*pP4<0.05 vs. P1
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starting at day 14 relative to P1 pellets (day 14: 52.2 ± 7.49 %/dw vs. 11.2 ± 2.77 %/dw
(p<0.0001); day 28: 43.5 ± 8.65 %/dw vs. 24.2 ± 4.33 %/dw (p<0.0001); day 42: 67.5 ± 8.56
%/dw vs. 27.1 ± 4.50 %/dw (p<0.0001), Figure 5.4b).
5.2.3.5 Substantial Collagen II Deposition of Late Passage SDSCs
Immunohistochemical staining revealed that collagen II deposition was more elaborate and con-
sistent in P4 pellets than P1 pellets (Figure 5.5f vs. Figure 5.5b). Intensity profiles through the
diameter of the construct confirm nonhomogenous sinusoidal distribution of collagen fibers initially
at P1 (Figure 5.5d) that fills in with increasing passage number to P4, maintaining intensity across
the pellet at an elevated gray value (Figure 5.5h). Collagen I deposition was localized mainly to the
periphery of all pellets (Figure 6a,e), though was increasingly consistent for P4 pellets compared
to their early counterparts (Figure 5.5g vs. Figure 5.5c).
5.2.4 Discussion
To our knowledge, this is the first study to characterize the changing surface marker expression
and migration pattern of SDSCs over time in culture. We have reported here that at early passages
(P1, P2), cultured SDSCs exhibit anodal migration under EF strengths previously used to elicit
galvanotaxis in chondrocytes. SDSCs switch their direction of migration on the same timescale,
moving preferentially toward the cathode, just as permanently differentiated chondrocytes do.
SDSCs show considerable plasticity over extended passages; this plasticity is sufficient to change
their migration direction in response to an applied EF. The SDSCs’ changes in migratory response
to an applied EF may occur by one of several mechanisms. First, migration changes may be
attributable to an altered differentiation state.
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Figure 5.5: Immunohistochemical stains of collagen I (a,e) and collagen II (b,f) for pellets comprised of P1
(top row) and P4 (bottom row) expanded cells. Intensity profiles (c,d,g,h) through the center of the pellet
reveal localized distribution patterns for each matrix component. Scalebar = 200 µm.
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During cell culture, SDSCs are exposed to a growth factor cocktail comprised of cytokines known
to be responsible for driving differentiation or redifferentiation of cells toward a chondrocyte-like
state (Ng et al., 2010; Sampat et al., 2011). In particular, progressive differentiation of the SDSCs
can mediate not only changes in simple physical parameters of the culture but, as we show here,
also expression of cell surface molecules.
Previous studies found that early passage MSCs share morphological characteristics with fi-
broblasts (elongated, flat cells (Alt et al., 2011)). Further, both express N-cadherin and neural cell
adhesion molecules (N-CAM) (DeLise et al., 2000), key regulators of cell-cell interaction and cell
migration (Eggers et al., 2011). Additional exposure to growth factors brings about a chondrocyte
differentiation process marked by distinct changes in cell morphology. Cells convert to a more
spherical shape that underlies varying physical traits known to influence motility. We also note
that in late passage SDSCs, actin filaments appear dense and contracted, which may limit mobility
and active migration. Alternatively, extended exposure to the growth factor cocktail may induce
molecular changes to the cell surface of the differentiating cells. Indeed, flow cytometry revealed
changes in surface molecules, although identifying the best candidates that may mediate changes
in EF responses will require further systematic study.
Expression of surface-associated proteins of chondrocytes (e.g. collagen II, keratin, sulfated
proteoglycans) that are shed into the ECM surrounding the cells also increases with further expan-
sion (Alegre-Aguaron et al., 2014). Changes in surface charge may be mediated by these surface-
associated proteins, causing the cells to respond differently to the applied EF. Regulation of specific
surface proteins can also change motility in EF-exposed cells. For example, upregulation of various
ECM receptors for collagen and fibronectin, such as the α2β1 integrin, have been reported to be
crucial for cell migration (Etienne-Manneville and Hall, 2001); these receptors polarize the inte-
grin and its downstream effector RhoA to influence directionality of migration (Tsai et al., 2012).
Whether there are any changes in the distribution of α2β1 integrin receptors at different passages of
SDSCs and if so, whether they alter organization of the ECM receptors and their related signaling
molecules have yet to be determined experimentally.
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The altered migratory patterns we measured in SDSCs are likely to be initiated through changes
in expression of cell surface markers, which accompanies increasing passages. We observed one such
change, namely, a significant decrease in the CD73 marker for stem cell expression. In addition to
bolstering our previous hypothesis that the cells have adopted a more chondrocyte-like phenotype
in P4 than in P1, these observations raise the possibility that CD73 or ecto-5′-nucleotidase, an
enzyme that catalyzes the conversion of extracellular nucleotides to adenosine, plays a direct role
in mounting a motility response to EF. Indeed, the observed motility decreases from P1-P4 support
reports implicating CD73 in directly regulating cell migration (Ode et al., 2011).
Additionally, exogenously delivered factors such as bFGF (Maniwa et al., 2001) and PDGF-ββ
(Schmidt et al., 2006) have been found to modulate and influence cell migration, perhaps as direct
chemokinetic factors, similar to the roles of receptors for epidermal growth factor and hepatocyte
growth factor during tumor invasion (Wells, 2000). Alternatively, components of the growth may
alter motility via their capacity to upregulate the extracellular-signal-regulated kinase (ERK) and
p38 mitogen-activated kinase (MAPK) signaling pathways (Giuliani et al., 1999). Upregulation
of MAPK-1 protein was indeed observed in this study. In keratinocytes and neutrophils, rapid
and sustained phosphorylation of ERK, MAPK and Src is also a direct consequence of exposure
to EF (Zhao et al., 2006). In fact, activated Src kinase polarizes in the migration direction and
recruits phosphatidylinositol 3,4,5-triphosphate (PIP3) to the leading edge of the cell, and targets
the tumor suppressor phosphatase and tensin homologue (PTEN) to the lateral and back edges.
Although the primary responder(s) to the EF are still unknown, the PIP3 and PTEN redistribu-
tions are mediated by the Phosphatidylinositol 3-OH kinase-γ (PI(3)Kγ) pathway and its upstream
activators, receptor tyrosine kinases (RTK) (Zhao et al., 2006). As such, it is reasonable to expect
cells at different passages, which exhibit different degrees of growth factor exposure and binding to
RTKs, will also exhibit varying responses to the applied EF. For example, an alteration or attenu-
ation in the distribution of PIP3 and PTEN that is caused by altered growth factor exposure could
shift the cells’ migration direction. Taken together, previous studies, along with results presented
here, point to the likelihood for growth factor priming and expansion to alter the behavior and
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response of the cells to external stimuli.
Late passage cells reveal the capacity to create cartilaginous-like tissue with increased expres-
sion of GAG and collagen by day 42. Surprisingly, however, these cells exhibited stunted GAG
deposition that may be due to the abundance of elaborated collagen that, for the first time, nears
native levels (∼60-70%/dry weight). This inverse relationship between GAG and collagen quanti-
ties follows trends noted previously for engineered cartilage (Bian et al., 2009). Confirmation of
the presence of type II collagen at P4, the form predominantly found in articular cartilage, via
immunohistological staining further suggests that only after multiple passages do cells possess a
phenotype that resembles chondrocytes. That this phenotype is correlated with chondrocyte-like
migration behavior suggests that collagen II receptors and their associated α10β1 integrins may be
directly involved in directed movement.
5.3 Cell Age and Species Origin Influence Migration Behavior
5.3.1 Introduction
For cartilage repair, the cells that are available may be limited and come from a variety of sources.
To understand whether the trends noted in Section 4.2 hold for an older population of cells and
from different species, a follow-up study was performed.
5.3.2 Materials and Methods
5.3.2.1 Cell Isolation and Expansion
The intimal layer of the synovium was harvested from juvenile and adult bovine and canine knee
joints. Synovial tissue was digested in αMEM with collagenase type IV (Worthington, Lakewood,
NJ) for 4 h at 37°C with gentle shaking. Cell suspensions were filtered through 70 µm mesh filters
and then retrieved from the pellet after bench-top centrifugation for 15 min at 1500 g. Viable
cells were counted in a hemacytometer with trypan blue and plated at 1.76×103 cells/cm2 in
alpha minimum essential medium containing 10% fetal bovine serum, 100 U/mL each of penicillin,
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streptomycin, and fungizone, and a growth factor cocktail (1 ng/mL TGF-β1, 5 ng/mL bFGF, and
10 ng/mL PDGF-ββ (Ng et al., 2010; Sampat et al., 2011)). Medium was changed every three
days. One subset of the cells at each passage was replated for further expansion and the other
subset was used for galvanotaxis experiments.
Human bMSCs were isolated from fresh unprocessed bone marrow (Lonza) of a 22 year-old
male donor. Following separation via Percoll gradient, mononucleated cells were plated (5×103
cells/cm2 in DMEM); adhered MSCs were expanded until passage 4, as described above. To ensure
a pure population, cells were only used starting after 2 passages.
5.3.2.2 Galvanotaxis
At confluence, cells were trypsinized and resuspended at 50×103 cells/mL in DMEM containing 5%
(v/v) FBS, amino acids (0.5× minimal essential amino acids, 1× nonessential amino acids), buffers
(10 mM HEPES, 10 mM sodium bicarbonate, 10 mM TES, 10 mM BES), and antibiotics (100 U/mL
penicillin, 100 mg/mL streptomycin) and allowed to equilibrate for 1 h. Cells were then plated at
2.65×104 cells/cm2 onto sterile glass slides (Fisher Scientific, Pittsburgh, PA) using removable
silicone wells. After cells were allowed to attach for 1 h in a 5% CO2 incubator at 37°C, the slide
was rinsed with medium to remove any nonadherent cells and placed into a custom galvanotaxis
chamber (described in Section 4.2.2.3, Figure 4.1) under aseptic conditions. Approximately 30-40
cells were observed in each field of view; images were acquired at 5 min intervals.
5.3.2.3 Cell Migration Parameters
The position of each cell was manually tracked via a custom MATLAB program that utilizes
measurements of the net centroid displacement from the starting position (set as origin) to calculate
overall speed of migration for each cell (the net displacement in the experiment divided by the 3 h
time span of observation). Migration direction was quantified as sinφ, where φ is the angle between
the x-coordinate axis and the migration vector, such that sinφ was defined as the value -1 when φ
= 4.71 rad (270°), the direction of the cathode. The directional velocity, defined as the component
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of the speed directed toward the negative pole (e.g. (Chao et al., 2000, 2007)), was obtained by
multiplying a cell’s speed by sinφ. Each data point represents the mean and standard deviation
60-80 samples.
5.3.2.4 Statistics
A two-way ANOVA was performed on cell speed, directed velocity, and total displacement for factors
of treatment (applied EF vs. control), and passage number to determine significance (p<0.05) of
the effect of each factor and also the interaction of the factors. Tukey’s honest significant difference
(HSD) post hoc test was performed to assess significance (p<0.05) between each treatment and
passage group.
5.3.3 Results
Although the same growth factor cocktail treatment was administered to each group, the origin of
the cell strongly influenced its response to an applied DC electric field. At early passage, SDSCs
from bovine synovium exhibit a more robust effect when exposed to an EF than those from canine
synovium (92% and 62% of cells exhibiting significantly greater migration than control samples for
adult and juvenile bovine SDSCs, respectively, p<0.05). In contrast, only 40% and 15% of adult
and juvenile canine SDSCs register a significant cell migration compared to control samples. Even
as cells were expanded in culture through passage 4, these trends remain constant with more SDSCs
from bovine tissue positively responding to the EF than the canine cells (100% and 73% of adult
and juvenile bovine SDSCs compared to 45% and 62% of adult and juvenile canine SDSCs).
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Figure 5.6: Representative polar plots of cell displacement of (a) adult and (b) juvenile bovine and (c)
adult and (d) juvenile canine SDSCs at early passage (P1, yellow circle) and late passage (P4, blue diamond)
subjected to EF. (0,0) represents the starting position of the cell (origin) with 90°as the anode (+) and 270°as
the cathode (-). Radial distance is cell displacement (µm). n=70-80 cells/group.
For cells that responded positively to the applied EF and exhibited significantly greater mi-
gration than control cells, the direction in which they migrated was dependent on cell source and
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age of tissue. The majority of adult and juvenile bovine cells migrate preferentially toward the
anode (90) at early passage time (72% and 70% of responding cells, respectively, Figure 5.6). With
increased passage, cells from both adult and juvenile bovine synovium exhibit a reversal in their
migratory direction, preferentially traveling toward the cathode (100% and 86% of responding cells,
respectively), similar to migration patterns consistent with chondrocytes (Chao et al., 2000). In
contrast, SDSCs originating from canine tissue, exhibited significantly different responses to an ap-
plied EF of the same strength. At early passage time, almost all cells migrated toward the cathode
(94% and 100% for adult and juvenile canine cells, respectively). Increased passage and exposure
to growth factors resulted in diminished preferential migration toward the cathode (70% and 51%,
respectively) that was independent of tissue age.
Interestingly, when the same protocol was applied to human bMSCs, the migration response
of human bMSCs to an applied DC EF followed the same trends exhibited by bovine SDSCs.
Increasing passage number revealed EF-induced migration progressively toward the cathode (Figure
5.7).
Furthermore, to investigate deeper parallels between the results seen with bovine SDSCs and
human bMSCs, micropellets were formed at late passage (following the protocol of Section 5.2.2.6)
and found to similarly produce cartilage-like tissue, characterized by their elevated biosynthetic
activity in producing GAG and collagen (GAG/DNA = 8.32 ± 4.4 µg/µg, COL/DNA = 128 ±
Figure 5.7: Cell migration parameters for passaged human bMSCs. Directed velocity for these cells is
oriented toward the anode at P2 before changing direction toward the anode for later passages.
CHAPTER 5. DIRECTING MESENCHYMAL STEM CELL MIGRATION USING APPLIED
DIRECT CURRENT ELECTRIC FIELDS 89
68.1 µg/µg).
5.3.4 Discussion
These varied findings from adult bovine and canine SDSCs as well as human bMSCs suggest that
the modulators that control cell migration are specific to cells of different origin (age and species)
and that it may be necessary to develop species-specific strategies for repair induction. Given the
correlative findings in Section 4.2 between passage number and migration potential, it is interesting
that the same trends are not consistently present across the different cell types. We can postulate
that this may be due to a differential effect of the growth factors on specific cells. Furthermore, it is
important to note that due to limited availability, cells from only one human donor were procured
for this study. Though our observations suggest human bMSCs are compatible and capable of
being shaped to behave like intended chondrocytes, intrinsic inter-donor variability warrant future
studies aimed at confirming a reliable and consistent cell profile and response before this technique
can be translated to clinical use.
5.4 Conclusion
The use of EFs directly controls cell migration and has the potential to influence therapeutic
regimes. In this chapter of the dissertation, EF studies were performed to characterize the behav-
ioral response of multiple cell types to use in a novel manner of identifying desirable cell populations.
The results described herein contribute to the literature on the effects of applied EF and provide a
greater understanding of the potential for using selected cells for guided wound repair. In particu-
lar, mesenchymal stem cells such as SDSCs offer a promising cell source for repair as they exhibit an
intrinsic resistance to the chemical factors that may be present in the injured joint. By investigat-
ing the relationship between cell phenotype and surface marker expression and migration patterns,
we developed a strategy to mobilize MSCs for cartilage repair. Applying growth factors during
expansion produces a unique profile of surface marker expression that changes with culture. As the
migration response of SDSCs mimics that seen for chondrocytes, so does their ability to produce
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cartilaginous tissue. Though we observed successful translation of this work from the bovine model
to human MSCs, our findings did not reflect behaviors noted for adult bovine or canine SDSCs,
confirming that cell priming protocols in strategies for targeted cartilage repair must be tailored
for the particular application.
CHAPTER 6. COCULTURE OF ENGINEERED CARTILAGE WITH PRIMARY
CHONDROCYTES INDUCES EXPEDITED GROWTH 91
Chapter 6
Coculture of Engineered Cartilage
with Primary Chondrocytes Induces
Expedited Growth
6.1 Introduction
Our lab and many others have investigated the use of chemical cues such as growth factors (TGF-β3,
TGF-β1, insulin-like growth factor, fibroblast growth factor (Byers et al., 2006; Mauck et al., 2003b,
2001; Thorp et al., 1992), corticosteroids (Awad et al., 2003; Bian et al., 2010b), and interleukins
(Aydelotte et al., 1992; Lima et al., 2008b; Ratcliffe et al., 1986)) in an effort to create engineered
cartilage with functional tissue properties. When implanted into the knee joints, constructs must
possess the fortitude to withstand the harsh mechanochemical environment. Though we have been
successful at producing constructs that match or exceed the Young’s modulus and GAG content
of native tissue (Lima et al., 2007), the dynamic modulus and collagen content in engineered
constructs is significantly lower than native cartilage. As such, we have continued searching for
novel media supplements to cultivate this growth. Soluble chemical factors can be introduced to
the culture system not only by exogenous delivery through the culture media, but also by the
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addition of a second population of cells. Underlying cell monolayers, or feeder layers, introduce
paracrine signaling between populations of cells and promote cell-cell interactions that have been
shown to modulate cellular activity (Guillotin et al., 2004; Hwang et al., 2007; Smola et al., 1993;
Solursh and Meier, 1973; Vats et al., 2006). For example, primary chondrocytes have been shown to
induce chondrocyte differentiation of embryonic stem cells and cause redifferentiation of cocultured
passaged chondrocytes by releasing soluble signaling factors. When cocultured, these highly plastic
stem cells adopt a more rounded phenotype and show increased production of aggrecan and Type II
collagen, characteristic of native chondrocytes (Bigdeli et al., 2009; Hoben et al., 2009; Vats et al.,
2006). Similarly, coculture systems including primary chondrocytes with passaged chondrocytes
can also induce stable redifferentiation (Ahmed et al., 2009a; Gan and Kandel, 2007; Taylor et al.,
2009). Reversion in phenotype of the passaged cells toward articular chondrocytes was confirmed by
increased expression of Type II collagen and cartilage oligomeric matrix protein (COMP) genes and
decreased expression of the Type I collagen gene. In further support of these findings, other studies
suggest articular chondrocytes expanded in monolayer cultures display characteristics similar to
those of mesenchymal stem cells (Barbero et al., 2003; Tallheden et al., 2003). This may explain
the ease in which passaged cells are able to reacquire their former phenotype. Taken together, these
studies suggest chondrocyte feeder layers have the potential to enhance and induce chondrocyte-
like behavior in populations of dedifferentiated cells (passaged cells or stem cells). It is unclear,
however, what effects coculture has on already differentiated cells, such as primary chondrocytes,
when they are encapsulated in a hydrogel matrix.
To investigate the use of a coculture system on engineered cartilage, we tested three hypothe-
ses: (1) coculturing of engineered cartilage constructs in the presence of a monolayer of primary
chondrocytes (“chondrocyte feeder layer”) expedites and increases development of their material
and biochemical properties; (2) the effects of coculture with a chondrocyte feeder layer arise from
paracrine effects (soluble factors) rather than direct cell-cell contact with the feeder cells; and (3)
the feeder layer effect depends on the specific morphology and expression of the two-dimensional
(2D) cell monolayer.
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6.2 Materials and Methods
6.2.1 Experimental Design
To investigate the effect of introducing a chondrocyte feeder layer to engineered cartilage constructs,
we developed a coculture model system (Figure 6.1). Briefly, to test Hypothesis 1, the effect of
culturing engineered cartilage in the presence of subconfluent (low-density) primary chondrocyte
monolayers was investigated (Study 1). To test Hypothesis 2, the dependence of this effect on cell-
cell contact was investigated by eliminating physical contact as a means of interaction using tissue
culture Transwellr inserts (Study 2). To test Hypothesis 3, the role of the monolayer’s phenotypic
expression in influencing tissue development in cocultured constructs was studied (Study 3). We
performed each study independently, using cell populations isolated and pooled from different
animals.
6.2.2 Cell Isolation and Culture
We isolated tissue from bovine carpometacarpal joints of freshly slaughtered 2- to 4-week-old calves.
Six to eight joints were used per study and cells were pooled from all joints for each study described
herein. Cartilage was digested in high-glucose DMEM with collagenase Type V (Sigma-Aldrich
Corp, St Louis, MO) for 11 hours at 37°C with shaking. Cell suspensions were filtered through
a 70µm porous mesh and sedimented in a bench-top centrifuge for 15 minutes at 1500 g. Viable
cells were counted with a hemocytometer and viability was assessed by trypan blue exclusion. Cell
suspensions (60×106 cells/mL) were mixed in equal parts with 4% low-gelling agarose (Type VII;
Sigma) to yield a final cell concentration of 30×106 cells/mL in 2% wt/vol agarose. We cast the
chondrocyte/agarose mixture into slabs and later cored using a sterile disposable biopsy punch
(Miltex Inc, York, PA) to final dimensions of 4-mm diameter and 2.34-mm thickness.
Cells from the same harvest and final suspension were plated into tissue-culture-treated 24-well
plates at a density of 0.1×106 cells/well (5.6×104 cells/cm2) in the presence of DMEM supplemented
with 5% FBS to facilitate cell attachment. We exposed developing engineered cartilage constructs
to different monolayer formulations in each of the three studies.
CHAPTER 6. COCULTURE OF ENGINEERED CARTILAGE WITH PRIMARY


















Transwell Insert- Culture 






Feeder layer configuration: 







Mechanical testing: EY, G* 
Biochemical assays: GAG, OHP, DNA 
Histology: Alcian Blue, Picrosirius Red 
Immunohistochemistry: Collagen I, II 
Figure 6.1: A schematic shows the experimental design of the three studies described
6.2.3 Co-Culture Setup
In Study 1, one construct was placed above the monolayer in each well and allowed to grow in
culture for the duration of the study (Figure 6.2a). In Study 2, to investigate the dependence on
cell-cell contact, we physically separated chondrocyte monolayers from the three-dimensional (3D)
engineered tissue by a Transwellr insert (Corning, Acton, MA) (Figure 6.2b).
Tissue-culture-treated membranes with a 3.0µm pore size, which is orders of magnitude larger
than the pore size of native cartilage (Mow and Ratcliffe, 1997) or 2% type VII agarose (Ng et al.,
2005), were used to permit free transport of diffusible signals but not direct cell-cell contact be-
tween the chondrocytes in the engineered constructs and feeder layer. In Study 3, we established
CHAPTER 6. COCULTURE OF ENGINEERED CARTILAGE WITH PRIMARY






Figure 6.2: Diagram illustrating the experimental coculture setup for (a) Study 1 (direct contact between
the construct and the feeder layer) and (b) studies 2 and 3 (separation between the construct and the feeder
layer by a Transwellr insert).
five subgroups to examine the dependence on cell manipulation and presentation as described below.
Primary chondrocyte monolayers were replated each week (“variable”) to contrast with monolay-
ers that were plated only once at the start of the study (“continuous”) to assess the effect of the
presentation of the feeder cells when introduced to the engineered construct. For the feeder layers
in the variable group, fresh harvests and tissue digestions were performed each week to yield a new
cell suspension for plating of primary cells at the same initial seeding density. Alternatively, to un-
derstand whether this effect was dependent on soluble factors released only transiently immediately
after a fresh harvest, after each harvest, and tissue digestion, we plated cell suspensions in a high-
density monolayer (0.4×106 cells/cm2) to preserve the chondrocyte phenotype (Watt, 1988). This
high-density monolayer was cultured for a week and then trypsinized and replated at a density of
0.1×106 cells/well (5.6×104 cells/cm2) the following week and used at Passage 1 (P1, “passaged”).
Then, to assess the dependence of this effect on feeder cell presentation resulting from changes in
morphology, we embedded cells (“encapsulated”) in low-gelling agarose at a final density of 0.5×106
cells/mL in 1% wt/vol agarose. An aliquot of the cell-agarose solution was then transferred to each
well such that the same number of cells (0.1×106 cells) was entrapped in the hydrogel feeder layer
to preserve cell morphology and replaced weekly to match the variable time course. Finally, to un-
derstand whether the effect was dependent on active processes of cellular division and proliferation
in the feeder layer, monolayers were first treated with mitomycin C (10 µg/mL), as it inhibits cell
proliferation and division, before use in the coculture setup (“mitomycin”).
Two days after cell plating, we transferred one construct over to each well for all the groups
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and cultured in 2 mL hgDMEM supplemented with 1X penicillin-streptomycin, 0.1 µmol/L dexam-
ethasone, 50 µg/mL ascorbate 2-phosphate, 40 µg/mL L-proline, 100 µg/mL sodium pyruvate, and
1X ITS+ premix (insulin, human transferrin, and selenous acid; Becton Dickinson, Franklin Lakes,
NJ) for the remainder of the culture period. Medium was further supplemented with 10 ng/mL
TGFβ-3 (Invitrogen, Carlsbad, CA) for the first 14 days of construct culture. Culture medium was
changed every other day. A minimum ratio of 1mL of medium per 1 million cells was maintained
throughout the duration of the study to encourage and promote tissue growth. As the total number
of cells in each well has been previously estimated to range from 1-2 million cells, 2mL of medium
was used per well.
6.2.4 Mechanical Testing
We tested five whole samples from each group in unconfined compression to assess Young’s equilib-
rium modulus (EY ) and dynamic modulus (G*) using a custom computer-controlled system (Soltz
and Ateshian, 1998). An initial 0.02N tare load was applied, followed by compression to 10% strain,
at a strain rate of 0.05% s−1 to measure Young’s modulus after stress relaxation. Dynamic modulus
was subsequently measured by superimposing a cyclical 2% peak-to-peak strain at 0.1 Hz.
6.2.5 Biochemical Analysis
After mechanical testing, we halved each sample, with one half dried and digested in proteinase K
solution overnight at 56°C, as described previously (Kelly et al., 2006), preserving the other half for
histology (Section 6.2.6). An aliquot was analyzed for GAG content via the 1,9-dimethylmethylene
blue dye-binding assay (Farndale et al., 1982). A further aliquot was hydrolyzed in 12 N HCl
at 110°C for 16 hours, dried, and resuspended in assay buffer (Kelly et al., 2006). Orthohy-
droxyproline (OHP) content was determined via a colorimetric assay in which chloramine T and
dimethylaminobenzaldehyde reaction was quantified (Stegeman and Stalder, 1967). We calculated
overall collagen content by assuming a 1:7.64 OHP-to-collagen mass ratio (Hollander et al., 1994).
Double-stranded DNA content was also assessed by the PicoGreenr assay (Invitrogen) according
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to the manufacturer’s standard protocols. Each biochemical constituent was normalized to tissue
wet weight (ww).
6.2.6 Histological Analysis
For histology, we fixed the other half of each sample in acid-formalin-ethanol (Lin et al., 1997),
paraffin embedded, sectioned (8 µm thick), and stained for histology to assess both proteoglycan
(alcian blue) and collagen (picrosirius red) distribution and organization. Immunohistochemistry
was performed to confirm the development of collagen II in developing constructs. Briefly, tissue
sections were digested in 5.0 mg/mL testicular hyaluronidase, swollen in 0.5 mol/L acetic acid,
blocked in 10% normal goat serum (NGS). We labeled the sections with 10% NGS containing pri-
mary antibody for Types I and II collagen (Abcam, Cambridge, MA). Alexa Fluorr 488-conjugated
goat anti-rabbit secondary antibody labeling (Molecular Probes, Eugene, OR) and counterstained
with diamidino-2-phenylindole nuclear counterstaining (Molecular Probes) to visualize the extra-
cellular matrix and cells, respectively. Three independent observers examined tissue sections on an
inverted confocal microscope (Leica Microsystems, Bannockburn, IL) to assess whether constructs
exposed to the feeder layer exhibited more extensive biochemical content and distribution and to
confirm the type of collagen produced.
6.2.7 Statistics
All data are reported as the mean ± SD of four to five samples per time point and group. In Study
1, to assess differences in mechanical and material properties of constructs exposed to a feeder layer
compared to control samples at each time point, a Student’s t test was performed. Similarly, in
Study 2, differences at each time point between constructs cocultured in direct contact with the
monolayer and constructs cocultured in the Transwell setup were determined by a Student’s t test.
In Study 3, to compare the properties of control constructs to those cultured in each experimental
group, a one-way ANOVA was performed, and differences were confirmed with Tukey’s honest
significant difference post hoc test. Statisticar software (StatSoft, Inc, Tulsa, OK) was used to
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perform all statistical tests.
6.3 Results
Study 1 showed the feeder layer stimulated growth of differentiated chondrocytes. For constructs
cocultured with a subconfluent population of primary chondrocytes, a beneficial effect was noted
on cells in the constructs: constructs exhibited higher (p = 0.005) Young’s modulus and greater (p
= 0.019) GAG and (p = 0.001) collagen content than controls; however, this effect was only noted
through Day 28 of culture (Figure 6.3). By Day 42 in culture, Young’s modulus and GAG content
were comparable (pEY = 0.176, pGAG = 0.734, pCOL = 0.251) whether constructs were cocultured
in the presence or absence of a cell monolayer (Figure 6.3).



















































Figure 6.3: Graphs show (A) Young’s modulus (EY ), (B) GAG content, and (C) collagen (COL) content
of constructs with time in culture in Study 1 (n = 5 per group). Increased mechanical properties and GAG
content occurred up to Day 28 of culture.
Confirming these quantitative findings, compared to controls (Figure 6.4a), histology sections of
tissue from cocultured constructs (Figure 6.4e) showed enhanced staining in alcian blue (for GAG)
over time in culture, suggestive of advanced extracellular matrix development and deposition for
sections exposed to a monolayer. Compared to controls (Figure 6.4b), enhanced staining for pi-
crosirius red (for nonspecific collagen) was also present for cocultured constructs (Figure 6.4f).
Similarly, when immunohistologic stains were analyzed, similar trends in Types I and II collagen
distribution were observed in cocultured constructs (Figure 6.4g-h) compared to controls (Figure
6.4c-d), suggesting increased deposition of both types of collagen were present after coculture.
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Figure 6.4: Representative constructs cocultured in the (a-d) absence and (e-h) presence of a feeder cell
monolayer at day 28 of culture stained with (a,e) alcian blue, (b,f) picrosirius red, (c,g) collagen I, and (d,h)
collagen II are shown. Cocultured constructs produced more extensive and organized tissue development, as
assessed by staining intensity from histology and immunohistochemistry.
In Study 2, cell-cell contact was not necessary to produce the same beneficial effect of coculture
as seen in Study 1, indicating the mechanism of intercellular signaling was primarily paracrine or
soluble factors that can diffuse through the porous membrane. By the end of the culture period,
constructs placed into Transwellr inserts and exposed to a subconfluent monolayer exhibited an
increase (p = 0.012) in Young’s modulus compared to both control and contact conditions (Figure
6.5a). This additional increase in stiffness was not paralleled in dynamic modulus; modest increases
in dynamic modulus were seen compared to constructs cultured without a monolayer, but there
were no differences (p = 0.286) between the constructs in contact with the monolayer and those
separated with a Transwellr insert (Figure 6.5b).
The specific presentation of the feeder cell monolayer was crucial in affecting the development
of engineered cartilage tissue (Study 3). As early as 14 days in culture, cell monolayers replaced
each week with a subconfluent population of cells freshly harvested from cartilage (“variable”)
showed positive influences of coculture. These constructs developed superior mechanical properties
and biochemical markers compared to control constructs cultured in the absence of any cells (pEY
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Figure 6.5: Graphs show normalized (A) Young’s modulus (EY ) and (B) dynamic modulus (G*) of con-
structs exposed to a feeder layer (in direct contact or with a Transwellr insert separation) compared to
feeder-free controls in Study 2 (n = 5 per group). Increased mechanical properties at Day 28 are achieved
when constructs are separated from the monolayer, confirming cell-cell contact is unnecessary.
<0.001, pG∗ <0.001, pGAG<0.001) or constructs cultured in the presence of a continuous monolayer
(pEY <0.001, pG∗ = 0.014, pGAG<0.001) (Figure 6.6). While collagen content for these constructs
was increased over control (p = 0.020), it was comparable to levels seen in constructs exposed to the
continuous monolayer (p = 0.357). The repeated replacement of the feeder layer with P1 cells did
not have the same effect; constructs exposed to these monolayers developed tissue with properties
comparable to control (pEY = 0.999, pG∗ = 1, pGAG = 0.945, pCOL = 0.450) (Figure 6.6). In
further support of the finding that replacing the cells weekly was not the sole factor responsible
for producing such an effect, cells encapsulated in 1% agarose and thus forced to adopt a rounded
morphology due to the hydrogel also produced results comparable to control constructs (pEY =
0.668, pG∗ = 1, pGAG = 0.406, pCOL = 0.543) (Figure 6.6). Finally, when cell monolayers were
mitotically inactivated by the application of mitomycin C, constructs exhibited delayed and stunted
growth, yielding lower properties than controls (pEY = 0.024, pG∗ = 0.059, pGAG <0.001, pCOL
<0.001) (Figure 6.6). DNA content in constructs from all groups at each timepoint was comparable
(DNAday14: 8µg/construct; DNAday28 : 10µg/construct, DNAday42 : 12µg/construct), confirming
the feeder layer did not adversely affect cellular viability.
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Figure 6.6: Graphs show (A) Young’s modulus (EY ), (B) dynamic modulus (G*), (C) GAG content, and
(D) collagen (COL) content of constructs with time in culture in Study 3 (n = 5 per group). When the cell
monolayer is replaced weekly, increased mechanical properties and biochemical content are achieved by the
cocultured tissue constructs.
6.4 Discussion
The principal focus of previous studies on the effects of coculture in cartilage tissue engineering
has been on the effects of primary cells on dedifferentiated chondrocytes (Ahmed et al., 2009a,b;
Taylor et al., 2009) or various stem cells (Hoben et al., 2009; Hwang et al., 2006; Vats et al., 2006).
Cells that have undergone dedifferentiation are believed to be more plastic, similar to stem cells,
allowing them to respond more efficiently to the chemical cues present during culture. Here, by
coculturing engineered cartilage constructs with a chondrocyte feeder layer, we investigated whether
differentiated chondrocytes already embedded in a 3D hydrogel scaffold exhibited a similar capacity
to respond to these cues, and if so, if the mechanism of cellular signaling was dependent on direct
cell-cell contact. Additionally, we looked at identifying specific plating conditions of the feeder
layer, which may be necessary to elicit such a response.
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Our studies are subject to some limitations. First, in our study, bovine chondrocytes from
skeletally immature animals were utilized, as they are readily available, well characterized, and
capable of robust tissue growth in culture (relative to adult cells). While their use facilitates
comparison of current findings to our earlier work (Hung et al., 2004; Lima et al., 2007) and
to the extensive body of literature using bovine cartilage and chondrocytes for cartilage basic
science and tissue engineering studies, it is unclear whether this technique would be applicable
for an older population of cells whose release pattern of chemical factors may vary from that of
younger, more robust cells. As such, further studies to identify an optimal cell source for the
underlying feeder layer are warranted. Second, as the beneficial effects of a coculture system are
heightened only when the feeder layer is replaced weekly with primary juvenile chondrocytes, the
utility of this system in its current setup is limited due to a decreased availability of cells and may
not be a clinically reasonable option. However, the data suggest soluble factors released by the
underlying cell feeder layer when in a particular presentation can influence the biosynthetic activity
of differentiated cells encapsulated in a 3D matrix. Our observations also suggest identifying one
or more soluble mediators responsible for the beneficial feeder layer effects will be important to
augmenting the coculture system and warrant future studies aimed at enhancing a chondrogenic
medium formulation that could be used independent of a feeder layer.
Cell-cell communication has been identified as an important regulator in the behavior of cells
and development of tissues (Bhatia et al., 1999; Gan and Kandel, 2007; Kelly et al., 2004; Watanabe
et al., 2010). For the first time, we have identified the possibility for the biosynthetic activity of
differentiated chondrocytes encapsulated in a 3D hydrogel matrix to be influenced by the presence of
an underlying feeder chondrocyte monolayer, leading to enhanced tissue development and superior
mechanical and material properties in the tissue construct (Study 1). While Young’s modulus
and GAG content were enhanced by the presence of a feeder layer this trend was not observed
for the dynamic modulus and collagen content, however. This may be explained by the fact that
the dynamic modulus is greatly influenced by the ability of collagen fibers to resist the cyclical
radial and circumferential tensile strains. In our system, most likely the soluble factors released
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are selectively targeting proteoglycan expression and production, exhibiting minor or no effects on
collagen orientation.
In Study 2, Transwellr inserts were used to provide physical separation between the developing
engineered construct and the underlying cell monolayer, allowing the effects of direct cell-cell contact
to be parsed out from paracrine signaling. While some studies have suggested direct cell-cell
contact provides signaling factors that upregulate the biosynthetic activity of cells compared with
the transfer of soluble factors between non[neighboring populations of cells (Watanabe et al., 2010),
these experimental setups generally consist of cell populations plated together on a membrane or
filter. In contrast, in our experimental setup, chondrocytes in the engineered cartilage tissue were
singularly embedded within the agarose hydrogel and prohibited direct contact with one another
and with the cells of the monolayer, even when directly placed upon it. Therefore, it is not surprising
the effects seen to facilitate this increased tissue growth and development were present even when
the construct was physically separated from the feeder layer and intercellular signaling relied on
the diffusible passage of chemical cues. In support of our findings, many reports in the literature
already utilize setups that physically separate the different populations of cells (Jikko et al., 1999)
or use conditioned media to provide chemical cues from one population of cells to another (Solursh
and Meier, 1973)
While our data indicate paracrine signaling is responsible for the expedited tissue growth in
a 3D scaffold system, the type and degree of soluble factors released by the monolayer appear
dependent on the specific presentation of the 2D feeder cell, which may be influenced by cellular
morphology, harvest freshness (eg, primary versus passaged cells), and their phase within the cell
division cycle (Study 3). Cell shape has been implicated in modulating the chondrocyte phenotype
(Benya and Shaffer, 1982); the feeder layers adopted in our study underwent an initial period
of preconfluence where cell morphology was more stellate before reaching confluence whereupon
chondrocytes assumed a more classical spherical morphology. Another factor known to influence
the chondrocyte phenotype and therefore the release of particular soluble factors is passaging; with
increased passage number, gene expression for collagen I increased while expression of collagen
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II, aggrecan, and cartilage oligomeric matrix protein (COMP), the major biomarkers present in
cartilage, were downregulated (Gunja and Athanasiou, 2007). It is feasible then downregulation of
these genetic markers can adversely affect the soluble cues being emitted from the cell monolayer.
Finally, mitomycin C, while used to halt the mitotic activity of cells, has been reported to induce
premature aging of fibroblasts (Petri et al., 1999). Aged cells are less biosynthetically active than
juvenile cells and remain in the quiescent stage of the cell cycle rather than undergoing active
division (Tran-Khanh et al., 2005). Taken together, these reports in the literature support our
results and indicate the presentation of the 2D feeder layer is crucial to providing the correct
chemical cues to the developing tissue construct.
6.5 Conclusion
Though co-culture systems have been studied extensively and used to elicit desired changes in a
population of cells, in this dissertation, by carefully and systematically manipulating the presenta-
tion of the feeder layer, we uncovered fresh insights regarding their use for tissue enhancement. In
particular, these encouraging results suggest differentiated cells such as chondrocytes encapsulated
in a 3D matrix have the potential to respond to soluble cues present in a coculture system and
that chemical factors can prime and modulate the development of engineered cartilage constructs.
Furthermore, while bovine cells were used in the engineered tissues and feeder layer of the current
study, studies in the literature suggest the possibility of using cells from disparate species with
beneficial effects (Ahmed et al., 2009a). In this manner, this work has the potential to be ap-
plied for donor cartilage allografts, which are currently in use clinically (Allen et al., 2005; Hennig
and Abate, 2007), to increase their functional tissue properties to improve success in vivo after
implantation.
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Articular cartilage is the connective tissue that lines the ends of diarthrodial joints and serves to
bear load and provide lubrication during motion (Mow et al., 1994). When the tissue is damaged
through physical injury or disease such as osteoarthritis (OA), the healing response is limited due
to its avascular nature and limited cellularity (Tew et al., 2001). These types of injuries often lead
to a disruption in the balance between anabolic and catabolic regulatory activities that lead to a
phenotypic shift in chondrocytes, cell death, and an increase in expression of inflammation-related
genes (Goldring et al., 2011) that leads to a loss of cartilage matrix components and deterioration in
the structural and functional properties of cartilage (Lee et al., 2005; Stevens et al., 2009). Catabolic
cytokines may also be generated by the fibroblast- and macrophage-like cells in the synovium, the
thin layer that lines the non-articulating surfaces of diarthrodial joints and maintains a synovial
fluid-filled cavity (Fan et al., 2009), in response to the breakdown products from damaged cartilage.
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Consequently, elevated levels of inflammatory cytokines such as interluekin-1 (IL-1) and tumor
necrosis factor-α (TNF-α) have been measured in the synovial fluid during cartilage pathology
(Pelletier et al., 1991; Sellam and Berenbaum, 2010).
Though TNF-α is the dominant cytokine responsible for joint swelling and acute inflammation,
it has been reported to be unlikely to play a role in tissue degradation (van den Berg et al., 1999).
In contrast, both forms of the IL-1 isoform, IL-1α and IL-1β, are reported to be responsible for
cartilage erosion and sustained cell infiltration, though their concentrations are highly dependent
on the stage of osteoarthritis (van den Berg et al., 1999) and the model system. As such, our
lab and others have chosen to focus on the effect of IL-1 on culture systems to better understand
the mechanisms behind erosive tissue breakdown and to potentially identify strategies for repair
(Aydelotte et al., 1992; Lima et al., 2008a,b; Murata et al., 2003; Temple et al., 2006; Wilusz et al.,
2008).
Strategies for using engineered constructs for cartilage tissue repair have focused on the im-
plantation of tissues possessing the mechanical integrity and chemical fortitude to withstand the
potentially harsh mechanochemical environment of the joint (Lima et al., 2008b). Catabolic medi-
ators from inflammation (Lotz, 2001) or the surgical intervention itself (Smeets et al., 2003) have
been shown to be especially pronounced in underdeveloped tissues (Lima et al., 2008b; Rotter
et al., 2005) in which cells are not fully embedded in the chondroprotective extracellular matrix
that accompanies construct maturity. Previous studies from our lab have reported that the linger-
ing effects of IL-1 to immature constructs remains in long-term culture, even after the cytokine has
been removed (Section 2.1.1, (Lima et al., 2008b)). In order to successfully utilize these constructs
for functional repair, it is important, therefore, to investigate potential strategies for preventing or
mediating the effect of cytokines on the developing constructs.
In cardiovascular systems, cellular preconditioning schemes by mechanical and chemical manip-
ulation have been used extensively to prime stem cells to a state in which they can withstand a harsh
microenvironment (Haider and Ashraf, 2010; Kamota et al., 2009; Kubo et al., 2008; Pasha et al.,
2008). In particular, brief exposure to a catabolic agent afforded longer term protection against
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subsequent attacks, offering the most effective means of cytoprotection (Murry et al., 1986). Mo-
tivated by the reported benefits of preconditioning, we hypothesized that the catabolic effects of
injurious IL-1 on engineered cartilage could be decreased by initially preconditioning them with
low doses of the cytokine.
This study investigates the effects of supplementing the culture media with a low concentration
of IL-1. Specifically, the effects of a 1-week preconditioning treatment on developing engineered
cartilage constructs is tested against exposure to a higher concentration of the cytokine, known
to elicit proteolysis as well as rapid degeneration of cartilage (Tyler, 1989). This phenomenon
is investigated using a well-established juvenile bovine chondrocyte model (Hung et al., 2004),
as well as an adult canine model (Ng et al., 2010) that can inform future in vivo studies in an
established large preclinical animal model. These tissue models have both been shown to produce
functional material properties (Young’s modulus) and glycosaminoglycan content similar to native
tissue (Bian et al., 2010a; Lima et al., 2007), providing a robust system to study potential therapies
for osteoarthritis. The use of a physiologically relevant tissue to study this method of protection
against cytokine exposure may shed light on the behavior of in situ cartilage during injury or
disease.
7.2 Materials and Methods
7.2.1 Experimental Design
Three consecutive studies are described here. In study 1, we used a bovine model of chondrocytes
from skeletally immature animals, as they are readily available, well characterized, and capable
of growing robust tissue in culture (relative to adult cells). Additionally, use of juvenile bovine
chondrocytes facilitates comparisons to our previous work , including the response of these cells to
in vitro applications of IL-1 (10 ng/mL, (Lima et al., 2008b)). In study 2, we investigate whether
results from the first study carry over to a preclinical canine model, also using chondrocytes from
skeletally mature animals. For each study, the same timeline was followed (Figure 7.1).
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Figure 7.1: Schematic of experimental design. Studies 1 and 2 utilized low-dose IL-1 preconditioning.
Study 3 examined the effect of CoCl2 preconditioning to verify the mode of protection.
Briefly, constructs were allowed to elaborate a threshold amount of extracellular matrix (attaining a
Young’s modulus of 100kPa or 150kPa for bovine and canine tissues, respectively), exposed to a low
dose concentration of IL-1α (for bovine) or IL-1β (for canine) for seven days and then subjected to
an injurious level of cytokine for the final seven days. The results of these studies motivated study
3. We hypothesized that the survival signal produced by preconditioning with interleukin relied
on the induction of hypoxia-inducible factor-1α (HIF-1α), similar to the mechanism suggested for
hypoxic and ischemic preconditioning schemes (Hu et al., 2008; Nanduri et al., 2008). To this end,
juvenile bovine constructs were preconditioned with cobalt chloride (CoCl2), a chemical inducer of
HIF-1α, and then exposed to an insult dose of IL-1α to investigate whether HIF-1α upregulation
was sufficient to provide protection against catabolic effects.
7.2.2 Tissue Isolation and Cell Culture
Articular cartilage was harvested from knee joints of either freshly slaughtered 2-4 week old bovine
calves or adult dogs. Four to six joints were used for each experiment and cells were pooled
from all joints. Cartilage was digested in high-glucose DMEM with collagenase IV (Worthington
Biochemical Corporation, Lakewood, NJ) for 11 h (bovine) or 8 h (canine) at 37 °C with shaking.
Cell suspensions were filtered through a 70µm porous mesh and sedimented in a bench-top centrifuge
for 15 min at 1500g. Viable cells were counted with a hemocytometer and trypan blue and plated at
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high density (20×103 cells/cm2) in a growth factor cocktail (1 ng/mL TGF-β1, 5 ng/mL bFGF, and
10 ng/mL PDGF-ββ (Ng et al., 2010; Sampat et al., 2011)). At confluence, cells were trypsinized,
resuspended (60×106 cells/mL), and mixed in equal parts with 4% low-gelling agarose (type VII,
Sigma) at 37°C. The chondrocyte/agarose mixture was cast into slabs and cores were produced
using a sterile, disposable biopsy punch (Miltex) to yield final dimensions (∅4mm×2.34 mm thick).
Constructs were cultured in DMEM supplemented with 1× penicillin, streptomycin, fungizone
(PSF, Sigma), 0.1 µM dexamethasone, 40 µg/mL L-proline, 100 µg/mL sodium pyruvate, and 1×
ITS+ premix (insulin, human transferrin, and selenous acid, Becton Dickinson, Franklin Lakes,
NJ). Using culture protocols optimized from earlier studies of juvenile bovine and adult canine
chondrocytes, respectively (Lima et al., 2004; Ng et al., 2010), medium was further supplemented
with 50 µg/mL ascorbate 2-phosphate daily and 10 ng/mL TGF-β3 (Invitrogen) for the first 14
days of culture (for bovine culture) or for the entire culture (for canine culture). Media was changed
every other day.
7.2.3 Preconditioning and Insult
Earlier studies have identified that constructs must comprise sufficient extracellular matrix to with-
stand the harsh catabolic effects of IL-1 (Lima et al., 2008b). Accordingly, for the current studies,
after constructs had attained an equilibrium Young’s modulus of ∼100 kPa (for bovine) and ∼150
kPa (for canine), one subset of samples was exposed transiently to a range of low dose concen-
trations of cytokine. For study 1, IL-1α, the more potent of the two isoforms in juvenile bovine
agarose-chondrocyte constructs (Lima et al., 2008a), was administered (0.1 ng/mL, 0.5 ng/mL, 1.0
ng/mL) for seven days. In study 2, IL-1β (0.2 ng/mL, 1.0 ng/mL, 2.0 ng/mL), the more potent
isoform for canine constructs was used (Cook et al., 2000; Kuroki et al., 2005). In study 3, con-
structs were exposed to media supplemented with 100µM CoCl2 (Figure 7.1). For all studies, a
negative control group was included where samples were handled similarly but no preconditioning
dosage was applied. Following the preconditioning period, constructs were then exposed to an
injurious level of IL-1 (10 ng/mL, isoform depending on cell species, (Cook et al., 2000; Lima et al.,
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2008b)) for an additional seven days. During the period of cytokine exposure, all media was void
of dexamethasone, previously shown to counter the catabolic effects of IL-1 (Lima et al., 2008b).
7.2.4 Mechanical Testing
Constructs were tested for their equilibrium Young’s modulus (EY ) and dynamic modulus (G*)
in unconfined compression using a custom computer-controlled system (Soltz and Ateshian, 1998).
An initial 0.02 N tare load was applied, followed by compression to 10% strain, at a strain rate of
0.05% s−1. After stress relaxation was achieved, a 2% peak-to-peak strain was superimposed at
0.01Hz. EY was measured from the stress-relaxation equilibrium response and is used as a measure
of the equilibrium behavior of cartilage after an applied load has been applied. G*, considered to
be a more physiologically relevant measurement of cartilage behavior in response to applied cyclic
loads, was determined from the slope of the stress-strain response under dynamic loading.
7.2.5 Biochemical Analysis
After material testing, the biochemical content of each sample was assessed by measuring the sample
wet weight, lyophilizing, and then measuring the dry weight. Construct swelling was quantified
by measuring the gross water content of the constructs (Lima et al., 2007). Dried samples were
digested in proteinase K buffer overnight at 56 °C, as described previously (Kelly et al., 2006).
One aliquot was analyzed for glycosaminoglycan (GAG) content via the 1,9 dimethylmethylene
blue dye-binding assay. A second aliquot was hydrolyzed with 12 N HCl at 110 °C for 16 h, dried,
and resuspended in assay buffer. Orthohydroxyproline content was determined using a colorimetric
assay via a reaction with chloramine T and dimethylaminobenzaldehyde, scaled for microplates
(Kelly et al., 2006). Overall collagen content was calculated using a 1:7.64 OHP-to-collagen mass
ratio (Stegeman and Stalder, 1967). Total dsDNA content was assessed by the Picogreen assay.
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7.2.6 Statistics
Statistical analyses were performed using two-way analysis of variance (ANOVA) with Tukey’s
Honest Significant Difference (HSD) post hoc tests (Statistica), with α=0.05 and statistical signif-
icance set at p≤0.05 to compare groups across day and treatment. Data is reported as the mean
and standard deviation of 4-5 samples per time point and group.
7.3 Results
7.3.1 Study 1 : Juvenile bovine chondrocytes - preconditioning culture
All three studies were started on constructs that had matured, i.e., elaborated sufficient ECM to
resemble in situ cartilage. For these constructs, maturation in culture to day 21 yielded significantly
greater mechanical stiffness and biochemical content compared with initial conditions (EY day21 =
96.8 ± 22.3 kPa vs. EY day0 = 2.32 ± 1.57 kPa; GAGday21 = 3.01 ± 0.27%/ww vs. GAGday0 =
0.05 ± 0.01%/ww).
Constructs were then exposed to low doses of IL-1α. At day 28, control constructs continued to
elaborate matrix and increase stiffness (EY = 380 ± 37.0 kPa; GAG = 4.47 ± 0.69%/ww, Figure
7.2), while those exposed to low doses of IL-1α exposure showed significantly lower mechanical





























Figure 7.2: Study 1. (a) Young’s modulus and (b) GAG content as a result of preconditioning with low
doses of IL-1.*p<0.05 vs. control
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stiffness and GAG composition, demonstrating a concentration-dependent degrading action of the
cytokine. For example, with 0.1 ng/mL and 0.5 ng/mL doses, slight tissue degradation was notice-
able, as evidenced by the 25% drop in mechanical properties compared to control samples (EY 0.1
= 278 ± 38.0 kPa, p0.1=0.02; EY 0.5 = 278 ± 51.7 kPa, p0.5=0.03, Figure 7.2a). A 15% and 22%
drop in GAG content, respectively, was noted for those same low-dose concentrations, though they
were not significantly lower relative to control samples (GAG0.1 = 3.80 ± 0.27%/ww, p0.1 = 0.10;
GAG0.5 = 3.53 ± 0.57%/ww, p0.5=0.05, Figure 7.2b). When 1.0 ng/mL IL-1α was introduced
into the culture medium, however, the catabolic effects were much more severe, lowering mechan-
ical stiffness by nearly 55% (EY 1.0 = 170 ± 55.6 kPa, p1.0<0.001, Figure 7.2b). Interestingly, 1.0
ng/mL IL-1α did not introduce a corresponding, severe drop in GAG properties; instead only a
27% decrease was measured compared to control samples (GAG1.0 = 3.25 ± 0.57%/ww, p1.0 =
0.02, Figure 7.2b). Collagen content was unchanged across all groups.
7.3.2 Study 1 : Juvenile bovine chondrocytes - insult culture
Following seven days of insult culture (10 ng/mL), positive control samples (no preconditioning
dose of IL-1α, 10 ng/mL IL-1α during insult period) showed a significant degree of degradation,
retaining only 23% of the construct’s mechanical stiffness (EY = 44.7 ± 11.1 kPa) and 40% of the
construct’s GAG content (GAG = 1.73 ± 0.41%/ww) compared to their levels prior to cytokine
insult (Figure 7.3). Preconditioning constructs with low doses of IL-1α the week prior to the insult
culture afforded dose-dependent protection against catabolic degradation. With 0.1 ng/mL IL-1α
preconditioning, constructs exhibited significantly greater mechanical stiffness (EY 0.1 = 109 ± 11.9
kPa, p=0.16, Figure 7.3a) and GAG content (GAG0.1 = 2.81 ± 0.48%/ww, p=0.01, Figure 7.3b)
than positive control samples, retaining nearly 70% of their original properties prior to insult. 0.5
ng/mL IL-1α preconditioning provided additional protection against degradation and constructs
were further enhanced (EY 0.5 = 164 ± 7.59 kPa, p=0.01; GAG0.5 = 3.29 ± 0.48%/ww, p=0.0003,
Figure 7.3). However, constructs preconditioned with the high dose of IL-1α (1.0 ng/mL) showed
the same degradation profile as that seen with positive control samples; they were not significantly
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different in mechanical stiffness (EY 1.0 = 36.8 ± 7.89 kPa, p=0.99, Figure 7.3a) or GAG content
(GAG1.0 = 1.88 ± 0.52%/ww, p=0.99, Figure 7.3b).
7.3.3 Study 2 : Adult canine chondrocytes - preconditioning culture
Similar to bovine chondrocytes, after 14 days of culture, adult canine chondrocytes elaborated
a significant amount of extracellular matrix that resulted in increased mechanical stiffness and
biochemical composition by day 14 (EY = 191 ± 17.0 kPa; GAG = 3.01 ± 0.27%/ww). By day
21, after 7 days of low dose concentrations of IL-1β, all constructs showed continued growth that
was not significantly different in the presence of the cytokine (p>0.42, Figure 7.4a). A slight, but
significant, drop in DNA content per construct was noted only for the 2.0 ng/mL IL-1β group
(DNAcontrol = 7.30 ± 0.79 µg vs. DNA2.0 = 5.92 ± 0.40 µg, p=0.0025, Figure 7.4b). Biochemical
composition for all groups was maintained.









































Figure 7.3: Study 1. Normalized (a) Young’s modulus and (b) GAG content after insult dose of IL-1
administered. *p<0.05 vs. control, #p<0.05 vs. 0 ng/mL group (positive control)
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Figure 7.4: Study 2. (a) Young’s modulus, (b) DNA, and (c) GAG/DNA content after low dose IL-1
preconditioning. *p<0.05 vs. 0 ng/mL group
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7.3.4 Study 2 : Adult canine chondrocytes - insult culture
Following cytokine insult (10 ng/mL), DNA content was significantly lower (47% and 43%, respec-
tively) in the groups with the two highest levels of preconditioning cytokine (p<0.0001, Figure 7.5b).
Biochemical constituents were normalized to DNA content to account for this change. Positive con-
trol samples exhibited significant decreases in mechanical properties (EY control = 240 ± 50.4 kPa
vs. EY poscon = 91.3 ± 9.10 kPa, p<0.0001, Figure 7.5a) and GAG content (GAGcontrol = 95.7 ±
14.8 µg/µg vs. GAGposcon = 55.7± 5.96 µg/µg, p<0.0001, Figure 7.5c). Preconditioning with low
doses of IL-1β (0.2 ng/mL) decreased catabolic degradation, as reflected in mechanical stiffness, i.e.
a significantly higher Young’s modulus (156 ± 13.1 kPa) was retained, compared to positive con-
trol samples (Figure 7.5a). However, the partial protection noted for mechanical stiffness was not
reflected in the biochemical composition of the samples; GAG/DNA (62.9 ± 7.40 µg/µg, p=0.90,
Figure 7.5c) was statistically similar to positive control samples. The reverse trend was seen for
higher (1.0 and 2.0 ng/mL) preconditioning doses of IL-1β; mechanical properties were similarly af-
fected by the insult level of cytokine as positive controls (EY 1.0 = 109 ± 34.4 kPa, p1.0 = 0.99;EY 2.0
= 98.5 ± 27.1 kPa, p2.0>0.99, Figure 7.5a) though GAG content recovered and was comparable to
negative control samples (GAG1.0 = 88.2± 2.22 µg/µg, p1.0 = 0.87;GAG2.0 = 97.9± 5.85 µg/µg,
p2.0>0.99, Figure 7.5c). Collagen content was unaffected for all groups.
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Figure 7.5: Study 2. Normalized (a) Young’s modulus, (b) DNA, and (c) GAG content after insult dose
of IL-1 administered. *p<0.05 vs. control, #p<0.05 vs. 0 ng/mL group (positive control)
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7.3.5 Study 3 : Juvenile bovine chondrocytes - CoCl2 preconditioning
In study 3, in lieu of preconditioning with low doses of cytokine, we explored the use of CoCl2 as a
means of activating HIF-1α transcription. On day 14, prior to the start of CoCl2 preconditioning,
constructs possessed appreciable extracellular matrix deposition and associated mechanical prop-
erties similar to those in mature constructs used in studies 1 and 2 (EY day14 = 174 ± 13.8 kPa;
GAGday14 = 3.21 ± 0.20%/ww). Following preconditioning with CoCl2, constructs exhibited signif-
icantly lower stiffness (70% of control, EY day21CoCl2= 189± 21.7 kPa, p=0.0076, Figure 7.6a), but
comparable dynamic modulus, GAG, and collagen content compared to control constructs (p>0.05,
Figure 7.6d). Preconditioned and control constructs were next exposed to insult levels of IL-1α.
Positive control samples behaved similarly to those in studies 1 and 2, degrading in mechanical
properties (EY poscon = 47.5 ± 13.8 kPa, p<0.0001; G*poscon = 0.44 ± 0.03 MPa, p=0.0019, Fig-
ure 7.7a,b) and GAG content (GAGposcon = 2.41 ± 0.50%/ww, p<0.0001, Figure 7.7c) compared
to control samples. Collagen content for these positive control samples was statistically similar
to control samples (COLposcon = 1.63 ± 0.07%/ww, p=0.55, Figure 7.7d). CoCl2-preconditioned
constructs showed resistance to the catabolic degradation imparted by IL-1α and were capable of
retaining more of their GAG content (GAGCoCl2= 3.08± 0.29%/ww, p=0.04, Figure 7.7c), lead-
ing to improved mechanical properties (EY = 89.7 ± 11.8 kPa, p=0.02, G* = 0.97 ± 0.01 MPa,
p=0.0008, Figure 7.7a,b) as compared to positive control samples. However, unlike in studies 1 and
2, collagen content for those preconditioned with CoCl2 decreased significantly (COLCoCl2= 0.97±
0.07%/ww, p<0.0001, Figure 7.7d) compared to control samples and positive control samples.
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Figure 6. Study 3. (a) Young’s modulus, (b) Dynamic modulus, (c) GAG content and (d) COL content after 
preconditioning with 100 μM CoCl2. *p<0.05 vs. controlFigure 7.6: Study 3. (a) Young’s modulus, (b) Dynamic modulus, (c) GAG content and (d) COL content
after preconditioning with 100 µM CoCl2. *p<0.05 vs. control
Figure 7. Study 3. Normalized (a) Young’s modulus, (b) Dynamic modulus, (c) GAG, and (c) COL 











































































Figure 7.7: Study 3. Normalized (a) Young’s modulus, (b) Dynamic modulus, (c) GAG, and (c) COL
content after insult dose of IL-1 administered. *p<0.05 vs. control, #p<0.05 vs. 0 µM group (positive
control)
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7.4 Discussion
Cartilage grafts introduced to an injured or arthritic joint will be subjected to a cytokine-rich envi-
ronment. Thus, in order to promote engineered cartilage as a clinically-relevant replacement tissue,
the construct must be able to survive the chemical and mechanical loads that are imparted upon
implantation. In this context, we explored a protection method by which functional engineered car-
tilage constructs that are capable of attaining native functional properties (bovine: ∼400-1000 kPa
(Bian et al., 2008; Lima et al., 2007); canine: ∼380 kPa (Bian et al., 2010a)) can better withstand
the harsh chemical environment of the joint. To our knowledge, this is the first study to show that
chemical preconditioning schemes impart protection against injurious IL-1 exposure. Specifically,
by varying the preconditioning dose, we were able to identify conditions under which mechanical
properties and biochemical composition were retained, despite subsequent exposure to injurious
levels of the cytokine. These results support our hypothesis regarding the benefits of cytokine
preconditioning. The successful translation of these results from a bovine to a canine model, a
large preclinical animal model system, corroborates the bovine work and provides encouragement
for eventual application of this strategy to therapies for cartilage repair in the clinic.
While many studies employ a classical concept of preconditioning involving cyclical exposure
to brief episodes (Haider et al., 2009; Kamota et al., 2009; Patel et al., 2005), other studies utilized
a single long-term exposure (Hu et al., 2008; Kubo et al., 2008; Rosova et al., 2008; Tang et al.,
2009) to initiate survival signaling that was then followed by the harmful insult. We chose to adopt
the latter as the longer preconditioning time frame would increase the likelihood of the cytokine
diffusing fully through the agarose construct within the preconditioning period. It is important to
note, however, that while the protective effect we observed here has been previously noted with
other chemical schemes to prepare individual cells against harsh conditions (Haider and Ashraf,
2010; Murry et al., 1986), this is the first time the effect has been observed for complex whole tissues
that include elaborated extracellular matrix. The dense matrix in cartilage constructs confounds
attempts to understand the potential mechanism(s) of protection. That is, the mode of protection
may arise from an altered state of the cells themselves, or because the preconditioning has induced
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the cells to develop a chondroprotective matrix that is able to mediate the effects of the cytokines.
Previous studies have supported the idea that a cell’s tolerance to subsequent insult events is
afforded by activation of a survival signal that depends on multiple signaling pathways or on the
release of chemical activators such as adenosine or nitric oxide (Patel et al., 2005). Furthermore,
other studies have found that modulation of growth factor expression either through the use of
specific factors during expansion (Murry et al., 1986) or through genetic manipulation can produce
similar beneficial preconditioning effects. Further studies are necessary to systematically identify
which pathways are involved in the protective process, however, we can postulate that, in agreement
with previous preconditioning studies (Hu et al., 2008; Nanduri et al., 2008) and as supported by the
results we observed, the HIF-1α pathway has a central role in the activation of this survival signal
against IL-1 catabolic degradation. Despite the protection afforded by preconditioning, however,
we noted a decrease in collagen content after preconditioning with CoCl2 that was not seen with
IL-1 preconditioning groups. This may point to the possibility that a downstream effect of inducing
hypoxia may be an upregulation of collagenases that did not occur in our other preconditioning
scheme. Additionally, though we did not directly assay for HIF-1α upregulation, previous studies
have found an association between hypoxia induction with the upstream activation of the p38
mitogen-activated protein (MAP) kinase pathway (Emerling et al., 2005). p38 MAP kinase has
been found to upregulate cytokine production via direct phosphorylation of transcription factors
(Ashwell, 2006), possibly leading to additional catabolic effects on the bulk construct. Further work
will be necessary to fully elucidate this possibility. Nevertheless, preconditioning with a low dose of
IL-1 had a similar effect as preconditioning with induced hypoxia, suggesting that the downstream
effect of IL-1 preconditioning may be attributable to upregulation of HIF-1α or a similar effect on
cellular transcription.
The heightened generation of a chondroprotective matrix is unlikely to be the only cause of
the protection. Previous studies have suggested that pools of GAG in the pericellular region and
inter-territorial regions change with culture time such that changes to the local environment of
the cell alter the cell’s function and response to external stimuli such as IL-1 (Quinn et al., 2002).
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However, under our current experimental conditions, unlike previously reported studies (Lima et al.,
2008b), we have observed vulnerability to IL-1 regardless of mechanical integrity or biochemical
composition, thus ruling out extensive cryoprotection by matrix components. Furthermore, samples
with the same composition and mechanical integrity responded differently to insult levels of IL-1
depending on their preconditioning (none vs. low dose IL-1 vs. CoCl2 treatment). It is important
to note, however, that our measurements of bulk properties and biochemical constituent content
may not detect compositional changes to the matrix. Changes in the composition of matrix could
be responsible for the protection against IL-1 that preconditioning with either low dose IL-1 or
CoCl2 elicits. Further analysis, however, using comprehensive proteomics gene expression arrays
will be required to better understand whether changes to the matrix or subsequent cellular changes
are responsible for resisting the catabolic damage brought about by IL-1 exposure.
Although the concentration of the cytokine used to inpart damage to the tissue was on par with
concentrations typically utilized for in vitro studies (5-20 ng/mL (Li et al., 2003; Temple et al., 2006;
Xu et al., 1996)), the dose we used is well above doses found in vivo (0.01-0.2 ng/mL (McNulty et al.,
2013; Wilusz et al., 2008)). We reason that in free swelling conditions, as described here, in the
absence of any mechanical loading, a higher concentration of cytokine may be necessary to elicit an
injurious effect. In fact, previous studies have demonstrated that engineered cartilage is insensitive
to interleukin at ≤0.01 ng/mL, and exhibits an all-or-nothing response at IL concentrations from
0.1 to 10 ng/mL (Lima et al., 2008a). Theoretical modeling of dynamic deformational loading of
hydrogels such as agarose have predicted that loading leads to enhanced transport of soluble factors
such as cytokines (Albro et al., 2008; Chahine et al., 2009; Mauck et al., 2003a,b). Accordingly,
it may be possible to utilize more physiologic levels of cytokines in tandem with dynamic loading
protocols in future evaluations of preconditioning schemes for tissue engineered cartilage (Lima
et al., 2007).
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7.5 Conclusion
In this chapter of the dissertation, a novel method for de-sensitizing engineered cartilage to cytokine
exposure was discovered. Though preconditioning protocols have been investigated and are widely
recognized for their use in hypoxic and ischaemic conditions, this is the first time such a protocol
has been applied for protection against cytokine insult. Preconditioning with a low dose of IL-1
immediately is capable of protecting the construct against subsequent catabolic destruction from
exposure to injurious levels of cytokine and offers an intriguing potential for using this technique for
clinical therapeutic applicability. These findings contribute to the existing basic science literature
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Chapter 8
Conclusions and Future Directions
The overall aim of this dissertation was two-fold: 1) characterize the functional nature of devel-
oping tissues by assessing their response to induced chemical or mechanical insult and 2) develop
reparative and protective strategies for enhancing the performance of engineered cartilage in vivo.
Our lab has adopted the long-term hypothesis that engineered cartilage must possess material
properties matching that of native cartilage in order to survive the harsh mechanochemical load-
ing environment of the knee joint. Towards this goal, this dissertation uncovered new findings on
these two interrelated themes and shed light on potential therapeutics for cartilage repair. The
studies described here spanned both 2D migration studies to characterize the limited wound repair
potential of cells as well as 3D culture studies to explore injury and protection effects at a tissue
level. Together, these models allowed us to capture the complexity needed to fully understand the
response of engineered constructs to injury and the potential in using it to repair wounded cartilage.
We first present a summary of the findings for each study and discuss them in the context of their
relevance toward our main goal. Finally, future studies motivated by the work described here are
suggested.
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8.1 Conclusions
To date, most studies have assessed the quality of the repair tissue by short-term factors such
as gene expression or protein analysis or with material properties such as mechanical strength,
biochemical composition, or histological properties. We have strived to characterize the biological
functionality of our engineered constructs in response to both chemical and mechanical insult in
an effort to understand the true biological functionality of our tissues and to predict how they may
perform after in vivo implantation.
8.1.1 Characterizing the Injury Response in Native and Engineered Cartilage
In Part I, we began this dissertation examining a cohort of earlier studies, to which I contributed,
that investigated the response of native and engineered cartilage to cytokine insult (Chapter 2).
While many studies have previously described interleukin-induced degradation of articular carti-
lage (Chowdhury et al., 2003; Legare et al., 2002; Li et al., 2003; Rotter et al., 2005; Stabellini
et al., 2003; Temple et al., 2006; Xu et al., 1996), our findings revealed that in our chondrogenic
medium formulation, native cartilage was resistant to the degradative effects of IL-1. Notably, the
response of engineered tissue to the same insult was reliant on the maturity of the construct; i.e. for
fledgling engineered cartilage lacking a chondroprotective ECM, constructs exhibited catastrophic
degradation. In comparison, ECM-rich constructs were capable of withstanding the insult with-
out degradation of properties, similar to native tissue. Even with the application of physiologic
deformational loading, underdeveloped constructs were not capable of surviving the exposure to
cytokines. These results direct the use of engineered cartilage for in vivo implantation only when
constructs have attained sufficient maturity.
The successful implantation of engineered cartilage requires the construct not only to be able to
withstand the cytokine-rich environment of the joint, but also to withstand the mechanical burdens
characteristic of a load-bearing joint. We explored this theme further by studying the effects of
mechanical injury under a controlled loading environment (Chapter 3). Many studies in the
literature have looked at the response of native articular cartilage to various modes of mechanical
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injury; we contribute to the literature in assessing two particular modes of iatrogenic injury and
offer suggestions how they may be modified to limit pervasive cell death. Our findings revealed
that by manipulating and controlling particular factors (e.g. insertion rate and rotational speed)
of the drill apparatus, cartilage tissue is preserved. Next, we filled a large gap in the literature by
providing insights into how engineered cartilage responds to similar types of injury. Surprisingly,
we found that engineered cartilage exhibited the potential for repair following injury, but that this
remained largely dependent on the mode of injury (cutting vs. overload induced cracking) as well
as the point in culture (early or late) at which the insult was applied. Briefly, underdeveloped
constructs were able to withstand the applied injury, most likely due to the lack of cell-matrix
development. As the constructs matured and ECM developed, only cut constructs were able to
withstand the insult. Mature overloaded constructs demonstrated a poor healing capacity following
cracking injury, analogous to the known behavior of native cartilage. Finally, our results also suggest
that disparities between the behavior of our engineered cartilage to native cartilage explants may be
due to the inclusion of a anabolic corticosteroid (dexamethasone) that works to not only promote
cartilage development, but also protect it against propagative cell death following injury. Therefore,
Hypothesis 1 was accepted. Together, these results further differentiate the response of engineered
cartilage from native cartilage to mechanical injury and begin to provide insights into how the
damage may be contained.
8.1.2 Strategies for Enhancing Cartilage Repair
In Part II of this dissertation work, we developed strategies for enhancing the performance of
engineered cartilage for in vivo repair. We first analyzed the limited migration of repair cells to
wound sites in cartilage and built upon the previous literature on using electric field stimulation
for directing cell migration by investigating the influence of extracellular environment. We focused
on one particular mechanosensor, the AQP1 water channel, and confirmed our hypothesis that
it plays a significant role in migration in the presence of applied EF (Chapter 4). Our results
highlighted a potential mechanism by which cells sense their environment and regulate key aspects
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of migration, including cell volume and cytoskeletal organization. This finding was then tested in
harsh environments, modulated both by extracellular medium osmolarity and cytokine exposure.
Though cytoskeletal structure was different in hypotonic vs. hypertonic environments, migration
capacity was not significantly different, revealing that altered cytoskeletal distribution does not
exclusively control directed migration under EF exposure. When cells were cultured in the presence
of IL-1, previously reported in the literature to similarly alter cytoskeletal distribution, chondrocytes
exhibited stunted migration. Surprisingly, SDSCs proved resistant to the effects of the cytokine,
maintaining similar migration profiles as control cells, implying that these SDSCs may be a better
source for cartilage repair (Chapter 5). From these collective results, we accept Hypothesis 2.
For tissue engineering efforts at creating functional cartilage replacement, we uncovered novel
strategies to foster better tissue development via co-culture systems (Chapter 6). Fresh chon-
drocyte feeder layers permit the transmission of soluble factors to encapsulated chondrocytes in
constructs; our results showed that these soluble factors were responsible for expediting growth of
engineered cartilage depending on the presentation of the feeder layer. This work revealed potential
culture techniques capable of producing more functional tissue.
In a precursor study described in Chapter 2, we identified a potential mediator of catabolic
degradation through the use of a natural cross-linker. We continued in this vein with efforts designed
at enhancing the resistance of engineered cartilage to catabolic factors (Chapter 7). These positive
results described mediated protection against cytokine insult when a preconditioning scheme was
first applied. These findings ultimately recommend the use of preconditioning with mechanical
and/or chemical factors to mediate the catabolic consequence of IL-1 and we accept Hypothesis
3; such findings motivate their potential use in therapeutics and for tissue engineering efforts at
creating clinically-relevant tissue-engineered constructs for the treatment of OA or following injury.
8.2 Future Directions
The collective findings of this dissertation have aimed to fill the gap in knowledge in understanding
how engineered cartilage responds to injury and identified potential methods by which that response
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Figure 8.1: Schematic of work described in this thesis (blue, purple pieces) in the context of previous lab
efforts (grey pieces). Complementary areas for future directions will add to this overall puzzle (green, orange
pieces).
can be mediated. The related themes of work described in this dissertation and future studies is
laid out in Figure 8.1. To date, our lab has focused on the creation and characterization of these
engineered cartilage constructs, with recent efforts focused on the enhancement of tissue properties
via “smart engineering”: applying a combination of mechanical loading and chemical stimuli to
produce functional tissues. This dissertation aimed to complement the previous studies by first
characterizing the biological functionality of engineered tissues. By subjecting the constructs to
conditions similar to those found in the in vivo environmental, we found that mature engineered
cartilage has the potential to behave like native cartilage, responding similarly to both chemical and
mechanical insults. These findings prompted the search into novel methods for enhancing cartilage
repair with the aim of protecting them from the potentially harsh mechanochemical factors present
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in the joint. These results have laid the groundwork for the next step: in vivo assessment of
engineered constructs that have been prepared using the methodologies described herein. They
also highlight areas for potential future complementary studies.
8.2.1 In vivo Assessment of Preconditioned Constructs
The findings described in Chapter 7 point to the ability of preconditioned engineered cartilage to
partially resist the catabolic factors present in the injured joint, however in vivo studies assessing
construct success are required to fully understand the potential of this protection scheme. The
pre-clinical large animal canine model already is well established (Ng et al., 2010), and has been
used to assess the biocompatibility of agarose-chondrocyte constructs.
Within the experimental conditions of our study, only one cytokine was applied during the
preconditioning or insult phase. It is likely, however, that a multitude of chemical factors are
present in an inflammatory environment and may render in vivo outcomes different from what we
previously observed. This may suggest the need to reexamine the literature for measured levels
of multiple cytokines (e.g. TNF-α, IL-6, leukemia inhibitory factor) found in the injured joint to
guide the use of particular cytokines for in vitro preconditioning.
8.2.2 Creation of a 3D Injury Model
We have examined directed cell migration in the context of a 2D environment. It has been widely
known, however, that the migration of cells in a 3D environment varies drastically. For example,
proteolytic digestion of the extracellular matrix is an essential step for efficient migration or invasion
into a tissue (Schwab et al., 2012). This is further supported by findings that SDSC migration is
facilitated in vivo only after the degradation of GAG molecules from the surface (Hunziker and
Kapfinger, 1998). To this end, while knowledge gained through the results presented in Chapters 4
and 5 is useful, further development of a 3D model may provide a more realistic view of how cells
truly behave when in the joint.
We have begun to assess this potential by co-culturing a SDSC monolayer onto a Transwell




Figure 8.2: (a) 21 days after introduction of a SDSC monolayer to a wounded tissue engineered construct,
a confocal stack of images of a representative construct (cartilage cells labeled green) show adhered SDSCs
(labeled blue) to the superficial surface of the tissue. (b) 3D reconstruction (white arrow represents face in
side view (c)) of the injured cartilage construct show SDSCs preferentially located close to and lining the
surface of the cut region (cut region outlined by white dashed lines).
membrane, and positioned it in direct contact with an adjacent wounded engineered cartilage
construct. Increased migration of SDSCs onto the surface and into the cut region of the injured
construct was observed. As early as seven days following the initial cut injury, confocal images of
the cut constructs showed significant migration of SDSCs onto the superficial surface of constructs.
By day 21, adhered SDSCs appear to localize to the vicinity of the cut region (Figure 8.2a). 3D
reconstruction and side views of the construct confirmed that SDSCs had begun infiltrating the
depth of the cut (Figure 8.2b-c).
These results, while preliminary, demonstrate the potential for SDSCs to migrate out of a
membrane into a cartilage wound site and describe a model system that can be used to study the
complex interplay of multiple tissues in a diarthrodial joint in response to an injury, and to gain
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further insights into the mechanisms that mediate the poor healing response of native cartilage to
trauma. These results also motivate further investigation into the homing potential of SDSCs to
a wound site as well as identifying modulators of cell migration that may be enhanced to increase
the reparative response of cartilage.
8.2.3 Use of Pulsatile DC Electrical Stimulation for Enhanced Cell Migration
In line with the aim of creating a 3D injury model, stimulating cells to migrate to a wound site would
be beneficial. While we have examined the effects of constant applied DC EF on cell migration in
2D, recent reports in the literature have reported success at generating migration in a 3D tissue
under pulsatile stimulation (Yuan et al., 2014). Though the extracellular ionic currents present
during wound healing constitute a relatively slow electrical phenomenon and are distinct from
faster, pulsatile electrical events (generally associated with action potentials in nerve or muscle
cells)(Soong et al., 1990), further investigation into the use of these fields may provide insights to
guide wound repair.
In limited preliminary work, we have identified that pulsatile DC electrical stimulation effec-
tively enhances cartilage tissue development. When human bMSC pellets were exposed to such
loading, pellets exhibited a dose-dependent growth development (Figure 8.3), with stimulated tis-
sues exhibiting greater staining for GAG and collagen distribution (Figure 8.4); parallel quantitative
trends were noted for these molecules. These results point to the potential to incorporate a pulsatile
EF stimulation regime during culture to enhance tissue development. Whether these effects lead
to enhanced migration within engineered cartilage, however, remains to be elucidated.







Figure 8.3: Gross morphology of human bMSC pellets exposed to a range of pulsatile DC EF strengths.
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Archiv - European Journal of Physiology, 444(1-2):276–285.
Shields, C. J., Winter, D. C., Geibel, J. P., O’Sullivan, G. C., Wang, J. H., and Redmond, H. P.
(2006). Hypertonic saline attenuates colonic tumor cell metastatic potential by activating trans-
membrane sodium conductance. J. Membr. Biol., 211(1):35–42.
Shields, C. J., Winter, D. C., Wang, J. H., Andrews, E., Laug, W. E., and Redmond, H. P. (2004).
Hypertonic saline impedes tumor cell-endothelial cell interaction by reducing adhesion molecule
and laminin expression. Surgery, 136(1):76–83.
Sieg, D. J., Hauck, C. R., and Schlaepfer, D. D. (1999). Required role of focal adhesion kinase
(FAK) for integrin-stimulated cell migration. Journal of cell science, 112 ( Pt 16):2677–2691.
Smeets, T. J. M., Barg, E. C., Kraan, M. C., Smith, M. D., Breedveld, F. C., and Tak, P. P.
(2003). Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix
metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from
patients with end stage, destructive rheumatoid arthritis. Annals of the rheumatic diseases,
62(7):635–638.
Smetana, K. J. (1993). Cell biology of hydrogels. Biomaterials, 14(14):1046–1050.
Smola, H., Thiekötter, G., and Fusenig, N. E. (1993). Mutual induction of growth factor gene
expression by epidermal-dermal cell interaction. The Journal of cell biology, 122(2):417–429.
Soltz, M. A. and Ateshian, G. A. (1998). Experimental verification and theoretical prediction of
cartilage interstitial fluid pressurization at an impermeable contact interface in confined com-
pression. Journal of biomechanics, 31(10):927–934.
155
Solursh, M. and Meier, S. (1973). A conditioned medium (CM) factor produced by chondrocytes
that promotes their own differentiation. Developmental biology, 30(2):279–289.
Soong, H. K., Parkinson, W. C., Bafna, S., Sulik, G. L., and Huang, S. C. (1990). Movements of cul-
tured corneal epithelial cells and stromal fibroblasts in electric fields. Investigative ophthalmology
& visual science, 31(11):2278–2282.
Stabellini, G., De Mattei, M., Calastrini, C., Gagliano, N., Moscheni, C., Pasello, M., Pellati, A.,
Bellucci, C., and Gioia, M. (2003). Effects of interleukin-1beta on chondroblast viability and ex-
tracellular matrix changes in bovine articular cartilage explants. Biomedicine & pharmacotherapy
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ABSTRACT
Unlike native cartilage explants that are used in autologous tissue transfer procedures, engineered carti-
lage constructs are typically highly fragile when first formed and must rely on cellular activity to develop
over time. However, inflammatory cytokines such as interleukin-1a (IL-1a) are often present in target
joints and may interfere with this development process. Herein we examine to what extent nascent en-
gineered tissue is susceptible to chemical perturbations by IL-1a (10 ng/mL), especially when compared to
native explants, and whether in vitro preconditioningmay promote sufficient integrity to lessen this impact.
The studies were carried out using a chemically defined medium supplemented with or without the anti-
inflammatory steroid dexamethasone. We find that engineered tissue (bovine chondrocytes in agarose
hydrogel) at early time points (days 0 and 14) does not growwhen exposed to the cytokine even temporarily,
but both bovine explants and more developed engineered tissue (day 28) are able to withstand the same
exposure without degradation of properties. We argue therefore that some in vitro preconditioning may be
necessary to promote both sufficient mechanical integrity and the chemical fortitude without which in-
sufficiently developed engineered constructs will not survive the harsh mechanochemical environment
within the joint.
INTRODUCTION
ACENTRAL TENET OF CARTILAGE tissue engineering is toreplace damaged or diseased cartilage with new tissue
composed of isolated, living cells embedded in a scaffold
carrier.1–8 Typically, this engineered tissue is highly fragile
when first formed, but over time it matures, depositing a
cartilaginous extracellular matrix and growing in stiffness
until, ideally, it possesses the same mechanical and bio-
chemical properties of native cartilage. Consequently, cli-
nicians have a choice of developmental states available to
them when using engineered tissue that would otherwise be
unavailable when using native cartilage. Some tissue en-
gineering strategies capitalize on the different states of
maturity by designing a system where the tissue matures
entirely in vivo, while other strategies implant the tissue
only after it has had a chance to partially mature in vitro. A
successful in vivo maturation system presents clear ad-
vantages in terms of speed and convenience over an in vitro
cultivation system; however, some preconditioning may be
necessary to promote both sufficient mechanical integrity
and, as we will argue here, the chemical fortitude without
which insufficiently developed engineered constructs will
not survive the harsh mechanochemical environment within
the joint.
After implantation, engineered tissue, unlike native tis-
sue, must continue to grow in a chemical environment that
is likely to contain potent catabolic mediators stemming
1Department of Biomedical Engineering, Columbia University, New York, New York.
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from chronic joint inflammation or even from the surgical
intervention itself.9–12 Proinflammatory cytokines and their
receptors are present in increased concentrations in the sy-
novial fluid of human subjects with cartilage pathology.13–15
The catabolic effects of these mediators may be especially
pronounced in underdeveloped tissues16–18 whose cells are
not yet fully embedded in the potentially chondroprotective
enclosure of a cartilaginous extracellular matrix.19 There-
fore, treatments aimed at restoring damaged or diseased
cartilage must account for continued exposure to chemical
mediators. Animal studies testing tissue engineering strate-
gies are usually carried out using healthy animals, but this
is unlikely to be the case clinically. It is therefore important
to establish a system for predicting the functionality of en-
gineered tissue. We chose long-term cultures of chondrocyte-
seeded agarose constructs as our in vitro model, a system
with clear tissue engineering applications in which both
chemical and mechanical stimuli can be carefully controlled.
The culture system preserves the chondrocyte phenotype by
maintaining a physiologic three-dimensional environment
and produces a functional extracellular matrix20,21 with a
proteoglycan composition more similar to that of native
cartilage than that produced using other scaffold materials.22
Using this model, our laboratory has been able to develop
engineered constructs with functional material properties
similar to those of the native tissue, exhibiting both physi-
ologic levels of glycosaminoglycans (GAG) and Young’s
modulus.23 In the current study, the effects of interleukin-1a
(IL-1a), a chemical mediator, on the mechanical and bio-
chemical properties of engineered tissue at different devel-
opmental states were compared to those effects on the native
tissue. This interleukin isoform was studied because it is a
potent enhancer of transcription and translation of metallo-
proteinases that leads to increased proteolysis in vitro and
in vivo.24 In vitro, IL-1a has been shown to inhibit synthesis
of core proteins at low concentrations,25 and increase pro-
teolysis of cartilage (as well as rapid degradation) at high
concentrations.26 We hypothesized that the catabolic effects
of IL-1a decrease with construct maturation in culture.
MATERIALS AND METHODS
Experimental design
Three consecutive studies carried out are discussed in this
manuscript: study 1 directly compared the effects of IL-1a
on immature (day 14) engineered cartilage and freshly har-
vested (day 0) native cartilage cultured in a chemically de-
fined (CD) medium. The results of this study (the cytokine
had deleterious effects only on engineered cartilage and not
on native explants) were unexpected, and motivated studies
2 and 3.
The engineered cartilage as used in study 1 had not yet
developed the extracellular matrix present in native ex-
plants. We hypothesized that this matrix, in conjunction with
an antiinflammatory chemical mediator in the culture me-
dium (dexamethasone), was necessary to mitigate the effects
of the cytokine. Thus, study 2 examined the possible miti-
gating effects of an accumulated extracellular matrix on
engineered constructs that were precultured in CD medium
for different durations and challenged with IL-1a. Study 3
examined the culture media for antiinflammatory chemical
mediators. For convenience of presentation, it was split into
two parts: study 3a specifically tested whether it was the
inclusion of dexamethasone in the CD medium that coun-
teracted the catabolic effects of IL-1a on native explants
in study 1; study 3b extended these findings to engineered
cartilage at different levels of maturity, testing whether
the inclusion or exclusion of dexamethasone counteracts the
catabolic effects of IL-1a on engineered cartilage precul-
tured for different durations. Each study was performed
independently using explants from different animals or in-
dividual cell isolations pooled across several different ani-
mals, and repeated at least once to ensure repeatability.
The timelines of all three studies are detailed in Figure 1.
For study 1 (n¼ 6 per group) freshly harvested native car-
tilage explants (mid-zone only) or immature engineered
tissue (day 14) was cultured in a CD medium and challenged
for 14 days with IL-1a (10 ng/mL) (Fig. 1, study 1). For
study 2 (n¼ 5–8 per group) engineered constructs were
maintained in CD medium and challenged with IL-1a at
different developmental stages in culture. Specifically, at
14-day intervals the control group was divided and a subset
was exposed to 10 ng/mL IL-1a for 14 days. Similarly, half
the previous IL-1a group was tested and the remainder
cultured in CD medium without IL-1a for an additional 14
days (recovery group) (Fig. 1, study 2). For study 3a
(n¼ 10–18 per group) native explants were cultured for 14
days in CD medium (þ/) dexamethasone and (þ/) IL-1a.
For study 3b (n¼ 8 per group) engineered constructs were
precultured for 14 days with transforming growth factor
beta-3 (TGF-b3) and exposed thereafter to IL-1a at various
times in culture (days 14 and 28) as in study 2 but with the
modification that the culture medium did or did not include
dexamethasone.
Cell isolation
Articular cartilage was harvested from bovine carpome-
tacarpal (CMC) joints of freshly slaughtered 1–3-week-old
calves. Three to five joints were used for each study, and
cells were pooled from all joints. Explants (studies 1 and 3a)
were cored using a sterile disposable punch (Ø 4 mm; Mil-
tex, York, PA) and then sectioned using a custom device to a
final thickness of 2.3 mm, keeping the mid zone only. For
engineered tissue (studies 1, 2, and 3b), chunks of cartilage
were harvested, combined, and digested in Dulbecco’s
modified Eagle’s medium (DMEM) with 390 U/mL colla-
genase type VI (Sigma, St. Louis, MO) for 11 h at
378C with stirring. The resulting cell suspension was then
filtered through a 70-mm-pore-size mesh and sedimented in a
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bench-top centrifuge for 10 min at 1000 g. Viable cells were
counted using a hemacytometer and trypan blue. One vol-
ume of chondrocyte suspension (at 60106 cells/mL) was
then mixed with an equal volume of 4% low-melt agarose
(type VII, Sigma) at 378C to yield a final cell concentra-
tion of 30106 cells/mL in 2% agarose. The chondrocyte/
agarose mixture was cast into slabs and cored using a sterile
disposable punch (Miltex) to final dimensions of 4 mm di-
ameter and 2.3 mm thickness.
Growth medium
The growth medium was changed every other day and
consisted of high-glucose DMEM supplemented with
1PSF (100 units/mL Penicillin, 100 mg/mL Streptomycin,
and 0.25 mg/mL Fungizone), 0.1 mM dexamethasone, 50 mg/
mL ascorbate 2-phosphate, 40 mg/mL L-proline, 100 mg/mL
sodium pyruvate, and 1ITSþ premix (insulin, human
transferrin, and selenous acid; Becton Dickinson, Franklin
Lakes, NJ). For studies using engineered-tissue (studies 1,
2, and 3b), CD medium was further supplemented with
10 ng/mL of TGF-b3 (R&D Systems, Minneapolis, MN)
for the first 14 days of culture.
Material testing
Cylindrical constructs were tested for both their equilib-
rium Young’s modulus (EY) and their dynamic modulus
(G*) in unconfined compression using a custom computer-
controlled testing system.27 The equilibrium EY is com-
monly used as a measure of the behavior of cartilage that has
been allowed to reach equilibrium after a known load or
displacement has been applied. The dynamic modulus is
considered to be a more physiologically relevant measure-
ment as it measures the behavior of the tissue during the
application of cyclic loads and better captures fluid pres-
surization within the biphasic tissue. To measure EY an ini-
tial 0.02 N tare load was applied, followed by a compression
to 10% strain, at a strain rate of 0.05%/s. EY was calculated
from the equilibrium stress at 10% strain. Previous studies
have shown EY to remain invariant across strain magni-
tudes ranging from 0% to 20% for cartilage explants. G*
was measured after achieving stress-relaxation equilibrium
by superimposing a 2% peak-to-peak sinusoidal strain at
0.01 Hz.
Biochemical content
The biochemical content of each sample was assessed by
first measuring sample wet weight, lyophilizing for 24 h, and
then measuring the sample dry weight. Gross water content
was determined from the difference. Once dry, the samples
were digested in proteinase-K overnight at 568C, as de-
scribed previously.28 Aliquots of digest were analyzed for
GAG content using the 1,9-dimethylmethylene blue dye-
binding assay.29 A further aliquot was acid hydrolyzed in
12 N HCl at 1108C for 16 h, dried over NaOH, and re-
suspended in assay buffer.28 Ortho-hydroxyproline (OHP)
content was then determined via a colorimetric assay by
reaction with chloramine T and dimethylaminobenzalde-
hyde,30 scaled for microplates. OHP content was converted
to total collagen content using the conversion of 1:7.64 ratio
of OHP:collagen.31 Each biochemical constituent (GAG
and collagen) was normalized to tissue wet weight. For
study 3, media samples were retained and tested for matrix
metalloproteinases-1 (MMP-1) and MMP-3 by the Luminex
assay (R&D systems) according to manufacturer’s protocol.
FIG. 1. (Study 1) Either freshly harvested explants (day 0) or
engineered constructs (initially at day 14) were cultured for 14 days
in CD medium (þ/) IL-1a. (Study 2) Engineered constructs were
cultured in CD medium for 42 days. The control group was divided
at 14-day intervals, and a subset exposed to IL-1a for 14 days.
These constructs were then maintained without IL-1a for an ad-
ditional 14 days recovery group (Revry). (Study 3a) Explants
were cultured for 14 days in CD medium (þ/) IL-1a (as in study
1) but also (þ/) dexamethasone. (Study 3b) Engineered con-
structs were exposed to IL-1a at various times in culture as in
study 2 but with the additional modification that the culture me-
dium did or did not include dexamethasone.
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Statistics
Statistics were performed with the Statistica (Statsoft,
Tulsa, OK) software package. Each data point represents the
mean and standard deviation. Groups were examined for
significant differences by analysis of variance (a¼ 0.05),
with EY, G
*, GAG, or OHP as the dependent variable. Tu-
key’s honest significant difference post hoc tests were car-
ried out with a statistical significance set at p¼ 0.05.
RESULTS
Study 1
The effects of IL-1a on cartilage explants were different
from the effects of the same cytokines on immature en-
gineered cartilage (Study 1, Fig. 2). Whereas the mechan-
ical and biochemical properties of immature engineered
cartilage degraded swiftly in the presence of IL-1a, there
was no such degradation in explants cultured in the same
chemical conditions.
Explants. All explant groups (regardless of cytokine
treatment) cultured in CD medium developed significantly
higher EY (Fig. 2A) and G
* (Fig. 2B) but not GAG (Fig. 2C)
or collagen (Fig. 2D) by day 14 of culture compared to day 0
values (EY¼ 2247 447 kPa, G*¼ 23 3 MPa, GAG¼
8.3 2.4% wet weight [%ww], and collagen¼ 21.2
4.4%ww). Further, on day 14 there were no significant
differences between the control and the cytokine-treated
group (EY¼ 3411 335 kPa, G*¼ 31 3 MPa, GAG¼
12.4 1.4%ww, and collagen¼ 21.1 10%ww).
Engineered constructs. For engineered constructs the
control group developed significantly higher EY (Fig. 2E),
G* (Fig. 2F), GAG (Fig. 2G), and collagen (Fig. 2H) by day
28 of culture (EY¼ 547 14 kPa, G*¼ 1.75 0.25 MPa,
GAG¼ 5.64 0.83%ww, and collagen¼ 1.70 0.22%ww)
compared to day 14 values (EY¼ 144 8 kPa, G*¼ 0.8
0.1 MPa, GAG¼ 3.5 0.46%ww, and collagen¼ 0.56
0.53%ww). Contrary to the explant results detailed above,
cytokine treatment to engineered constructs resulted in sig-
nificant differences from the control and from the initial
day 14 values. By day 28 the IL-1a group (EY¼ 20 2 kPa,
G*¼ 0.19 0.02 MPa, GAG¼ 0.71 0.19%ww, and col-
lagen¼ 0.94 0.38%ww) had significantly lower EY, G*,
GAG, and collagen compared to the control. These values
were also significantly lower than initial day 14 values in EY,
G*, and GAG.
FIG. 2. (A, E) Equilibrium Young’s modulus, (B, F) dynamic modulus at 0.01 Hz, (C, G) GAG (% wet weight), and (D, H) collagen
(% wet weight) for explants (top row) or engineered constructs (bottom row) cultured for 14 days in CD medium (þ/) IL-1a. Dotted
line indicates initial value (day 0 for explants; day 14 for engineered constructs); horizontal shaded bar indicates standard deviation.
{p 0.05 for day 0 versus all other groups; *p 0.05 versus control; ^p 0.05 versus day 0; NS, not significant.
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Study 2
Engineered constructs subjected to IL-1a at early time
cultures (days 0 and 14) exhibited tissue degradation and
GAG loss that was not present in tissue subjected to IL-1a at
later time points (day 28) (Fig. 3). These degradative effects
appeared to be long term: discontinuation of IL-1a treatment
on engineered constructs (day 14 or 28) did not lead to re-
covery of tissue properties 14 days later (Fig. 3, recovery
group).
Engineered constructs cultured under control conditions
grew significantly in all values measured over the 42 day
culture period, increasing from day 0 values (EY¼ 9 1
kPa, G*¼ 0.04 0.01 MPa, GAG¼ 1.1 0.4%ww, and
collagen¼ 0.7 0.4%ww) to day 42 values (EY¼ 1312
70 kPa, G*¼ 5 0.01 MPa, GAG¼ 7.3 1.8%ww, and
collagen¼ 2.2 0.5%ww) for the control group. The day 14
IL-1a group had no significant differences to day 0 and was
significantly lower than the day 14 control group in all
values except collagen. The day 28 IL-1a group also had no
significant differences to day 0 and was significantly lower
than both day 14 and day 28 control in all values except
collagen. The day 42 IL-1a group, however, was signifi-
cantly higher than the day 28 control and further had no
significantly differences to the day 42 control group in all
values. The IL-1a recovery groups had no significant dif-
ferences to day 0 or to their preceding IL-1a groups at all
times measured (Fig. 3).
Study 3a
Explants (þ/) dexamethasone (þ/) IL-1a. Explants
cultured in the absence of dexamethasone (Fig. 4, nodex)
maintained initial day 0 values throughout the culture pe-
riod for all measurements assessed. Explants cultured in the
presence of dexamethasone (Fig. 4, dex) developed signifi-
cantly higher G*, but not EY, GAG, or collagen, than day 0
and nodex groups. These constructs also had significantly
higher EY and G
* than the nodexþ a group.
Explants challenged with IL-1a in the presence of dexa-
methasone (Fig. 4, dexþ a) did not develop any significant
differences from the dex-only group and similarly displayed
significantly higher properties when compared to the nodex
FIG. 3. (A) Equilibrium Young’s modulus, (B) dynamic modulus at 0.01 Hz, (C) GAG (% wet weight), and (D) collagen (% wet
weight) for engineered constructs. Subsets of control (solid lines) were challenged at each time point with IL-1a (dashed lines) and
subsequently allowed to recover without IL-1a (dotted lines). *p 0.05 versus control group at all time points other than day 0;
§p 0.05 versus previous time points within same group; NS, not significant.
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and nodexþ a groups. Explants challenged with IL-1a in
the absence of dexamethasone (Fig. 4, nodexþ a), however,
degraded significantly over the 14 days of culture, dropping
to 27% of the EY (Fig. 4A), 42% of the G
* (Fig. 4B), and
58% of the GAG (Fig. 4C), but with no significant differ-
ences in collagen (Fig. 4D) when compared to initial values.
Examination of the spent growth medium for matrix me-
tallopeptidase proteins revealed significantly higher MMP-3
but not MMP-1 in the nodexþ a group compared to all other
groups.
Study 3b
Engineered constructs (þ/) dexamethasone (þ/) IL-
1a over time. Engineered constructs cultured with dexa-
methasone grew significantly in all values measured over
the culture period, increasing from day 0 values EY¼ 10
 5 kPa, G*¼ 0.05 0.02 MPa, GAG¼ 0.6 0.2%ww, and
collagen¼ 0.0 0.2%ww, to EY ¼ 678 37 kPa, G*¼ 2.8
 0.08 MPa, GAG¼ 7.2 0.3%ww, and collagen¼ 3.0
0.6%ww by day 35 in culture (Fig. 5, dex control group).
Unlike native explants, engineered constructs cultured
without dexamethasone did not differ significantly from the
dex group at any time tested during culture, reaching the
following values by day 35 in culture (Fig. 5, nodex control
group): EY¼ 692 71 kPa, G*¼ 2.6 0.28 MPa, GAG¼
5.2 0.7%ww, and collagen¼ 5.2 1.9%ww.
The effect of IL-1a on engineered constructs was de-
pendent on both the amount of preculture time and the
presence or absence of dexamethasone in the culture me-
dium. Engineered constructs subjected to IL-1a starting on
day 14 of culture exhibited tissue degradation and GAG loss
by day 28 regardless of whether the culture medium con-
tained dexamethasone. Engineered constructs subjected to
IL-1a starting on day 28, however, exhibited tissue degra-
dation and GAG loss only when dexamethasone was absent
from the culture medium; in the presence of dexamethasone
these constructs did not differ significantly from IL-1a–free
controls (Fig. 5).
DISCUSSION
For the current studies, we adopted a CD medium that
has been used extensively by our laboratory for the culture
of chondrocyte-seeded agarose constructs; using this me-
dium formulation, we have been able to develop engineered
constructs with functional material properties similar to
FIG. 4. (A) Equilibrium Young’s modulus, (B) dynamic modulus at 0.01 Hz, (C) GAG, and (D) collagen (% wet weight) for explants
cultured for 14 days in CD medium (þ/) dexamethasone and (þ/) IL-1a. Dotted line indicates day 0 time point; horizontal shaded bar
indicates standard deviation. (E) MMP-1 and MMP-3 response in spent media with or without dexamethasone. {p< 0.05 vs.
nodexþ a; {p< 0.05 for groups with dex vs. groups without dex; §p< 0.05 vs. day 0; *p< 0.05 for nodexþ a vs. other groups.
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those of the native tissue. To our knowledge, this is the first
study that has examined the effects of an interleukin cy-
tokine on engineered cartilage constructs exhibiting both
physiologic levels of GAG and Young’s modulus.
Despite the varied experimental conditions in the litera-
ture, including differences in species and age and media
type, most studies have reported interleukin-induced deg-
radation of articular cartilage.16,17,19,32–37 However, under
the culture conditions of the current studies, we observed the
presence of a chondro-protective soluble mediator in the
culture medium that was able to suppress the interleukin-
induced matrix degradation effects, the most likely of which
was insulin or dexamethasone. Interestingly, the protective
effects of this mediator were realized only for engineered
cartilage constructs that were mature and exhibited native
levels of GAG content and corresponding material proper-
ties (Figs. 3 and 5). It should be noted that in discussing
maturity of engineered tissue we are not referring to cell age,
but rather to the development of functional properties and
extracellular matrix components relative to the native tissue.
In our studies both explants and cells were harvested from
immature tissue. Examining the effect of cell age on our
findings could be an interesting and clinically relevant future
study.
Explant studies in the literature have reported IL-1a–
induced tissue degradation in culture media that do not
include insulin or dexamethasone in their composi-
tion.16,17,19,32–37 Dexamethasone has been found to be a
potent antiinflammatory corticosteroid that has been well
documented to modulate the anabolic–catabolic activities of
explants. It was used here at a dose typically used for the
culture of mesenchymal stem cells and at the lower range of
that used clinically.14,38 The dose of interleukin was typical
for what is used in vitro,16,17,19,32–37 and high for what is used
in vivo.39–41 The results of studies 3a and 3b clearly identify
dexamethasone as the chondro-protective chemical mediator
FIG. 5. (A) Equilibrium Young’s modulus, (B) dynamic modulus at 0.01 Hz, (C) GAG (% wet weight), and (D) collagen
for engineered constructs cultured in CD medium with (dex) or without (nodex) dexamethasone. Subsets of control were challenged at
each time point with IL-1a (dexþ a or nodexþ a). *p< 0.05 vs. all groups in previous time point; §p< 0.05 vs. IL-1a free controls;
{p< 0.05 vs. day 35 dexþ a.
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in our culture medium, as both explants and engineered
constructs subjected to interleukin cytokine insult degrade in
the absence of dexamethasone (while in the continued pres-
ence of insulin). While the dependence on dexamethasone in
protection against interleukin appears similar for cartilage
explants and mature engineered constructs, the mechanism
affording this protection is unclear and may be different for
each. A case for differing mechanisms is supported by find-
ings that explants cultured in CD medium maintained stiff-
ness without dexamethasone or increased stiffness with
dexamethasone over the same free-swelling culture period
(study 3a), whereas engineered constructs exhibited similar
increases in stiffness in the absence or presence of dexa-
methasone. As such, disparities in the behavior of explants
and engineered cartilage to interleukin (with dexamethasone-
supplemented media) should be considered in the context of
this underlying difference.
The steric exclusion of interleukin from mature constructs
due to decreasing permeability with culture time associated
with increasing extracellular matrix density is unlikely to be
a key mechanism behind our maturation-dependent findings,
as the engineered tissues exhibit hydraulic permeabilities
that are still much higher than that for native cartilage (as
noted from the disparity in dynamic modulus); further, in-
terleukin has been shown to degrade explant tissue in the
absence of dexamethasone. Future studies will be required to
better understand whether cellular changes or changes to the
elaborated matrix with culture time, or both, are responsible
for this protective effect. One may speculate that freshly
digested cells are hypersensitive to interleukin and become
increasingly less so as constructs mature. Alternatively, one
can argue that changes in the extracellular environment offer
protection to interleukin in conjunction with dexamethasone
or insulin. From the current series of studies we can com-
ment on the latter.
In the field of cartilage tissue engineering, the ability to
generate constructs possessing native levels of collagen has
eluded researchers. Interestingly, the relatively low collagen
levels achieved in our studies (*10% of native levels with
long-term culture), while on par with the highest levels re-
ported in the literature for engineered cartilage, does not
generally appear to be the underlying cause for the lack of
protection afforded to engineered constructs compared to
native explants by dexamethasone. There is the possibility
of course that a requisite amount of collagen is necessary to
trigger the protection, or that the location and not the quan-
tity of collagen is the determining factor, especially if the
collagen is concentrated in and around the pericellular ma-
trix. We have previously reported local pericellular matrix
development with positive type VI collagen staining in our
chondrocyte-seeded constructs.42 Interleukin-1 treated aga-
rose cultures have been reported to respond with increased
sequestration and retention of type VI collagen in an ex-
panded microenvironment surrounding the chondrocytes,
suggesting a role for type VI collagen in the differentia-
tion of the pericellular microenvironment in vitro.43 The
presence of this pericellular matrix may affect how dexa-
methasone functions in apposition to the inflammatory cy-
tokine.
It is also possible that the dexamethasone effect is related
to tissue GAG levels present on the day the cytokine was
introduced. For example, in study 1 these levels were only
12% of the native tissue values on day 14 but already 70% of
those values on day 28; conversely, the collagen levels on
those 2 days were only 4% of the native tissue on day 14 and
still 10% on day 35. The mechanism behind the protective
effects of GAG in conjunction with dexamethasone might be
related to chondrocyte volume changes. Quinn et al.44 have
reported chondrocyte volume changes with culture time (as
well as GAG deposition) suggestive of alterations in volume
regulatory mechanisms. Additionally, the pools of GAGs in
the pericellular region and inter-territorial regions change
with culture time. We may therefore speculate that changes
to the local physical environment of the cell with matrix
elaboration that alter cell function may be important in our
observations. While our engineered tissues grow to resemble
native cartilage by its appearance, Young’s modulus, and
GAG levels, they begin with little or no extracellular matrix.
However, cell matrix elaboration is likely governed by a
negative feedback mechanism, where tissue metabolism de-
creases as the amount of existing matrix surrounding the cell
increases.45 As such, there is the potential therefore that the
IL-1a effects observed are mediated in part by variations in
the level of cell metabolism with culture. In this scenario, it
would be difficult to delineate if it is matrix amount or cell
metabolism or both that govern the culture time–dependent
variations in interleukin-induced effects.
By examining the response of the engineered tissue to IL-
1a at different levels of maturity as we have defined it, we
have drawn attention to important differences in engineered
cartilage and native cartilage that can have significant im-
pact on clinical success after implantation. The results of
study 1 show that engineered constructs subjected to IL-1a
at early culture time will not develop functional mechanical
properties even if IL-1a is removed from their culture en-
vironment (Study 1, Fig. 2). This implies that even transitory
exposure to chemical factors, which may arise from in-
flammatory responses resulting from surgery as an example,
could have long-lasting effects on the development of im-
mature tissue within the joint. The findings of this study
support the contention that engineered cartilage constructs
should be implanted when the tissue is more functionally
mature because the presence of an extracellular matrix may
not only protect cells mechanically, allowing the constructs
to better withstand the load bearing demands of the joint, but
also play a role in protecting the cells from chemical assault
such as the presence of inflammatory agents such as IL-1a.
Further, they point toward a need to assess engineered tissue
on multiple functional levels—both mechanically to assess
load-bearing capabilities in comparison to native tissue, as
well as biologically to assess chemical sensitivity in com-
parison to native tissue.
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a b s t r a c t
An interplay of mechanical and chemical factors is integral to cartilage maintenance and/or
degeneration. Interleukin-1 (IL-1) is a pro-inflammatory cytokine that is present at elevated
concentrations in osteoarthritic joints and initiates the rapid degradation of cartilage when cultured
in vitro. Several short-term studies have suggested that applied dynamic deformational loading may
have a protective effect against the catabolic actions of IL-1. In the current study, we examine whether
the long-term (42 days) application of dynamic deformational loading on chondrocyte-seeded agarose
constructs can mitigate these catabolic effects. Three studies were carried out using two IL-1 isoforms
(IL-1a and IL-1b) in chemically defined medium supplemented with a broad range of cytokine
concentrations and durations. Physiologic loading was unable to counteract the long-term catabolic
effects of IL-1 under any of the conditions tested, and in some cases led to further degeneration over
unloaded controls.
& 2008 Published by Elsevier Ltd.
1. Introduction
Articular cartilage is a specialized connective tissue that bears
load and reduces friction across moving joints. It is composed of
an extracellular matrix that contains no nerves or blood vessels
and relatively few cells. Once injured, articular cartilage does not
heal well, but often degenerates further, leading to pain and loss of
function (Hangody and Modis, 2006). Tissue engineering offers
great hope for expanding the range of treatment options by
generating healthy replacement cartilage from a combination of
isolated, living cells embedded in a scaffold carrier (Cima et al.,
1991; Capito and Spector, 2003; Hung et al., 2004; Giannoudis and
Pountos, 2005; Giannoni and Cancedda, 2006; Habibovic et al.,
2006; Raghunath et al., 2007; Schulz and Bader, 2007).
In order to function within a defect site an engineered implant
must have both the mechanical competency and the chemical
fortitude to survive and flourish within an environment that is
likely to contain potent catabolic mediators stemming from
chronic inflammation (van den Berg and Bresnihan, 1999; Schiff,
2000; Lotz, 2001; Smeets et al., 2003). Interleukin-1 (IL-1) is a
pro-inflammatory cytokine that has been shown to be elevated in
osteoarthritis (Towle et al., 1997) and leads to cartilage degrada-
tion in in vitro tests (Ratcliffe et al., 1986; Morales and Hascall,
1989; Temple et al., 2006). The catabolic effects of IL-1 may be
especially pronounced in underdeveloped engineered cartilage
(Xu et al., 1996; Cook et al., 2000; Rotter et al., 2005; Lima et al.,
2008), whose chondrocytes are not yet fully embedded in a dense
chondroprotective cartilaginous extracellular matrix (Li et al.,
2003).
As the interplay of mechanical and chemical factors is integral
to cartilage maintenance and/or degeneration, it motivates
researchers to examine the combined effects of chemical and
mechanical stimuli (Mauck et al., 2003a, b). The chondrocyte-
seeded agarose system has clear basic science and tissue-
engineering applications in which both chemical and mechanical
stimuli can be carefully controlled. Several short-term studies
using an agarose culture model have suggested that applied
loading may have a protective effect against the catabolic actions
of IL-1 (Gassner et al., 1999; Honda et al., 2000; Xu et al., 2000;
Agarwal et al., 2001; Chowdhury et al., 2001).
Chowdhury et al. (2001, 2003) have shown that dynamic
loading counteracts IL-1-induced increase of nitric oxide (NO)
and PGE2 in chondrocyte-seeded agarose constructs. Mio and
co-workers have reported that RNA expression of anabolic factors
(aggrecan and type II collagen) in chondrocyte-seeded agarose
constructs increases with application of dynamic loading for 24 h.
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Long-term culture of chondrocytes in agarose results in the
formation of a functional matrix (Buschmann et al., 1992, 1995)
and applied deformational loading can enhance development of
tissue properties (Mauck et al., 2000, 2003a, b; Lima et al., 2007).
The culture system preserves the chondrocyte phenotype by
maintaining a physiologic three-dimensional environment and
produces extracellular matrix components with a proteoglycan
composition and corresponding Young’s modulus similar to that
of native cartilage (Mouw et al., 2005).
In the current in vitro study, we examine the effects of IL-1 on
the mechanical and biochemical properties of engineered tissue
and explore whether the long-term application of physiological
levels of dynamic deformational loading on chondrocyte-seeded
agarose constructs can mitigate these effects.
2. Materials and methods
2.1. Experimental design
Three studies were carried out in this set of experiments. In Study 1 (n ¼ 5–7/
group), we establish a broad range of response by culturing constructs for 28 days
with or without dynamic deformational loading in a chemically defined (CD)
medium with one of two IL-1 isoforms (IL-1a and IL-1b, 10 ng/mL). Based on these
results, we selected the most potent isoform (IL-1a) for the remaining two studies.
In Study 2 (n ¼ 6–9/group), we examined the dependence on cytokine concentra-
tion by testing a logarithmic range from 0.01 to 10 ng/mL over 42 days in culture.
In Study 3 (n ¼ 8/group), we repeat the logarithmic range of concentrations;
however, we restrict IL-1 exposure to periods of deformational loading only. Thus,
in Study 3 IL-1 is present for 3 h/day (for both loaded and unloaded groups), while
in Studies 1 and 2 IL-1 is present 24 h/day. The timelines of the studies are detailed
in Fig. 1. Each study was performed independently, using individual cell isolations
pooled from different animals, and repeated twice. Values reported were averaged
across repeat studies.
2.2. Cell isolation
Articular cartilage was harvested from bovine carpo-metacarpal (CMC) joints
of freshly slaughtered 1–3-month-old calves. The cartilage tissue was digested in
high-glucose Dulbecco’s Modified Eagle’s Medium (hgDMEM, 7.5 mL/g) with
collagenase type IV (390 activity units/mL, Sigma, St. Louis, MO) for 11 h at 37 1C
with stirring. The resulting cell suspension was filtered, combined, and cast into
slabs with a final cell concentration of 30106 in 2% agarose (Type VII, Sigma). The
slabs were cored to final construct dimensions (+0.40.23 cm) and maintained
in culture in one of the two medium formulations (described below) for up to 42
days depending on the study (Fig. 1).
2.3. Growth medium
CD medium consisted of hgDMEM supplemented with 1PSF, 0.1mM
dexamethasone, 50mg/mL ascorbate 2-phosphate, 40mg/mL L-proline, 100mg/mL
sodium pyruvate, and 1X ITS+premix (insulin, human transferrin, and selenous
acid, Becton Dickinson, Franklin Lakes, NJ). CD medium was further supplemented
with 10 ng/mL of TGF-b3 (R&D Systems, Minneapolis, MN) for the first 14 days of
culture. All culture media was changed every other day. This protocol has been
shown to promote significant matrix elaboration that results in engineered tissue
with native equilibrium modulus and proteoglycan content (Lima et al., 2007). The
final mechanical and biochemical properties attained within the culture period
can vary depending on the cell isolation, as is typical of the native tissue.
2.4. Interleukin supplementation
In Study 1, cell-seeded agarose constructs were cultured for 14 days in CD
medium without IL-1. For the subsequent 14 days, constructs were exposed to
either IL-1a or IL-1b at 10 ng/mL and either dynamically loaded (DL) 3 h/day or
maintained in free swelling (FS). Mechanical testing and biochemical analysis was
carried out as described below on days 0, 14, and 28.
In Studies 2 and 3, constructs were cultured for 14 days in CD medium without
IL-1 as above. In Study 2, for the subsequent 28 days, the culture medium was
supplemented with 0.01, 0.1, 1, or 10 ng/mL IL-1a and constructs were loaded or
remained in FS. In Study 3, for the subsequent 28 days the constructs were exposed
to 0.1, 1, or 10 ng/mL IL-1a during loading times only (for 3 h/day both FS and DL
constructs were transferred to Petri dishes with new IL-1a-supplemented
medium). For concentrations and time-courses see Fig. 1.
2.5. Loading protocol
Dynamic sinusoidal strain was applied at 1 Hz, with a nominal amplitude of 5%
(10% peak-to-peak deformation) above a 10% tare strain, in unconfined compres-
sion with impermeable platens. Loading was applied continuously for 3 h/day, 5
days/week, beginning on day 14 (previously found to be optimal CD medium
formulations (Lima et al., 2007)). Built-in compliance in the loading devices
compensated for increasing stiffness in developing constructs, altering the load
and displacement profiles and circumventing platen lift-off through the entire
culture period as described previously (Lima et al., 2007).
2.6. Material testing
Cylindrical constructs were tested in unconfined compression using a custom
computer-controlled testing system (Soltz and Ateshian, 1998). Samples were
loaded to 10% strain at a strain rate of 0.05% strain/s, after an initial 0.02 N tare
load. After achieving stress–relaxation equilibrium, the unconfined compression
dynamic modulus G* was measured by superimposing 2% peak-to-peak sinusoidal
strain at 1 Hz.
2.7. Biochemical content
The biochemical content of each sample was assessed according to wet weight.
Samples were digested in proteinase-K overnight at 56 1C and analyzed for either
glycosaminoglycan (GAG) content using the 1,9-dimethylmethylene blue dye-
binding assay (Farndale et al., 1982) or ortho-hydroxyproline (OHP) content via a
colorimetric assay by reaction with chloramine-T and dimethylaminobenzalde-
hyde (Stegemann and Stalder, 1967), as described previously (Kelly et al.,
2005). Cell viability (not shown) was measured via Live/Dead assay (Invitrogen,
Carlsbad, CA).
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Fig. 1. Study 1: (testing IL-1 isoform dependence) tissue-engineered constructs
were cultured for 14 days in a CD medium supplemented with TGF-b3. For the
subsequent 14 days constructs were exposed to either IL-1a or IL-1b and either DL
3 h/day or maintained in FS without TGF-b3. Study 2: (testing IL-1 concentration):
constructs were cultured for 14 days in CD medium with TGF-b3 and for the next
28 days were exposed to IL-1a in a logarithmic range of concentrations (0, 0.01, 0.1,
1, or 10 ng/mL) with or without loading. Study 3 (testing IL-1 exposure time):
constructs were cultured as in Study 2, with the exception that IL-1a was added
only during loading periods (3 h/day).
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2.8. Histological analysis
Samples were fixed in acid formalin ethanol (Lin et al., 1997), paraffin
embedded, sectioned (8mm thick), and stained with safranin-O (1% in dH2O, pH 6.7)
to view proteoglycan distribution. To ensure consistency, all time points and
experimental groups were stained at the same time in a single batch, with native
explant groups serving as controls. Distribution of intensity across a section was
quantified using ImageJ (NIH). Gray scale intensity was normalized to mean
intensity at center of histological section for the ordinate and percentage across the
cross-section for the abscissa and averaged for all samples in each group.
2.9. Statistics
Statistics were performed with the Statistica (Statsoft, Tulsa, OK) software
package. Groups were examined for significant differences by two-way analysis of
variance (a ¼ 0.05) using Tukey’s honest significant difference test (HSD) with EY,
G*, GAG, or OHP as the dependent variable, and time in culture and loading
condition as the independent variables.
3. Results
3.1. Study 1 (testing medium and IL-1 isoform dependency)
All experimental groups cultured in CD medium without the
addition of IL-1 grew in culture, developing significant differences
in EY, G
*, and GAG by day 28 when compared to day 14 (Fig. 2A–C).
The application of dynamic loading resulted in significantly
increased mechanical properties (Fig. 2A and B) by day 28
compared to FS controls, but with no significant differences in
GAG (Fig. 2C) or collagen (not shown).
The presence of interleukin resulted in lower EY, G
*, and GAG
when compared to IL-1 free controls, regardless of the isoform
used (Fig. 2A and B). The application of dynamic loading did not
mitigate this effect; both the DL+IL-1a and the DL+IL-1b groups
developed no significant mechanical or biochemical differences
compared to the FS+IL-1a or the FS+IL-1b groups.
Between the two isoforms, IL-1a was the more potent; both
FS+IL-1a and DL+IL-1a were significantly lower in EY, G*, and
GAG compared to FS+IL-1b and DL+IL-1b, but there were no
significant differences in collagen values between the two groups
(not shown).
Safranin-O staining indicated clear differences between the
control groups and the cytokine-treated groups: whereas both FS
and DL control groups had a largely uniform distribution of
staining across their cross-sections, constructs that had been
treated with IL-1a or IL-1b had an uneven distribution of staining,
with the majority of GAG loss occurring at the periphery (Fig. 3).
3.2. Study 2 (testing the effect of IL-1a concentration)
All experimental groups cultured in CD medium without the
addition of IL-1 grew in culture, developing significant differences
in EY, G
*, and GAG at each time point tested (Fig. 4A–C).
The application of dynamic loading resulted in significantly
increased mechanical properties (Fig. 4A and B) compared to FS
controls by day 28. There continued to be a significant increase in
EY for the DL control by day 42, but with no further significant
changes in G*, GAG (Fig. 4B, C). Collagen values were unaffected by
supplementation with IL-1a (not shown).
Exposure to the cytokine seemed to have an all or nothing
effect. At concentrations above 0.01 ng/mL constructs did not
develop mechanical or biochemical properties above their day 14
values, with no significant differences between the treated groups.
This result was true regardless of whether constructs were
maintained in DL or FS culture. Exposure at the lowest dosage
tested (0.01 ng/mL) did not inhibit development, with no
significant differences from untreated controls on day 28 or 42
(Fig. 4). There were no detrimental effects on cell viability (not
shown) with any of the concentrations tested.
3.3. Study 3 (IL-1 added only during loading)
Similarly to Study 2, all experimental groups grew and
developed significant higher EY, G
* and GAG at each time point
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Fig. 2. (A) Equilibrium Young’s modulus, (B) dynamic modulus at 0.1 Hz and (C)
GAG (% wet weight) for tissue-engineered (TE) constructs cultured first in FS
culture (14 days) and then an additional 14 days in either FS or DL culture in CD
medium with IL-1a or IL-1b. Dotted line indicates day 14 time point. Horizontal
shaded bar indicates standard deviation. zpo0.05 vs. day 14, *po0.01 vs. FS or DL
control, +po0.03 for DL control vs. FS control, Bpo0.01 vs. IL-1b.
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tested during the 42-day culture period, and the application of
dynamic loading significantly increased EY and G
* compared to FS
controls by day 42 (not shown). The 3 h daily exposure to IL-1a at
0.1 and 1 ng/mL, however, did not result in significant mechanical
or biochemical differences from controls regardless of the dosage.
At the highest concentration (10 ng/mL), IL-1a did result in
significantly lower GAG and this was not counteracted by the
application of dynamic loading.
4. Discussion
The findings of the current set of studies suggest that
physiological loading is unable to counteract the long-term
catabolic effects of IL-1 in chondrocyte-seeded agarose constructs.
Under the conditions of this study, interleukin-induced tissue
degradation was apparent from the decreased material and
biochemical properties (but with no loss of cell viability) after
tissue treatment irrespective of the application of loading.
Conversely, the stimulatory effects of mechanical loading, in the
absence of IL-1, were noted by the significantly increased stiffness
of dynamically loaded constructs compared to FS constructs.
It was our goal to establish a controlled, long-term in vitro
model that approximates both the chemical and mechanical
environment within the joint. In Study 1, we attempted to
establish a broad foundation for this model by examining the
effect of dynamic deformational loading on constructs cultured in
a CD medium formulation and exposed to one of the two cytokine
conditions.
We adopted a dynamic deformational loading tissue culture
protocol that we have demonstrated to foster development
of functional tissue engineered (TE) cartilage (Lima et al., 2007).
This protocol is based on the sequential application of growth
factor (TGF-b3) followed by physiologic deformational loading
(i.e. loading is introduced starting at day 14 in culture when
TGF-b3 is discontinued). As such, we chose to introduce
interleukin treatment coincident with applied loading, either
during the 3 h-loading period (Study 3) or continuously in culture
(Study 1 and 2).
Similarly, both IL-1a and IL-1b isoforms have been widely used
as inducers of inflammation and degradation in experimental
models of osteoarthritis (Smith et al., 1991; Pattoli et al., 2005).
We found that IL-1a induced a stronger response than IL-1b in
our bovine chondrocytes-seeded agarose constructs; however,
the application of dynamic deformational loading did not
ameliorate these catabolic effects over the long-term with either
isoform.
Interestingly, the decrease in GAG content seemed greatest
at the periphery of the dynamically loaded and interleukin
(DL+IL-1a) group, indicating that dynamic loading may not only
fail to protect against degenerative effects, but also increase the
rate of matrix loss. There are a number of experimental
parameters to consider that together will modulate the degree
of cellular exposure to the inflammatory cytokine. These include
the concentration of IL-1, the day in culture that IL-1 was first
introduced, the total number of days of IL-1 treatment, and the
amount of time per day of IL-1 treatment. The application of
dynamic deformational loading may be yet another way to
modulate the degree of cellular exposure to the cytokine.
Theoretical analysis of dynamic deformational loading of
neutrally charged gels (such as agarose) predicts that loading
can lead to enhanced transport of solutes such as growth factors
and cytokines (Mauck et al., 2003a, b; Chahine et al., 2005). The
transient concentration of these solutes within the gel during
loading can even be enhanced to values many times above the
surrounding bathing solution. Thus, although the application of
dynamic deformational loading has clearly been shown to reduce
the catabolic response of chondrocytes in the short term—
reducing or abolishing IL-1b-induced release of NO and PGE2
(Chowdhury et al., 2001, 2006), we speculated that long-term
development may be inhibited by higher concentrations of the
cytokine within the gel.
We indirectly examined this possibility in Studies 2 and 3 by
modulating the dosage and exposure time of IL-1a. We anticipated
that the application of dynamic deformational loading at lower
concentrations would result in increased degradation of the
dynamically loaded group over the FS group, as these DL
constructs would be exposed to transitory spikes in the concen-
tration of IL-1 above that of FS. This was not the case. In Study 2,
modulating the concentration of IL-1 did not result in a gradient of
mechanical and biochemical properties, but instead had an equal
degradative effect at 0.1, 1, and 10 ng/mL and no effect at a 0.01 ng/
mL concentration. Thus, exposure to the cytokine seemed to have
an all or nothing effect once the cytokine dosage was above an
activation threshold.
We were interested to see if there was evidence in the
literature of an activation threshold beyond which further
increases in IL-1 concentration would not lead to further
ARTICLE IN PRESS
Fig. 3. Safranin-O staining for GAG comparing FS and DL constructs with IL-1a, IL-
1b, or as untreated control (Study 1, day 35, CD medium). Graph indicates gray
scale intensity normalized to mean intensity at the center of histological section
for the ordinate and percentage across the cross-section for the abscissa (each data
point represents 1% across). Boxes indicate the region used for quantification.
Graphs represent the average of four samples within each group.
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degradative response. In a study by Kuroki et al. (2005), canine
chondrocytes were cultured in agarose for 9 days in a serum-free
medium with a gradient of IL-1a and IL-1b concentrations (20, 50
and 100 ng/mL). They found all concentrations were equally
inhibitory as measured by RNA expression. Chowdhury et al.
(2001, 2006) also examined the short-term IL-1b response in
both bovine and human chondrocytes in agarose with a range
(0.1–100 ng/mL) of concentrations. They found that nitrite and
PGE2 production by bovine chondrocytes increased in a step-like
manner with increasing IL-1b concentrations, but that the human
response increased rapidly at 0.1 ng/mL with no further significant
increases at higher concentrations of cytokine. Thus, although the
evidence in the literature is somewhat mixed, the results of the
current investigation lead us to believe that transient increases
in IL-1a concentration due to loading are not in themselves
responsible for further cell-mediated catabolic degradation.
The transient concentration of cytokine may also be critical in
interpreting the results of Study 3, where IL-1a was included for
3 h/day. In this study there was little or no effect of the cytokine
regardless of the bathing concentration. Since the solutes take
time to diffuse through the scaffold, it is likely that the actual
cellular exposure to IL-1a was at a significantly lower concentra-
tion than the bathing medium due to the relatively short
treatment duration (3 h). This limited concentration and transient
exposure to the cytokine could account for the lack of cytokine-
induced tissue degradation. In an arthritic patient, exposure to
pro-inflammatory IL-1a within the joint is likely to be of a near
constant duration (as in Study 2) rather than transitory in nature
(as in Study 3) and at an average concentration of 0.17 ng/mL
(Marks and Donaldson, 2005; Pattoli et al., 2005).
It is important to note that results of the current experiments
differ from those in the literature that have reported protective
effects of applied loading on IL-1-treated chondrocyte constructs
(Chowdhury et al., 2001). In these earlier studies, experiments
were performed on agarose-encapsulated chondrocytes before
significant matrix was elaborated and for short culture durations,
whereas our study examined cultures grown as long as 42 days
with concomitant matrix elaboration and a much longer duration
of interleukin exposure. Differences in matrix composition
between engineered constructs can lead to disparities in the
manner in which IL-1, physical stimuli, or the combination of both
is presented to chondrocytes. At early time points in culture,
chondrocyte deformation is similar to that which is applied to the
agarose matrix, but in as little as 6 days cells can elaborate a
pericellular matrix that is stiffer than the surrounding hydrogel
matrix, shielding the chondrocytes from full deformation (Lee and
Bader, 1995). At later culture times, coalescence of an elaborated
matrix re-establishes loading-induced cell deformation in the
culture system (Guilak et al., 1995; Chahine et al., 2007). The
results of the current study suggest the application of dynamic
ARTICLE IN PRESS
Fig. 4. (A) Equilibrium Young’s modulus, (B) dynamic modulus at 0.1 Hz and (C) GAG (% wet weight) for constructs cultured first for 14 days in FS culture and then an
additional 14 days in either FS or DL culture in CD medium. DL groups were additionally exposed to IL-1a in a logarithmic range of concentrations (0, 0.01, 0.1, 1, or 10 ng/
mL). *po0.01 for vs. FS 0 and FS 0.01 on same day. ypo0.05 for FS on day 28 vs. DL on day 42. §po0.05 for day 42 groups vs. same groups on day 28.
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deformational loading is insufficient to protect against degrada-
tion over the long term.
A greater understanding of the potential interplay between
mechanical stimuli and cytokines may help to elucidate mechan-
isms that underlie cartilage degeneration in OA, including the
effects of load, pro-inflammatory cytokines, and their combina-
tion on both intact articular cartilage and on developing
engineered tissue. The findings of this study reject the hypothesis
that physiologic loading counteracts the catabolic effects of IL-1 in
chondrocyte-seeded agarose constructs.
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Abstract: Genipin is a naturally-derived biocompatible
cross-linking agent commonly used to generate three
dimensional tissue-engineered scaffolds or to fix biologi-
cally derived scaffolds prior to implantation. Here we pro-
pose a novel use for genipin as a long-term culture me-
dium supplement to promote cross-linking of de novo cell
products that are produced in engineered cartilage. We
hypothesize that the application of genipin will stabilize
the extracellular matrix components and increase the me-
chanical properties of developing engineered cartilage.
Chondrocytes encapsulated in agarose hydrogel (a neu-
trally charged polysaccharide scaffold that is unaffected by
genipin cross-linking) were cultured in a chemically-
defined growth medium that was supplemented with
varying concentrations of genipin (22 lM, 220 lM, 2200
lM) for various durations (continuous or intermittent). Tis-
sues developed significantly higher mechanical properties
(+28% dynamic modulus and +20% Young’s modulus) by
day 42 with genipin treatment compared to untreated con-
trols. These increases were not immediate, but presented
over culture time after genipin treatment. The genipin
treated groups were also more resistant to cytokine-
induced degradation with interleukin-1a; maintaining an
EY (+218%), G* (+390%) and glycosaminoglycan (GAG)
content (+477%) over genipin-untreated constructs sub-
jected to interleukin. We hypothesize two mechanisms
through which the physical enhancement of tissue proper-
ties may be fostered: (1) by cross-link mediated reorganiza-
tion and enhanced retention of cell-elaborated extracellular
matrix components, and (2) through reduction of the loss
of extracellular matrix components by increasing their re-
silience to catabolic degradation. These studies demon-
strate a potential use of genipin as a medium supplement
to develop enhanced engineered cartilage.  2008 Wiley
Periodicals, Inc. J Biomed Mater Res 91A: 692–700, 2009
Key words: cartilage tissue engineering; mechanical proper-
ties; cross-linking; ECM (extracellular matrix); cell culture
INTRODUCTION
Osteoarthritis (OA) is a common and painful dis-
order characterized by the degeneration of the artic-
ular surfaces of diarthrodial joints. One of the most
promising approaches to treat OA is the design of
engineered tissue that reproduces the functional
properties of healthy cartilage. This tissue engineer-
ing approach typically entails the use of living cells
embedded in a three-dimensional scaffold that is cul-
tured over time in a growth medium supplemented
with various physical or biological stimulants to en-
courage development.
Recently, our laboratory has been able to cultivate
engineered cartilage with an equilibrium modulus
(EY) and an glycosaminoglycan (GAG) content that
match the native tissue, using the temporal applica-
tion of growth factors over a 6-week culture period.1
While these findings are encouraging, the dynamic
modulus (G*) and the collagen content for these con-
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structs amount to less than a quarter of those of
native articular cartilage. Of the two mechanical
measurements, G*, which is correlated with the col-
lagen content, is considered to be more physiologi-
cally relevant as it measures the behavior of the tis-
sue during the application of cyclic loads and better
captures fluid pressurization within the biphasic tis-
sue. No group has currently been able to reproduce
native values of collagen regardless of the tissue en-
gineering strategy employed. Obtaining native val-
ues of G* and collagen therefore remains an impor-
tant but elusive challenge.
Cross-linking agents such as glutaraldehyde, form-
aldehyde, or epoxy are typically used to chemically
treat (or fix) devitalized xenografts and allografts to
reduce the immune rejection or the enzymatic degra-
dation that is typical of transplanted bioprostheses.2,3
Typically, however, cross-linking agents are lethal to
cells. The use of genipin, a naturally occurring cross-
linker with toxicity levels 10,000-fold less than glu-
taraldehyde,4 as a biocompatible and stable cross-
linker has been established by other groups5,6 and
this provides a promising new avenue to explore for
tissue engineering.
Genipin cross-linking works by forming intra- and
intermolecular cross-links of the amino residues on
tropocollagen or proteoglycan molecules. A modified
cyclic form of genipin can reside stably within the
extracellular network, adding bridges across adjacent
fibers. As such, previous groups have explored the
use of genipin as a onetime treatment to fix tissue
prior to implantation,7 for the assembly of tissue engi-
neering scaffolds prior to cell seeding,8,9 or to modu-
late the release of growth factors from degradable scaf-
folds or beads.5 Genipin has also been studied for its
anti-inflammatory effects, administered either directly
to different cell lines10,11 or orally to animals.12,13 More-
over, genipin cross-linking has been shown to affect
the mechanical properties of biological tissues, increas-
ing the tensile strength of bovine pericardium,14 por-
cine tendon,15 and type I collagen gels.16
Our laboratory uses agarose hydrogel as a scaffold
system for cartilage tissue engineering. This gel has
been used extensively in chondrocyte biology studies
and has shown some promise for tissue engineering
applications. Agarose is a neutrally charged polysac-
charide and as such is unaffected by genipin. How-
ever, the chondrocytes embedded in the gel elabo-
rate an extracellular matrix over time in culture
which exhibits amine groups that are subject to geni-
pin cross-linking. In this set of studies, we propose a
novel use for genipin: not as a scaffold cross-linker,
but as a medium supplement to promote cross-link-
ing of de novo cell products, as they are produced.
We hypothesize that the application of genipin will
stabilize the extracellular matrix components and
increase the mechanical properties of developing car-
tilaginous tissue in our agarose hydrogels. We
hypothesize two mechanisms through which the
physical enhancement of tissue properties is fos-
tered: (1) by reorganization and enhanced retention
of cell synthesized extracellular matrix components,
and (2) through reduction of the loss of extracellular
matrix components by increasing their resilience to
catabolic degradation.
MATERIALS AND METHODS
Both the concentration and duration of genipin were
modulated as variables in the current set of studies. In a
preliminary study, three concentrations of genipin were
examined to establish cell toxicity. Based on these results
the two most promising concentrations were selected for
use in long-term culture. In study 1, genipin was applied to
the culture medium continuously throughout the culture
duration. In study 2, genipin was applied to the culture me-
dium briefly (24 h) on selected days only. Finally, we exam-
ined one of our hypotheses for the mechanisms behind the
accumulated benefits in study 3 by perturbing the system
with the inflammatory cytokine interleukin-1a (IL-1a).
Cell isolation
Articular cartilage was harvested from bovine carpome-
tacarpal joints of freshly slaughtered 1–3-month-old calves.
Three to five joints were used for each study, and cells
were pooled from all joints. Each study was repeated at
least once with different cell isolations and the results
were combined and averaged. The sample size stated
before each study represents the combined number of
samples for all repeated studies. The cartilage tissue was
combined, weighed, and digested with type IV collagenase
(Sigma Chemicals, St. Louis, MO) for 11 h at 378C, with
stirring in high-glucose Dulbecco’s modified Eagle’s me-
dium (hgDMEM). Collagenase-supplemented medium
mixture was added at 7.5 mL/g of tissue, with the collage-
nase concentration normalized to 390 activity units/mL.
The resulting cell suspension was filtered through a 70-lm
pore size mesh and sedimented in a bench-top centrifuge
for 10 min at 1000g. Viable cells were counted using hema-
cytometer and trypan blue. One volume of chondrocyte
suspension (at 60 3 106 cells/mL) was then mixed with an
equal volume of 4% low-melt agarose (type VII; Sigma) at
378C to yield a final cell concentration of 30 3 106 in 2%
agarose. The chondrocyte/agarose mixture was cast into
slabs and cored using a sterile disposable punch (Miltex,
York, PA) to final dimensions of 0.4 cm diameter and 0.23 cm
thickness (0.029 cm3). Some bovine explants (used in the
preliminary study) were also cored from the original undi-
gested tissue and cut to the same dimensions (resulting in
midzone cartilage only).
Chemically defined cell culture
Constructs were maintained in serum-free growth me-
dium for up to 52 days (with variable genipin concentra-
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tions and time courses as illustrated in Fig. 1). The serum-
free growth medium for studies 1 and 2 consisted of
hgDMEM supplemented with 13 PSF (100 units/mL peni-
cillin, 100 lg/mL streptomycin, 0.25 lg/mL fungizone),
0.1 lM dexamethasone, 50 lg/mL ascorbate 2-phosphate,
40 lg/mL L-proline, 100 lg/mL sodium pyruvate, and 13
ITS þ premix (insulin, human transferrin, and selenous
acid; Becton Dickinson, Franklin Lakes, NJ). The growth
medium for study 3 was identical to the previous two
studies with the exception that beginning on day 42 dexa-
methasone supplementation was discontinued (it is a
known anti-inflammatory agent that interferes with IL-1a).
For all studies, growth medium was changed every 3 days
and supplemented additionally with 10 ng/mL TGF-b3
(R&D Systems, Minneapolis, MN) for the first 2 weeks of
culture.
Genipin supplementation
In the preliminary study, cell-seeded agarose constructs,
cell-free controls, and freshly harvested bovine explant car-
tilage were incubated in culture media supplemented with
0, 22, 220, 2200 lM of sterile genipin (Sigma-Aldrich) for
7 days. Mechanical testing and cell viability (using the mo-
lecular probes live/dead viability/cytotoxicity kit) was car-
ried out on days 0, 3, and 7. Based on these results, three
additional studies were performed. In study 1, constructs
were exposed to 0, 22, or 220 lM genipin continuously
throughout the 42-day culture period and tested on days
0, 14, and 42. In study 2, on days 13 and 41 a subset of the
genipin-free controls were isolated and exposed to genipin
for 24 h at the same concentrations as study 1. These con-
structs were tested immediately after 24 h of exposure
(days 14 and 42) and also 7 days after exposure (days 21
and 49). In study 3, constructs were exposed to 22 lM of
genipin (the low range reported in the literature14) from
days 42 to 49, after which genipin supplementation was
discontinued and the cross-linked constructs were chal-
lenged with IL-1a (10 ng/mL) for 3 days (until day 52).
For concentrations and time courses see Figure 1.
Material testing
Cylindrical constructs were tested for both their equilib-
rium Young’s modulus (EY) and their dynamic modulus
(G*) in unconfined compression using a custom computer-
controlled testing system.17 To measure EY an initial 0.02N
tare load was applied, followed by a compression to 10%
strain, at a strain rate of 0.05%/s. EY was calculated from
the equilibrium stress at 10% strain. Previous studies have
shown EY to remain invariant across strain magnitudes
ranging from 0 to 20% for cartilage explants. G* was meas-
ured after achieving stress-relaxation equilibrium by super-
imposing a 2% peak to peak sinusoidal strain at 0.1 Hz.
Biochemical content
The biochemical content of each sample was assessed by
first measuring the sample wet weight, lyophilizing over-
night, and measuring dry weight. Gross water content was
then determined from the difference. Once dried, the sam-
ples were digested in proteinase-K overnight at 568C, as
described previously.18 Aliquots of the digest were ana-
lyzed for GAG content using the 1,9-dimethylmethylene
blue dye-binding assay.19,20 Additional aliquots were ana-
lyzed for DNA content using the PicoGreen assay. A fur-
ther aliquot was acid hydrolyzed in 12N HCl at 1108C for
16 h, dried over NaOH, and resuspended in assay buffer
(24 mM citric acid monohydrate, 0.012 v/v glacial acetic
acid, 85 mM sodium acetate trihydrate, 85 mM sodium hy-
droxide, pH 6.0). Ortho-hydroxyproline (OHP) content
was then determined via a colorimetric assay by reaction
with chloramine T and dimethylaminobenzaldehyde,21
scaled for microplates. OHP content was converted to total
collagen content using the conversion of 1:10 ratio of
OHP:Collagen. Each biochemical constituent (DNA, GAG,
and collagen) was then normalized to the tissue wet
weight to correct for differences in construct size.
Statistical analysis
Statistics were performed with the Statistica (Statsoft,
Tulsa, OK) software package. Each data point represents
the mean and standard deviation. Groups were examined
for significant differences by analysis of variance (a 5
0.05), with EY, G*, GAG, or OHP as the dependent vari-
able. Tukey’s Honest Significant Difference Test for
unequal n post hoc tests were carried out with a statistical
significance set at p 5 0.05.
RESULTS
For the preliminary study, live/dead assays estab-
lished that after 7 days of continuous supplementa-
tion there were no differences in cell mortality from
the genipin-free control for both the 22 and 220 lM
genipin groups (>98% cells vital); however, there
was complete cell death in the same period for the
2200 lM group (Fig. 2). There were no differences in
the mechanical properties (EY, G*) of these tissue-
engineered constructs at any concentration tested
(EY 5 11 6 1 kPa, G* at 0.1 Hz 5 0.07 6 0.01 MPa).
Likewise there were no changes in the mechanical
properties or visual appearance of the cell-free aga-
rose scaffolds.
Explant cartilage treated with genipin became
dark purple over a 24-h period, but just as in the
case of tissue-engineered constructs, the mechanical
properties of genipin-treated explants were found to
be identical to untreated controls (EY 5 1011 6
97 kPa, G* at 0.1 Hz 5 13 6 1.3 MPa). From these
results, only the 22 and 220 lM concentrations were
deemed suitable for long-term culture and the high-
est concentration (2200 lM) was eliminated.
In study 1, live/dead assays carried out after
42 days of continuous incubation in genipin con-
firmed no change in cell viability compared with
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untreated controls using these concentrations (data
not shown). The mechanical properties and the
physical appearance of the constructs treated with
genipin were significantly different from controls.
Engineered constructs turned purple with the addi-
tion of genipin, with higher concentrations of geni-
pin yielding greater intensities of purple (Fig. 3).
This change in color is characteristic of genipin as it
spontaneously reacts with the amine groups and
indicates cross-linking. In study 2, BE groups (con-
structs were removed from genipin 24 h after expo-
sure and cultured in genipin-free growth medium)
visually maintained the intensity of color for the 7
days tested (data not shown). Genipin-supplemented
culture medium also turned purple, even when there
were no constructs present, suggesting that constitu-
ents within the aqueous formulation were being
cross-linked.
By day 42 in culture the mechanical properties of
the continuous exposure (CE) groups were as fol-
lows: both CE controls (EY 5 788 6 63 kPa, G* 5 2.5 6
0.5 MPa) and CE 22 lM (EY 5 873 6 92 kPa, G* 5
3.2 6 0.2 MPa) developed significantly higher
mechanical properties over time in culture (study 1,
Fig. 4). The G*, in particular, was significantly higher
for the CE 22 lM group than the control group, but
the CE 220 lM group, in contrast, remained at day 0
mechanical properties (EY 5 23 6 22 kPa, G* 5 0.3
6 0.03 MPa). Cell viability assays of this group indi-
cated the cells remained alive while PicoGreen
assays indicated no differences in cell proliferation
over other groups. GAG and collagen levels
increased significantly over time in culture for all
groups; however, total GAG values for the CE 220 lM
group was significantly less than the CE 22 lM and
control groups.
For brief exposure (BE) groups (24-h duration,
study 2), there were no significant differences in me-
chanical properties from controls immediately after
24-h incubation (day 42: BE 22 lM: EY 5 790 6 60 kPa,
G* 5 2.7 6 0.2 MPa; BE 220 lM: EY 5 739 6 69 kPa,
G* 5 2.6 6 0.3 MPa); however, after 7 days of cul-
ture without genipin these groups developed signifi-
cantly higher mechanical properties compared with
Figure 2. Cell viability staining after 7-day continuous incubation in genipin-supplemented media at four genipin con-
centrations: (A) 0 lM, (B) 22 lM, (C) 220 lM, and (D) 2200 lM. Bright green indicates living cells. Dim red indicates
dead cells. Scale bar 5 250 lm. [Color figure can be viewed in the online issue, which is available at www.interscience.
wiley.com.]
Figure 1. Schematic of genipin exposure over culture pe-
riod. Control groups were not exposed to genipin. Study 1:
Constructs were exposed to genipin continuously (continu-
ous exposure) in the culture medium. Study 2: Constructs
were exposed to genipin for 24 h only (brief exposure) and
tested 1 and 7 days later. Study 3: On day 42, dexametha-
sone was removed from the culture medium and con-
structs were exposed to genipin continuously for 1 week
prior to a 3-day interleukin-1a (IL-1a) challenge. [Color
figure can be viewed in the online issue, which is available
at www.interscience.wiley.com.]
Figure 3. Gross morphology of tissue engineered cylin-
drical constructs on day 42 after continuous incubation in
genipin-supplemented media at three concentrations: (A) 0
lM, (B) 22 lM, and (C) 220 lM. The tissue volume at the
lower concentrations has increased by 20–30% compared
with the 220 lM concentration which remained at the orig-
inal volume. Scale bar 5 1 mm. [Color figure can be
viewed in the online issue, which is available at www.
interscience.wiley.com.]
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controls (day 49: BE Control: EY 5 1068 6 123 kPa,
G* 5 3.4 6 0.43 MPa; BE 22 lM: EY 5 1279 6 214
kPa, G* 5 4.02 6 0.9 MPa; BE 220 lM: EY 5 1200 6
128 kPa, G* 5 3.5 6 0.5 MPa). There were no differ-
ences in GAG and collagen between the day 42 and
day 49 groups (Fig. 5).
Since the culture medium itself changed colors
when exposed to genipin it is possible that genipin
cross-links constituents within the culture medium
and diluted the dose that was delivered to the con-
structs. To account for this possibility, a separate
study (not shown) was carried out in which con-
structs were bathed briefly (1–3 h) in genipin-supple-
mented phosphate-buffered saline (PBS) and subse-
quently returned to genipin-free culture medium.
The results using this protocol were consistent with
those observed in study 2 with direct medium sup-
plementation for 24 h.
In study 3, constructs treated with IL-1a (and not
genipin) dropped significantly in EY (269%), G*
(286%), and GAG (281%), but not collagen (Fig. 6).
The genipin þ IL-1a group also developed signifi-
cantly lower EY (233%), G* (244%), but interestingly
GAG values did not measurably change compared
with controls. Collagen values, similarly, did not
change significantly. When compared with the IL-1a
group, the genipin þ IL-1a group maintained signifi-
cantly higher EY (þ218%), G* (þ390%), and GAG
(þ477%). Figure 6 presents these values normalized
to controls for comparison; the actual values
obtained on day 52 were as follows: Control: EY 5
640 6 88 kPa, G* 5 2.90 6 0.35 MPa, GAG 5 6.6% 6
0.2% (ww), Col 5 2.33% 6 0.2% (ww); Genipin-
treated control: EY 5 731 6 134 kPa, G* 5 2.74 6
0.41 MPa, GAG 5 6.8% 6 0.3% (ww), Col 5 2.3% 6
0.3% (ww); IL-1a treated: EY 5 197 6 10 kPa, G* 5
0.34 6 0.01 MPa, GAG 5 1.3% 6 0.5% (ww), Col 5
3.1% 6 0.5% (ww); and genipin þ IL-1a treated:
EY 5 431 6 47 kPa, G* 5 1.34 6 0.07 MPa, GAG 5
6.1% 6 0.8% (ww), Col 5 3.8% 6 0.4% (ww).
DISCUSSION
The hypothesis governing this set of studies was
that genipin would cross-link the extracellular matrix
within the developing engineered constructs as the
extracellular matrix proteins are produced and
would thereby increase the mechanical properties of
the constructs over time. The fundamental premise
of the hypothesis was supported: there were
increases in mechanical properties without signifi-
cant changes in cell viability or biochemical quanti-
ties of GAG or collagen, suggesting a genipin-
induced enhancement of tissue stiffness.
There is no established concentration for the use
of genipin; therefore in the current set of studies we
used values that span both the low (22 lM14) and
high (2000 lM16) range reported in the literature.
Figure 4. Equilibrium Young’s modulus (EY), dynamic modulus at 0.1 Hz (G*), GAG (%ww), and collagen (%ww)
of constructs incubated in genipin continuously throughout the culture period. CE, continuous exposure. *p < 0.05 for con-
trol versus genipin groups. §p < 0.05 against all groups in the previous time points. **p < 0.05 for 220 lM versus other
day 42 groups.
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Figure 6. Equilibrium Young’s modulus (EY), dynamic modulus at 0.1 Hz (G*), GAG (%ww), and collagen (%ww) of
constructs challenged with IL-1a for 3 days. Values are normalized to day 49 controls. *p < 0.05 against either control
group. þp < 0.05 for Genipin þ IL-1a versus IL-1a group.
Figure 5. Equilibrium Young’s modulus (EY), dynamic modulus at 0.1 Hz (G*), GAG (%ww), and collagen (%ww) of
constructs incubated for 24 h in genipin (on days 13 and 41). A subset of untreated control was used at each treatment
point. BE, brief exposure. §p < 0.05 against all groups in the previous time points. *p < 0.05 for control versus genipin
groups. **p < 0.05 for control versus 22 lM group. þp < 0.05 for BE 220 lM versus other day 21 groups.
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Additionally, we adopted two durations for medium
supplementation—continuous and intermittent sup-
plementation of genipin. The toxicity of genipin
when supplemented directly to the culture medium
was found to be dependent on both dose and dura-
tion of exposure. Long-term CE (study 1) was lethal
at 2200 lM, detrimental (but not lethal) at 220 lM,
and beneficial at 22 lM. Short-term exposure (study
2) at 220 and 22 lM on the other hand was sufficient
to obtain the benefits on the tissue level without the
detrimental effects on the cellular level.
In both long-term and short-term exposure proto-
cols we observed similar increases in mechanical
properties over time in culture, but in both cases
these benefits did not occur until later time points.
This suggests that the tissue must reach some degree
of extracellular maturity prior to genipin treatment.
It also suggests that prolonged medium supplemen-
tation is probably unnecessary, but that BE, in
growth medium or in PBS, followed by continuing
cultivation may be the best method to realize the
benefits of biocompatible cross-linking.
It is notable that genipin-induced changes did not
occur immediately but took several days to manifest
(Fig. 5). Initially we believed this was due to the na-
ture of the agarose hydrogel scaffold. However, we
found that there were similarly no immediate
changes to native cartilage explant mechanical prop-
erties when exposed to the same concentrations of
genipin. Together these observations indicate that
the increased stiffness of the constructs is not due
directly to physical strengthening of the extracellular
network via genipin cross-links, but it is attributable
to other mechanisms that lead to a cumulative
increase of tissue properties over time.
One possibility is that genipin directly affected cell
metabolism in addition to cross-linking the extracel-
lular matrix. There have been no studies reported on
the effect of genipin on chondrocytes specifically,
but there is evidence that genipin suppresses cell
proliferation and alters RNA activity in subconjuncti-
val fibroblast10 and some epithelial cell lines.11 There
was no decrease in cell proliferation in the current
set of studies as confirmed by PicoGreen DNA quan-
tification (not shown). Likewise, there were no sig-
nificant differences in matrix accumulation of GAG
or collagen over time. Additionally, we examined
the effect of genipin on chondrocytes cultured on tis-
sue culture plates and found no significant differen-
ces on cell proliferation and cell morphology after
14 days of CE at 22 lM (results not shown); there-
fore, we do not believe that alterations in cell metab-
olism were the main cause for the increased mechan-
ical properties observed.
Instead, we speculate that the presence of cross-
links may have modulated the nature of subsequent
matrix deposition by the chondrocytes, either by
leading to a more consistent fiber alignment for geni-
pin-treated constructs relative to untreated controls,
or by reducing the catabolic loss of matrix compo-
nents as suggested by study 3.
Chondrocytes in culture balance catabolic and ana-
bolic activities to remodel their surrounding extracel-
lular matrix. By challenging the chondrocytes with
IL-1a (study 3) we artificially amplified the catabolic
process. Cross-linking has been shown to increase
resistance to enzymatic degradation through collage-
nase digestion.2,4,22,23 We have previously observed
that in our culture system IL-1a triggers a rapid loss
in GAG content, along with higher matrix metallo-
proteinase-3 levels, but with no significant changes
in collagen content within the first 14 days of treat-
ment.24,25 Here we observed that indeed the extracel-
lular matrix degraded less after pretreatment with
genipin, demonstrating an increased resilience to
degradation through cell-mediated processes. Geni-
pin cross-linking may have led to mechanical bene-
fits over time by increasing the chemical resistance
of a variety of extracellular matrix components, such
as GAG, to catabolism associated with normal ma-
trix remodeling. Interestingly, although the mechani-
cal properties of these genipin treated tissues
dropped with exposure to IL-1a, their GAG values
remained unchanged. This suggests that some other,
as of yet unmeasured matrix constituent was
affected by the cytokine and responsible for the
decreased construct stiffness. Alternatively, as we
have not analyzed the size of GAGs that are retained
in genipin-treated constructs subjected to interleukin
(and compared to control) we could speculate that
GAGs were indeed broken down and their interrela-
tionship with the collagen network disrupted, lead-
ing to the observed significant decrease in functional
material properties. In this scenario, GAG and colla-
gen content may not have changed because the geni-
pin cross-links entrapped the degradative products
within the construct rather than permit them to dif-
fuse into the culture medium.
As a corollary to study 3, genipin treatments, as
described in this article, may be useful to reduce the
inflammatory response of the engineered tissue
upon implantation. Implanting allogenic tissue in the
body generally invokes an immune reaction except
for certain immunologically privileged area26 such as
the eye and the brain. Allogenic chondrocytes are
considered to be to some degree immunoprivi-
leged,27,28 because they reside within a dense extrac-
ellular matrix that is not vascularized and, therefore,
has less interaction with blood born leukocytes.
Even so, the presence of extracellular matrix constit-
uents, such as collagen, can themselves invoke an
immune reaction29 and can lead to the rejection and
degradation of the allograft within the joint.30,31 The
immunologic reactivity and susceptibility of grafts
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appear to be inversely related to the amount and
maturity of cartilage-specific extracellular matrix
present.32 Reducing the number of free amino resi-
dues in the collagen through various cross-linking
methods, such as genipin, has been shown to reduce
the antigenicity of the resulting tissue.33,34
Inflammatory cytokines, such as interleukin-1a,
are often present in the joint, either as preexisting
chronic condition or as a result of the surgical inter-
vention itself.35–38 Previously we have shown that
engineered cartilage can be more susceptible to deg-
radation by these cytokines than mature endogenous
cartilage.24 In those studies, engineered tissue that
was exposed temporarily to IL-1a stopped growing,
catabolically degraded the surrounding extracellular
matrix, and did not recover. In study 3 genipin mod-
ification of the tissue resulted in increased resistance
to IL-1a degradation. This result suggests a mecha-
nism by which the tissue developed higher mechani-
cal properties over time and that it might provide a
means to protect the tissue from transient insults of
inflammatory cytokines during or after surgery.
In summary, genipin supplementation of the cul-
ture medium as described here led to significant
increases over control in both the dynamic (þ28%)
and Young’s (þ20%) modulus. This demonstrates
the potential for long-term gains in mechanical prop-
erties using biocompatible cross-linking agents as
direct medium supplements. However, considering
that the magnitude of the findings were relatively
incremental in the context of the dynamic modulus
value for native articular cartilage (4 MPa vs. 20–40
MPa for explants25) the most clinically relevant find-
ing may be the potential reduction in antigenicity
and the increased resistance to enzymatic degrada-
tion with genipin treatment. This approach warrants
further investigation toward optimizing effects of
genipin on engineered constructs used in vivo.
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MSC mesenchymal stem cell
SDSC synovium-derived stem cell
bMSC bone marrow-derived stem cell
AQP aquaporin
HIF hypoxia-inducible factor
Cytokines and Growth Factors
IL interleukin
TNF tumor necrosis factor
TGF transforming growth factor
FGF fibroblast growth factor
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PDGF platelet derived growth factor
Medium Components
DMEM Dulbecco’s Modified Eagle’s Medium
CM chondrogenic Medium
FBS fetal bovine serum
